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ABSTRACT
Surfaces modulate β-amyloid peptide aggregation
associated with Alzheimer’s disease
by
Elizabeth Anne Yates
A hallmark of Alzheimer's disease, a late onset neurodegenerative
disease, is the presence of neuritic amyloid plaques deposited within the brain
composed of β-amyloid (Aβ) peptide aggregates. Aβ can aggregate into a variety
of polymorphic aggregate structures under different chemical environments,
specifically affected by the presence of differing surfaces. There are several
point mutations clustered around the central hydrophobic core of Aβ (E22G Arctic
mutation, E22K Italian mutation, D23N Iowa mutation, and A21G Flemish
mutation).

These mutations are associated with hereditary diseases ranging

from almost pure cerebral amyloid angiopathy to typical Alzheimer’s disease
pathology with both plaques and tangles. To determine how these different point
mutations, which modify both peptide charge and hydrophobic character, altered
Aβ aggregation and morphology under free solution conditions, at an anionic
surface/liquid interface and in the presence of supported lipid bilayers, atomic
force microscopy was used.

Additionally, the non-native conformation of Aβ

leads to the formation of nanoscale, toxic aggregates which have been shown to
strongly interact with supported lipid bilayers, which may represent a key step in
potential toxic mechanisms. Understanding how specific regions of Aβ regulate
its aggregation in the absence and presence of surfaces can provide insight into
the fundamental interaction of Aβ with cellular surfaces. Specific fragments of Aβ
(Aβ1-11, Aβ1-28, Aβ10-26, Aβ12-24, Aβ16-22, Aβ22-35, and Aβ1-40), represent a variety of
chemically unique regions along Aβ, i.e., the extracellular domain, the central
hydrophobic core, and transmembrane domain. Using various scanning probe
microscopic techniques, the interaction of these Aβ sequences with lipid

membranes was shown to alter aggregate morphology and induce mechanical
changes of lipid bilayers compared to aggregates formed under free solution
conditions. Lastly, in order to determine how chemical environment can lead to
distinct polymorph fibril formation influencing disease pathology, various peptide
preparation and fibril growth conditions of Aβ were studied in free solution and
with a model lipid membrane.
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1. Introduction: Surfaces, including lipid membranes, modulate
protein aggregation associated with Alzheimer’s disease

There are a vast number of neurodegenerative diseases associated with
the rearrangement of specific proteins to non-native conformations that promote
aggregation and deposition within tissues and/or cellular compartments. The
interaction of such proteins with liquid/surface interfaces is a fundamental
phenomenon with potential implications for protein misfolding diseases. Kinetic
and thermodynamic studies indicate that significant conformational changes can
be induced in proteins encountering surfaces, which can play a critical role in
nucleating aggregate formation or stabilizing specific aggregation states.
Surfaces of particular interest in neurodegenerative diseases are cellular and
subcellular membranes that are predominately comprised of lipid components.
The two-dimensional liquid environments provided by lipid bilayers can
profoundly alter protein structure and dynamics by both specific and nonspecific
interactions. Importantly for misfolding diseases, these bilayer properties can not
only modulate protein conformation, but also exert influence on aggregation
state. A detailed understanding of the influence of (sub)cellular surfaces in
driving protein aggregation and/or stabilizing specific aggregate forms could
provide new insights into toxic mechanisms associated with these diseases. The
influence of surfaces in driving and stabilizing protein aggregation with a specific
emphasis on lipid membranes will be discussed in this introductory chapter.
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aggregation associated with Alzheimer’s disease
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1.1 Protein aggregation
A common motif of several neurodegenerative diseases is the ordered
aggregation of specific proteins, leading to their deposition in tissues or cellular
compartments.1 Often referred to as protein conformational or misfolding
disorders, such diseases include Alzheimer’s disease (AD), Parkinson’s disease
(PD), Huntington's disease (HD), amyloidoses, a1-antitrypsin deficiency, and the
prion encephalopathies to name a few. The common structural motif of protein
aggregates associated with these diseases is the formation of extended, β-sheetrich proteinaceous fibrillar aggregates that are commonly referred to as
amyloids.2 Despite no apparent correlation between aggregating proteins in size
or primary amino acid sequence, the characteristic lesions of each disease
typically contain fibrillar structures with common biochemical characteristics,1,3
indicating the potential for a conserved mechanism of pathogenesis linking these
phenotypically diverse diseases. The earliest potential event in the disease
process may be the conversion of a protein to a critical abnormal conformation,
resulting in toxic gain of function for the monomer, and/or the formation of toxic
nanoscale aggregates (Figure 1.1). The elusive toxic species along the
aggregation pathway whether monomeric or higher-order, may subsequently
initiate a cascade of pathogenic protein-protein interactions that culminate in
neuronal dysfunction. The precise timing of such interactions and the
mechanisms by which altered protein conformations or aggregates trigger
neuronal dysfunction are unclear.
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The formation of fibrils is complex, often proceeding via a heterogeneous
mixture of metastable intermediate aggregate structures associated with the
fibrillization pathway,4 including a variety of protofibrils and globular oligomers
(Figure 1.1). To further complicate the issue, several aggregates have been
identified that may be off-pathway to fibril formation, such as annular structures.
While there are often specific mutations or dysfunctional processing that can be

Figure 1.1: A generic aggregation scheme for amyloid-forming proteins. Proteins
fold into their native structure, which is typically a low free energy configuration.
However, the energy landscape for protein folding often can have localized minima in
which a protein can become trapped into a misfolded conformation, which can lead to
aggregation into β-sheet rich amyloid fibrils. The formation of fibrils often proceeds
through a heterogeneous mixture of intermediate species, including oligomers and
protofibrils. Off-pathway aggregates can also form, such as annular aggregates.
These aggregates accumulate into amyloid plaques or inclusions in the diseased
brain. The aggregation pathway for any given amyloid-forming protein can vary
considerably depending on the protein and its folding environment.

1. Introduction: Surfaces, including lipid membranes, modulate protein
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directly linked to aggregation, the nature and location of protein aggregates in
vivo depends on the specific protein associated with disease. As protein
aggregation often progresses from misfolded monomers to oligomeric precursors
and finally mature fibrils, intensive research activity has been devoted to
determining the most toxically relevant aggregate species in many of these
diseases. This is particularly important, as for the vast majority of these diseases,
there are no widely effective preventative measures or therapeutic treatments.

1.2 Alzheimer’s disease and β-amyloid
The neuropathological and neurochemical hallmarks of AD include:
synaptic loss and selective neuronal cell death; decreases in markers for certain
neurotransmitters;

and

abnormalities

in

neurons

and

their

processes

(neurofibrillary tangles comprised of Tau and dystrophic neurites) as well as in
the extracellular space (cerebrovascular, diffuse, and neuritic plaques

-

composed predominantly of the amyloidogenic peptide Aβ).5,6 β-amyloid (Aβ) is
formed by endoproteolytic cleavage of a single-transmembrane, receptor-like
protein termed the β-amyloid precursor protein (APP), a transmembrane protein
containing 677-770 amino acids encoded by a gene on chromosome 21 (Figure
1.2A). The primary function of APP is unknown, although it has been implicated
in synapse dysfunction and is critical in the pathogenesis of AD.7 Successive
cleavage by β-secretase and g-secretase results in the release of an intact
monomeric, soluble Aβ peptide (Figure 1.2B). Aβ contains a portion of APP's
transmembrane domain, as well as an extracellular portion, resulting in an

1. Introduction: Surfaces, including lipid membranes, modulate protein
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amphipathic peptide ~39-43 residues in length. The C-terminus of Aβ is
hydrophobic representing the transmembrane domain, while the N-terminus is
predominantly hydrophilic representing the extracellular domain (Figure 1.3). Aβ
is thought to be intrinsically unstructured, meaning it lacks stable tertiary

Figure 1.2: Schematic of the proteolytic processing pathway that leads APP to
the formation of Aβ . (A) The schematic structure of the transmembrane protein APP
is shown with the Aβ region in light blue. (B) The two major cleavage sites (βsecretase in the extracellular domain and g-secretase in the transmembrane region)
indicated in red, generate an intact Aβ fragment.

structure and is considered to be random coil. All AD patients develop neuritic
plaques in brain regions subserving memory and cognition. These plaques are a
hallmark of AD and consist of extracellular masses of Aβ filaments and other
plaque associated proteins (e.g. apolipoprotein E (apoE), apolipoprotein J (apoJ),
inflammatory molecules) which are intimately associated with dystrophic

1. Introduction: Surfaces, including lipid membranes, modulate protein
aggregation associated with Alzheimer’s disease

5!

Figure 1.3: Schematic representation of Aβ . Using the hydropathy index,
hydrophilic amino acids (red), hydrophobic (blue) and slightly hydrophobic (light blue)
are marked in the full Aβ1-40 peptide. Two β-strands (orange lines at residues 11-21
and 29-40) have been identified in the structure of Aβ with a β-turn (purple line) at
residues 23-29. The hydrophobic core (green line) is located at residues 16-21.

dendrites and axons, activated microglia, and reactive astrocytes.8 The Aβ
component of amyloid plaques found in the diseased brain consist primarily of
two versions of the peptide, which are 40 and 42 amino acids long (Aβ1-40 and
Aβ1-42 respectively). Aβ1-42 aggregates more quickly than Aβ1-40 and is thought to
play a major role in AD.9 The studies described in this dissertation will primarily
focus on the physicochemical aspects of Aβ (i.e. hydrophobicity, electrostatic
interactions, chemical environment) and their corresponding aggregation on
various surfaces.
Compelling data suggests that Aβ plays a central role in AD pathogenesis.
This notion is supported most strongly by the fact that 3 known genetic
alterations that underlie familial AD increase the production and deposition of Aβ
in the brain.10 Studies of humans with AD, persons with Down syndrome (who
have 3 copies of the APP gene on chromosome 21 and 100% of whom develop
AD neuropathology),11 and of transgenic AD mouse models,12,13 all indicate that
Aβ accumulation in the neocortex and hippocampus is an early and invariant
event in the development of AD pathology. Based on these and other
1. Introduction: Surfaces, including lipid membranes, modulate protein
aggregation associated with Alzheimer’s disease
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observations, the amyloid hypothesis of disease, which states that excessive Aβ
accumulation and deposition could trigger a complex downstream cascade
resulting in the symptoms of AD, was formerly proposed.14,15 Recent
observations have led to new versions of the amyloid hypothesis that postulates
the gradual accumulation and aggregation of Aβ initiates a slow, deadly cascade
causing synaptic alterations, activation of microglial and astrocytic responses,
modification of the normally soluble tau protein into oligomers and then into
insoluble paired helical filaments, and progressive neuronal loss associated with
multiple neurotransmitter deficiencies and cognitive failure.16

1.3 Aβ Polymorphisms
Like many other amyloid-forming peptides, Aβ can form a variety of
aggregate structures on and off pathway to fibril formation, including distinct
oligomers and protofibrils.6,17 Fibril structures associated with several different
amyloid-forming proteins have been experimentally resolved, and a common
motif of fibrillar aggregates is a cross-β structure.18-27 While the structural spine of
fibrils share this common intermolecular β-sheet structure, a variety of
possibilities are available for the packing of protofibrils into the fibril structure,
even for the same protein/peptide. This variability can lead to distinct amyloid
fibril morphologies. Such variable protofibril arrangements give rise to distinct
fibril morphologies, often termed polymorphisms.28-31 A variety of environmental
factors can influence the emergence of different polymorphic fibrils. Aggregation
conditions that lead to these distinct polymorphic fibrils can modulate toxicity
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associated with Aβ. For example, subtle alterations in fibril growth conditions
results in two structurally distinct polymorphic fibrils of Aβ1-40 with significantly
different levels of toxicity to neuronal cell cultures.32 In Chapter 5, experiments
relating Aβ preparation to polymorphic aggregate formation and their
corresponding interaction with lipid bilayers will be explored. Further studies have
indentified other fibrillar polymorphs of Aβ extracted from AD patient brains that
had the ability to seed further aggregation.33 More recent studies demonstrated
variations in Aβ1-40 peptide preparation and changes in aggregation conditions
resulted in at least five structurally-distinct fibrillar aggregates in vitro.34 Fibril
polymorphs have been observed for several other amyloid-forming proteins, such
as calcitonin,35 amylin,36 glucagon,37 the SH3 domain of phosphatidylinositol-3′kinase,37-39 insulin,40-42 and lysozyme.39 Polymorphic fibrils can differ in the crosssectional thickness or helical pitch of the fibril, which can be observed via high
resolution imaging techniques like transmission electron microscopy (TEM) or
atomic force microscopy (AFM). While polymorphs are often observed for various
in vitro aggregation reactions, polymorphs have been observed in amyloid fibrils
extracted from tissue as well.43,44 It has been proposed that polymorphic fibrils
may result in distinct biological activities and variable toxicity related to the
different aggregate structures.45,46 These distinct fibril morphologies may also
have distinct aggregate intermediates associated with their formation, adding to
the heterogeneity of potential protein aggregates and further complicating efforts
aimed at elucidating the relative role of discrete aggregates in disease related
toxicity.
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1.4 The role of surfaces in Aβ aggregation
Another contributing factor to the emergence of distinct polymorphic
aggregates is the presence of surfaces. Aβ aggregates into distinct forms in the
presence of mica and graphite (Figure 1.4).47-49 The addition of disease-related
point mutations can directly lead to distinct polymorphic aggregates of Aβ in the
presence of surfaces as seen in Chapter 3, suggesting that electrostatic and
hydrophobic interactions between the peptide and surface strongly influence the
aggregation process. The role of surfaces may underlie the ability of different
synthetic nanoparticles, which have high surface to volume ratios, to either
promote50 or inhibit51 Aβ aggregation, and thus could prove useful in
understanding their potential therapeutic use.
While protein preparation and environment influence the structural
polymorphs of protein aggregates in vitro, determining what environmental
factors influence aggregation in vivo remains difficult. However, the interaction of
proteins at solid interfaces, including cellular membranes comprised of lipid
bilayers, may prove to be a fundamental phenomenon with potential implications
for protein misfolding diseases. Solid surfaces, such as mica, graphite, gold, and
Teflon, have been shown to heavily influence aggregation kinetics and the
resulting aggregate morphology for a variety of amyloid-forming proteins.52-54 A
variety of kinetic and thermodynamic studies point to significant conformational
changes being induced in proteins encountering surfaces.55 These surface
induced conformational changes in proteins could play a critical role in nucleating
amyloid formation or altering aggregate morphology to specific toxic species.
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Such phenomenon are well demonstrated by a study of immunoglobulin light
chain aggregation on mica.56 Small pieces of mica were incubated in solutions
containing a recombinant amyloidogenic light-chain variable domain of smooth
muscle actin (SMA) antibody, under conditions in which fibrils normally do not
form (i.e., low concentration and no agitation). At short times, amorphous
aggregates appeared on mica, and fibrils were observed within 10 hours and
fibrils were not formed in the solution within the same time frame. The fibrils on
the surface of mica grew from the amorphous aggregates and the assemblies of
oligomers present on mica. The use of such solid surfaces as model systems
provides the opportunity to elucidate how specific surface environment influence
protein aggregation.
In regards to disease-related protein aggregation, surfaces of more
physiological relevance are cellular and subcellular membranes that are
predominately comprised of lipid bilayers. Like solid surfaces, the presence of
lipid membranes can alter the aggregation of disease-related proteins by
increasing aggregation rates, nucleating aggregation, promoting specific
polymorphs,

or

even

stabilizing

potentially

toxic,

transient

aggregate

intermediates. A significant question remains regarding why amyloid fibrils form
in vivo at concentrations that are orders of magnitude lower57 than the critical
nucleation concentrations required in vitro.58,59 A possible answer is the ability to
create local concentrations of protein adsorbed onto molecular surfaces, such as
cellular and subcellular membranes. Lipid interaction appears to be a common
modulator in fibril formation, as studies of α-synuclein (α -syn),60-62 islet amyloid
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polypeptide (IAPP),63 and Aβ64-68 all demonstrate accelerated fibril formation in a
membrane environment in comparison to bulk solution. General physicochemical
properties of lipid membrane, including phase state, bilayer curvature, elasticity
and modulus, surface charge, and degree of hydration, modulate protein
aggregation.69 The exact chemical composition and lipid constituents of a lipid
bilayer can also influence the aggregation process.70 Potentially important
chemical properties of membrane components include the extent of acyl chain
unsaturation, conformation and dynamics of lipid headgroups and acyl chains,
and protein–lipid selectivity arising from factors such as the hydrophobic
matching at the protein–lipid interface.71 Although lipid bilayers may act
catalytically to induce aggregation by providing environments that promote
protein conformation and orientation conducive to fibril assembly,72-74 cell
membranes may also be targeted by protein aggregates to induce physical
changes in the membrane, leading to dysfunction and cell death. This may be
due to the ability of amyloid forming peptides to induce membrane
permeabilization by altering bilayer structure via the sequestration of membrane
components into fibrils72,74-77 or by forming unregulated pore-like structures.78 In
Chapter 2, a variety of amyloid-forming proteins, including Aβ, IAPP, and
huntingtin (htt), have been shown to locally change the rigidity of model lipid
bilayers. Furthermore, the presence of lipid membranes can also influence the
ability of small molecules to prevent or destabilize protein aggregates, having a
major impact on several therapeutic strategies. Such a scenario has been
demonstrated experimentally as (−)-epigallocatechin gallate (EGCG), which has
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been shown to inhibit the aggregation of several amyloid-forming proteins in the
absence of surfaces,79,80 was less effective at inhibiting aggregation of human
IAPP at a phospholipid interface.81

1.4.1 The aggregation of Aβ on solid surfaces
The amphiphilic nature of Aβ is thought to drive its aggregation and may
play an important role in its interaction with solid surfaces and ability to insert
and/or penetrate lipid membranes.82,83 Hydrophobic Teflon surfaces can be
considered mimics of the nonpolar plane of lipid membranes. While both Teflon
and Aβ carry a negative charge at physiological pH, protein dehydration effects
lead to substantial adsorption of Aβ at pH 7.84 Aβ1-40 and Aβ1-42 adsorption to
Teflon particles increased aggregation and fibrillogenesis.50 Adsorption of Aβ to
another hydrophobic surface, highly ordered pyrolytic graphite, results in
extended aggregate formation in a nucleation dependent manner.47 Using a
variety of surfaces with tunable hydrophobicity or hydrophilicity (as well as
supported lipid bilayers), weakly adsorbed peptides with two-dimensional
diffusivity were found to be critical precursors to surface growth of Aβ1-42 fibrils.85
As the adsorption of Aβ on highly hydrophilic surfaces was negligible, fibril
growth was inhibited on such surfaces. On highly hydrophobic surfaces, the two
dimensional diffusion of Aβ along the surface was too low, also inhibiting fibril
formation. It appears that surface properties that promote weak adsorption of Aβ
to the surface and maintain translational mobility result in local concentrations of
Aβ due to confinement within the plane of the surface, allowing for fibril formation
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at a concentration far below the critical concentration observed in bulk solutions.
The adsorption of Aβ to hydrophilic silica surfaces is pH dependent, occurring at
pH 4 and 7 when Aβ has an overall positive charge,86 suggesting a vital role of
electrostatics on Aβ's adsorption to surfaces.
Due to the ability of AFM to be operated in solution and track the formation
and fate of individual aggregates with time on surfaces,53 the impact of surface
chemistry on the morphology of Aβ aggregates has been extensively studied with
this technique. On mica, a hydrophilic surface, Aβ1–4087 and Aβ1-4247 form small,
highly mobile oligomeric aggregates that organize into elongated prefibrillar
aggregates that continually elongate with time (Figure 1.4A). These aggregate
structures are similar in morphology to those formed in bulk solution from
similarly prepped Aβ stocks.47,88 However, Aβ1-42 aggregates into morphologically
distinct structures on a graphite surface (Figure 1.4B), forming extended
nanoribbons with heights of ~1–1.2 nm and widths of ~18 nm.47 These
dimensions suggest that Aβ adopts a fully extended β-sheet conformation
perpendicular to the long axis of the nanoribbons. These nanoribbons elongated
with time, organize themselves into parallel, raft-like structures with a preferential
alignment along the graphite lattice. Aβ adsorbs to and aggregates on surfaces
functionalized with methyl, carboxyl, or amine groups; however, aggregate
morphology and surface affinity is dependent on the specific surface
chemistries.48 Hydrophobic surfaces promote formation of spherical amorphous
clusters; charged surfaces promote the formation of protofibrils.48 Studies
showcased in Chapter 3 of the aggregation of Aβ peptides containing single point
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mutations, clustered around the central hydrophobic core of Aβ, on mica further
support the notion that electrostatics play an important role in Aβ adsorption and
aggregation on surfaces.
Figure 1.4: Aβ aggregation is
modulated by the presence of
chemically
distinct
solid
surfaces. (A) On a negatively
charged, hydrophilic mica surface,
Aβ forms discrete oligomers that
maintained some lateral mobility
along the plane of the surface.
These oligomers could organize
into
elongated
protofibrillar
structures. (B) On highly ordered
pyrolytic graphite, Aβ aggregates
into extended nanoribbons that
are epitaxially ordered on the
surface. The distinct orientation of
Aβ aggregates on graphite is
attributed to the optimization of
the contact between the peptide
and
underlying
hydrophobic
carbon
lattice.
Schematic
representations of the structure of
each surface (graphite and mica)
are provided under each image.

1.4.2 The interaction of Aβ with lipid surfaces
With respect to surfaces, a potentially relevant environmental factor
regulating Aβ aggregation is lipid bilayers. The fluid surfaces provided by lipid
bilayers are well known to influence protein structure and dynamics, which can
nucleate the aggregation process. Importantly for AD, lipid bilayer properties alter
protein conformation and exert enormous influence on the aggregation state, as
substantial enhancement of Aβ aggregation is observed in the presence of lipid
membranes.68,89-92 It has been hypothesized that a potential pathway for Aβ
1. Introduction: Surfaces, including lipid membranes, modulate protein
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toxicity may lie in its ability to modulate lipid membrane function. This hypothesis
is based on the observation that Aβ bears a portion of the APP transmembrane
domain. Thus, elucidating the interaction between Aβ and membrane lipids could
be critical in understanding potential pathways of Aβ toxicity, especially given the
results of studies that demonstrate that changes in membrane composition occur
in AD along with the association with plaques, tangles, and neuritic dystrophy.
Importantly, it has often been observed that exogenously added Aβ will
selectively bind a subset of cells in an apparent homogenous population of cells
in culture.93,94 This cell selectivity may be influenced by the presence of specific
lipid components or membrane properties.95-97 Once Aβ aggregation begins in or
near a membrane, the potential toxic mechanism includes disruption of the
bilayer structure, changes in bilayer curvature, and/or the creation of membrane
pores or channels.65,66,69,98-100 The majority of studies on membrane-mediated
fibrillogenesis

have

been

undertaken

with

model

systems

including

amyloidogenic peptides or proteins and lipid vesicles or supported bilayers of
varying composition.72,101-103 These studies often point to the importance of the
chemical nature of membrane lipids and the mode of protein–lipid interactions in
determining fibrillogenic properties of membrane bound Aβ. Lipids can also
stabilize toxic protofibrils and even revert mature fibrils into such toxic species,104
providing another potential role for lipid surfaces in toxicity.
While several physicochemical aspects of membranes (such as phase
state, curvature, charge, and elasticity) associated with lipid composition play an
important role in specific peptide/lipid interactions, these interactions are also
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dependent on protein properties. Understanding the basic interaction between Aβ
and lipid membranes could lead to a better understanding of Aβ aggregation
associated with cellular membranes. A potential mechanism for amyloid-forming
proteins, such as Aβ, is their ability to alter membrane structure and integrity,
leading to permeation of cellular membranes. Detergent-like effects arise from
the amphiphilic nature of Aβ, leading to reduced membrane surface tension
leading to membrane thinning and hole formation.105 Several AFM studies
performed in solution have provided valuable insight into the aggregation of Ab
on a variety of model lipid membranes, leading to altered membrane morphology.
The interaction of Aβ1-40 with bilayers formed from total brain lipid extract (TBLE)
revealed that Aβ1-40 will partially insert into bilayers, growing into small fibers.68 In
the same study, larger fiber-like structures associated with disruption of the
bilayer morphology and integrity were observed as measured by increased
surface roughness and formation of holes, respectively. Large fibrils were often
highly branched and associated with edges of disrupted bilayer. The TBLE
bilayers also aided in nucleation and enhancement of fibril growth. Interestingly,
preformed fibrils were not capable of disrupting the TBLE bilayers, which may
indicate that the act of aggregation, that is prefibrillar aggregates, may be key in
Aβ-induced membrane disruption. A variety of studies indicate the ability of Aβ to
bind membranes is highly dependent on the presence of specific lipid
components, i.e., cholesterol,92,106,107 sphingolipids,108 gangliosides,65 and neutral
or

charged

phospholipids.66,109,110

This

may

be

due

to

specific

chemical/electrostatic interactions between membrane components and Aβ
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and/or the mechanical properties of the bilayer associated with their specific
composition. For example, altering the cholesterol content of supported TBLE
bilayers changes Aβ aggregation on membranes. Aβ1-40 induced bilayer
disruption and its ability to form fibrils on the bilayer was strongly dependent on
cholesterol content of the supported bilayers.92 Cholesterol depletion of bilayers
inhibited the ability of Aβ1-40 to perturb bilayer structure. Further discussed in
Chapter 3, point mutations in Aβ1-40 also altered the aggregation on and ability to
disrupt TBLE bilayers. In Chapter 4, how specific sequences of Aβ aggregate on
and interact with lipid bilayers is examined.
While cellular membranes may act to aid protein aggregation,70,111,112
these same membranes may be damaged by the aggregation process, leading to
membrane dysfunction caused by membrane permeabilization by Aβ either
perturbing bilayer structure75,113 or by Aβ's ability to alter cellular ion
concentrations, calcium in particular, through the formation of unregulated
pores.78,114-116 Initial evidence for this scenario came from the observation that
phosphatidylserine bilayers that had Aβ1-40 directly incorporated into them
displayed linear current/voltage relationships in symmetrical solutions.98 Further
evidence for this scenario was provided by studies on phospholipid vesicles that
had either Aβ1-42117 or Aβ1-40118 directly incorporated into them. In both cases,
these vesicles stiffened in the presence of calcium, due to calcium ion-induced
charge–charge repulsion inside the vesicles, binding of calcium to lipids and
proteins, and an enhanced efficiency of lipid–protein interactions. This increased
stiffness of the vesicles could be blocked by pretreatment with anti-Aβ antibodies,
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Tris, or zinc, all of which would block putative calcium channels. The formation of
a variety of similar aggregate structures in lipid membranes has also been
demonstrated computationally.114,119 Endothelial cells exposed to Aβ1-40, Aβ1-42,
and Aβ25-35 undergo morphological changes and cell disruption, with the highest
sensitivity to Aβ1-42.120 While cell disruption was induced by nanomolar
concentrations of Aβ1-42, micromolar concentrations of Aβ1-40 were required to
trigger similar effects. Similar observations were reported for fibroblasts in the
presence of nanomolar Aβ1-42, as morphological changes along the periphery of
the cell were observed that could be blocked by anti-Aβ antibodies, zinc, and the
removal of calcium.120
The major risk factor associated with AD is aging. Age-related changes in
membrane composition and/or physical properties may facilitate an increased
cellular susceptibility to Aβ cytotoxicity. For example, both enhanced cellular
cholesterol content121-123 and oxidative damage124,125 are associated with aging,
decreased fluidity of membranes, and AD. Oxidative damage of polyunsaturated
fatty acids, in general, increase lipid bilayer rigidity as a result of increased steric
hindrance restricting the movement of lipid acyl chains.125,126 Furthermore, Aβ
oligomers display preferential accumulate at oxidatively damaged plasma
membranes of cells,127 and there is evidence of enhanced oxidative damage in
AD brains.128,129 Such studies suggest that altered membrane mechanics play a
role in facilitating Aβ/lipid interactions.
AFM studies further illustrate that the alteration of bilayer mechanical
properties induced by lipid composition impact the ability of Aβ to bind
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membranes, by demonstrating that astrocyte secreted lipoprotein particles
containing diﬀerent isoforms of apoE, of which the apoE4 allele is a major risk
factor for the development of AD, protect TBLE bilayers from Aβ1-40 induced
disruption.89 The apoE4 allele was less eﬀective in protecting these bilayers from
Aβ1-40 compared with their apoE3 counterparts, and further analysis revealed that
this was due to the varying ability of the lipoprotein particles containing different
alleles of apoE to modulate the fluidity of bilayers by acquiring bilayer
components (most likely cholesterol and/or oxidatively damaged lipids). There is
evidence that peptide/membrane affinity in vascular cells can also be related to
the ability of cholesterol to modulate membrane fluidity and structure.130 Other
cell culture assays, using PC-12 and SH-SY5Y cells, demonstrated that depleting
cells of cholesterol increased the cellular binding of Aβ1-40.92
While the mechanical properties of bilayers can influence their
susceptibility to Aβ binding, once Aβ binds a membrane, this association may
also alter the mechanical properties of the membrane, leading to dysfunction.
Such a scenario is plausible considering the observed morphological changes
associated with lipid membranes exposed to Aβ.67,89,90 Anisotropy studies with 1palmitoyl-2-oleoylphosphatidylcholine

(POPC)

and

1-palmitoyl-2-oleoyl-

phosphatidylglycerol (POPG) lipid membranes demonstrated that monomeric Aβ
had initially little impact on bilayer fluidity; however, oligomers were able to
decrease bilayer fluidity.131 Furthermore, oligomers prepared at pH 6 had a larger
impact on bilayer fluidity compared to oligomers that formed at a neutral pH,
suggesting that distinct, polymorphic oligomers were formed under the different
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conditions.131 Studies performed on supported phospholipid membranes
revealed that exposure to Aβ modifies morphology and local mechanical
properties of bilayers, reducing the force required to break through the
membrane with an AFM probe.132 Collectively, these results suggest Aβ can
negatively impact the mechanical integrity of lipid membranes.

1.5 Atomic force microscopy
Owing to the dynamic aggregation mechanism of Aβ from globular
oligomers to mature fibrils, as well as the debate of which aggregate form(s)
represent the toxic species, there is a need for techniques capable of
characterizing and differentiating specific aggregate morphologies within a
heterogeneous aggregation reaction. In order to study the physicochemical
aspects of Aβ aggregation, AFM has become an important and useful technique
in studying biological systems.47,133-143 Invented in 1986 by Binning and
Rohrer,144 AFM has become a remarkable technique that allows for the
measurement of surface structure with accuracy and extremely high-resolution
images. The principle components of AFM are shown in Figure 1.5. AFM
measures the vertical displacement of a flexible cantilever affixed with an ultra
sharp probe tip as it physically interacts with a surface. In AFM, a laser beam is
reflected off the back side of a cantilever onto a four-segment position-sensitive
photodetector. Acting as an optical lever, as the end of the lever physically
interacts with the surface, the lever bends and the position of the laser spot on
the detector changes.
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There are three main modes of AFM operation: a) contact (or static), b)
tapping (or intermittent contact), and c) non-contact. In contact mode, cantilever
deflection is monitored and the tip is in constant contact with the sample surface.
Although it is a widely used technique, in contact mode the applied force leads to
a high lateral force applied to the sample. Lateral forces, such as drag and

Figure
1.5:
Basic
schematic of an atomic
force microscope (AFM).
The cantilever is raster
scanned across the sample
while
monitoring
the
interaction between the
surface
and
tip
to
reproduce
topographical
images. There are three
main modes of AFM
operation: contact, tapping,
and non-contact mode.

friction, can cause soft biological samples to be damaged or changed by the
process of scanning. Tapping mode has the ability to reduce such lateral forces
and is the most commonly used mode of AFM in biological studies. Tapping
mode is a non-destructive imaging technique that can map the surface
topography by monitoring the oscillation amplitude of a cantilever when the
cantilever is driven harmonically near its resonance frequency. The tip
intermittently contacts the sample, decreasing the cantilever oscillation amplitude
from the free amplitude to a tapping amplitude. A three-dimensional
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topographical map of the sample surface is obtained by the aid of a xyz
piezoelectric scanner, which raster scans the probe across a surface (xy) while
maintaining cantilever deflection or amplitude value by vertically displacing a
sample. The three dimensional imaging capability of AFM images makes it
possible to measure the height and volume of nanoscale objects. Non-contact
mode is another example of an oscillating mode. In non-contact mode AFM, the
cantilever tip does not contact the sample surface and is oscillated at a frequency
above the resonance frequency. A limiting factor of non-contact mode is in
ambient conditions; there is a contamination layer present on most surfaces
which causes tip to surface interaction forces to be heavily influenced by the
capillary forces between the contamination layer and the tip. To alleviate this
issue, non-contact mode AFM is predominantly done using high vacuum
conditions, which are not ideal for the biological systems that are being studied
here.
Tapping mode AFM can also be easily implemented in fluids, allowing
dynamic biological systems to be imaged under near physiological conditions
and the fate of individual features to be followed over time.145

47,134,136

It’s

important to note that AFM does not involve extensive sample preparations (i.e.
staining, gold sputtering, etc.) commonly used with other forms of microscopy,
and can be easily implemented with other optical microscope techniques. AFM is
useful in studying the importance of surfaces in the processes leading to
pathological peptide assembly and can be used to observe morphological
changes associated with protein aggregation in real time. The ability of AFM to
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image biological systems and to physically interact with samples to obtain
physicochemical properties of the system is useful in studying how amyloid
forming peptides modulate mechanical changes on surfaces (i.e. mica and lipid
membranes) and is not found in other imaging techniques.

1.5.1 Scanning Probe Acceleration Microscopy
Scanning probe acceleration microscopy (SPAM), allows for the
measurement of mechanical properties with nanoscale spatial resolution.146 This
capability should allow for the determination of how amyloidogenic proteins, in
particular Aβ, change local mechanical properties of lipid bilayers. SPAM is
based on the well-established tapping mode AFM technique (Figure 1.6). During
each oscillation cycle in tapping mode, the tip approaches and retracts with
respect to the surface during each tap, analogous to the force curves used during
single-cell compression studies. Therefore, if one can recover the tip/surface
interaction force while imaging, mechanical properties of the local surface can be
determined by similar analysis of the data. SPAM makes it possible to recover
these force interactions by taking advantage of the fact that the second derivative
of the cantilever trajectory yields the tip acceleration, which is related to the force
by Newton’s second law (force = mass x acceleration). Taking the second
derivative of tip trajectory amplifies the noise; therefore, an appropriate filtering
strategy needs to be applied. As the tip is driven harmonically, the tapping
interaction between the tip and sample excites higher harmonic frequencies of
the cantilever. Taking advantage of this fact, a Fourier transform can be used to
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convert the noisy deflection signal from time space to frequency space. Keeping
only intensities of harmonic frequencies, an inverse Fourier transform can be
applied to recover a reconstructed deflection signal with vastly reduced noise.
This reconstructed signal can be converted into instantaneous tip/force
trajectories using the second derivative and scaling by the effective mass of the
cantilever. SPAM combines high spatial resolution of tapping mode AFM with
force curve analysis to provide an indirect measurement of local surface
mechanical properties in contrast to the gross surface mechanical properties
described in single-cell compression, i.e. local Young’s modulus, compressibility,
viscoelasticity, and rigidity.

Figure 1.6: Scanning probe acceleration microscopy (SPAM). SPAM allows
indirect measurement of surface mechanical properties by reconstructing the
instantaneous force between the tip and surface in tapping mode AFM.

There are several advantages of SPAM in studying biological systems.
Based on tapping mode AFM, SPAM reduces cellular damage due to the
elimination of frictional forces while maintaining high spatial resolution.
Furthermore, SPAM is also capable of being operated in aqueous solution.
These advantages make the specialized technique of SPAM suitable for studying
the mechanical differences of biological surfaces such as lipid membranes and
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the mechanical differences of biological surfaces such as lipid membranes and
how membrane mechanics are altered due to amyloidogenic protein interaction.
In this thesis, SPAM is used to study the relationship between amyloid protein
aggregation (i.e. Aβ1-40, htt, amylin, and a synthetic polyQ peptide in Chapter 2,
specific Aβ fragments in Chapter 4, and different preparations of Aβ1-40 in
Chapter 5) and the physical properties of supported lipid membranes. By using
SPAM, the impact of amyloid aggregation on the physical integrity of supported
lipid membranes and how the aggregation process affects the mechanical and
physicochemical properties of the surface will be studied with nanoscale spatial
resolution.
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2. Amyloid-forming proteins alter the nanoscale mechanical
properties of lipid membranes1

A diverse number of diseases, including Alzheimer’s disease, Huntington’s
disease, and type 2 diabetes, are characterized by the formation of fibrillar
nanoscale protein aggregates termed amyloids. The precise mechanism by
which aggregates are toxic remains unclear; however, these proteins have been
shown to interact strongly with lipid membranes. The morphological and
mechanical changes of model lipid bilayers exposed to amyloid forming proteins
are investigated with nanoscale spatial resolution by reconstructing the tapping
forces associated with AFM imaging in solution. Tip/sample forces contain
information regarding mechanical properties of surfaces. Interpretation of the
mechanical changes in the bilayers was aided by numerical simulations of the
entire AFM experiment. Amyloid forming proteins disrupted distinct regions of the
bilayer morphology, and these regions were associated with decreased Young's
modulus and adhesive properties. These changes in bilayer mechanical
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properties upon exposure to amyloid-forming proteins may represent a common
mechanism leading to membrane dysfunction in amyloid diseases.

2.1 Introduction: Amyloid-forming proteins and disease
A vast number of diseases are characterized by the misfolding of specific
proteins, causing these proteins to assemble into a wide array of extracellular
and/or intracellular aggregates. Disease-associated protein aggregation results in
extended, β-sheet-rich, proteinaceous fibrillar structures, termed amyloids. These
fibrils often have globular, soluble protein aggregate precursors, referred to as
oligomers. These diseases include AD, HD, type 2 diabetes, and many others.1
For example, one of the hallmarks of HD is caused by an expanded
polyglutamine expansion in the htt protein that leads directly to its aggregation
into inclusion bodies in affected neurons,2 and amyloid deposits of amylin are a
pathological characteristic of the pancreas in Type 2 diabetes.3
The two-dimensional liquid environment of lipid bilayers can profoundly
influence protein structure and dynamic properties, thereby influencing the
aggregation state of amyloid-forming proteins.4 Fibril formation has been shown
to be accelerated in a membrane environment for several amyloid-forming
proteins, including amylin5 and Aβ.6-10 While lipid membranes may play a role in
facilitating aggregation,11,12 such membranes may be direct targets of toxic
mechanisms

associated

with

amyloid

formation,

such

as

membrane

permeabilization associated with altered bilayer structure due to sequestration of
membrane components into aggregates11,13-20 or the formation of unregulated
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pores.21,22 Aβ is a cleavage product of APP, and as such, contains a portion of
the APP transmembrane domain, which can facilitate Aβ's interaction with lipid
membranes. The subcellular localization and interaction of htt containing
expanded polyQ domains with membranous surfaces has been well documented
and suggests that these interactions play a role in HD pathogenesis.23-27 Amylin
has been shown to disrupt lipid bilayers by forming either defects18 or pores.28,29
The association of amyloid-forming proteins with cellular membranes may
represent a common step associated with a variety of mechanisms of toxicity.
The exact chemical composition and lipid constituents contained within a lipid
membrane can heavily influence the aggregation process.30 For example,
cholesterol10,19,31,32 and oxysterols33 have been shown to modulate the
interaction of Aβ with lipid membranes. The interaction of amyloid-forming
proteins with lipid membranes may also play an important role in modulating the
effectiveness of small molecules designed to inhibit aggregation, as was
demonstrated with (−)-EGCG, which inhibits amyloid formation in the absence of
lipid membranes,34,35 but is less effective at a phospholipid interface.36
In this chapter, the interaction of four amyloid-forming proteins, Aβ, htt, a
synthetic polyQ peptide, and amylin (Figure 2.1), with TBLE bilayers are
investigated. These peptides represent two potentially different mechanisms of
interaction with lipid membranes. The interaction of Aβ with lipid bilayers is driven
by in amphipathic character associated with being a fragment of a
transmembrane protein.37 htt, synthetic polyQ peptide, and amylin all contain αhelical lipid binding domains.38,39 In particular, a variation of in situ tapping mode
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Figure 2.1: Schematic representations of the amyloid-forming proteins. (A) The
primary sequences of Aβ1-40, htt exon1-51Q, a synthetic htt peptide, and amylin are
shown with important domains within the protein indicated. (B) The lipid binding
domains of htt and amylin form amphipathic α-helixes.

AFM and SPAM was used, which allowed simultaneous determination of the
morphological and mechanical impact of exposure to amyloid-forming proteins on
the bilayers. Tapping mode AFM is a well-established imaging technique capable
of nanoscale resolution; however, the time-resolved tip/sample forces associated
with tapping mode AFM contain information concerning mechanical surface
properties, i.e., adhesion, rigidity, energy dissipation, and compressibility. The
SPAM technique is able to reconstruct the tapping force for every cantilever
oscillation cycle during imaging by taking the second derivative (or acceleration)
of the cantilever deflection signal after Fourier transform based filtering.40
Furthermore, SPAM is operable in aqueous solution, making it highly applicable
to biologically relevant samples. Numerical simulations of the entire tapping
mode AFM scanning process are also provided to assist in the interpretation of
the acquired tip/sample tapping forces.
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2.2 Materials and methods
2.2.1 Preparation of defect free bilayers patches.
Lyophilized total brain lipid extract (porcine) was purchased from Avanti
Polar Lipids (Alabaster, AL) and resuspended in phosphate buffered saline (PBS)
(pH 7.3) at a concentration of 1 mg/mL. By using an acetone/dry ice bath,
bilayers and multilayer lipid
sheets were formed by five
cycles

of

treatment.7

freeze-thaw
Vesicle

formation within the lipid
Figure 2.2: Formation of total brain lipid extract
(TBLE) bilayer. A sequence of time-lapse in situ AFM
images that demonstrate the formation of a supported
TBLE bilayer on mica via vesicle fusion is shown.
Initially, round bilayer patches appeared on mica as
vesicles encountered the surface. With time, these
patches gradually fused to form a defect-free bilayer
patch, which provided an excellent model surface for
studying the aggregation of amyloidogenic proteins.

suspensions was promoted
by bath sonication for 30
minutes. All experiments
were performed with the
same lot of lipids. 25 µL of

the suspended vesicle solution, diluted with 25 µL of PBS (pH 7.3), was added
directly to the AFM fluid cell and placed onto freshly cleaved mica. Vesicles were
allowed to absorb to the mica and fuse together to form a supported bilayer (40 x
40 µm) (Figure 2.2) that was relatively defect-free as assessed by an AFM image
(Figure 2.3).
Once the bilayer formed, 2-3 washes with PBS were performed to remove
excess lipid vesicles. For the experiments in this chapter, the lipid to peptide ratio
was approximately between 5-15. The uncertainty is due to several factors. First,
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TBLE is a complex mixture of lipids,
so there is not a straightforward way
to calculate the moles of lipid
components.

Second,

despite

efforts to be as consistent as
possible,
Figure
2.3:
AFM
image
of
a
representative,
relatively
defect-free
TBLE bilayer supported on mica. The
image represents a 40 x 40 µm area, and
the inset zooms into a 5 x 5 µm area. Holes
and defects of the size detectable by AFM
are relatively few, if any.

the

efficiency

of

the

washing step after formation of the
bilayer may vary, resulting in slightly
different amounts of total lipid in the
fluid cell.

2.2.2 Preparation of protein samples.
Wild Type Aβ1-40 (AnaSpec, San Jose, CA) and human amylin (1-37)
(AnaSpec, San Jose, CA) were prepared based on published protocols that
result in monomeric solutions.18,41-43 Aβ1-40 and amylin were treated separately
with hexafluoroisopropanol (HFIP) to dissolve pre-existing aggregates and
seeds. The resulting solutions of Aβ1-40 or amylin were placed under vacuum to
remove the HFIP, resulting in peptide films. Aβ1-40 films were resuspended in
10µL of dimethyl sulfoxide (DMSO) and vortexed to make 2000 µM stock
solutions, which were dissolved directly into PBS buffer (pH 7.3) to a final
concentration of 20 µM. The amylin films were resuspended in PBS and
vortexed, resulting in a final concentration of 50 µM. Controls were performed by
exposing bilayers to all vehicles used in this study, and DMSO did not induce any
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of the changes observed by exposing bilayers to Aβ and amylin (Figure 2.4). The
preparation of Aβ and amylin with DMSO allowed for monomeric, un-aggregated
protein samples, with reproducible aggregation and membrane interaction. htt
exon1-51Q was purified from
Escherichia
glutathione

coli

as

a

S-transferase

(GST)-htt fusion protein by
Figure 2.4: AFM images of defect-free
TBLE bilayer exposed to 1% DMSO in PBS.
The image represents a 2 x 2 µm area of
TBLE, alone which is exposed to the vehicle
(1% DMSO in PBS) over the course of 16h.
The vehicle did not induce any changes in the
bilayer over time.

protocols

that

result

predominately in monomeric
protein.44,45

The

fusion

proteins were purified from

lysates using a BioLogic LP system (BioRad) equipped with a GST affinity
column. Gel electrophoresis was used to determine purity and to verify the
relevant fractions. The GST moiety was cleaved with Factor Xa (Promega,
Madison, WI), which initiates aggregation. Prior to the addition of the cleaving
agent, solutions of GST-htt fusion proteins were centrifuged at 20,000g for 30
min at 4°C to remove any pre-existing aggregates. The concentration of htt
exon1-51Q was determined using a Bradford assay, and solutions of htt exon151Q were prepared to a final concentration of 20 µM. Synthetic polyQ peptides
(Keck Biotechnology Resource Laboratory, New Haven, Connecticut) were
dissolved for three hours in a 1:1 mixture of trifluoroacetic acid (TFA) and HFIP to
a concentration of 0.5 mg/mL, which results in a monomeric stock based on
published protocols.46 After vortexing, the solvent was evaporated off, producing
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a thin peptide film. The polyQ peptide film was resuspended in ultrapure water
adjusted to pH 3 with TFA to a concentration of 2.0 mg/mL. This stock solution
was diluted in PBS to a final concentration of 20 µM and pH of 7.3. For Aβ,
amylin, and polyQ peptide preparations, aliquots of each solution were spotted
on mica as soon as prepared to verify the absence of aggregates via AFM
imaging in air. Bovine serum albumen (BSA) (Thermo Scientific) was diluted in
PBS to a final concentration of 20 µM and used directly.

2.2.3 AFM and SPAM imaging conditions.
In situ AFM experiments were performed with a Nanoscope V MultiMode
scanning probe microscope (Veeco, Santa Barbara, CA) equipped with a closedloop “vertical engage” J-scanner and a sealable tapping fluid cell. Images were
acquired with V-shaped oxide-sharpened silicon nitride cantilevers (Veeco, Santa
Barbara, CA) with nominal spring constants of ~0.5 N/m and nominal tip radius
less than 10 nm. Scan rates were set at 1–2 Hz with cantilever drive frequencies
ranging from ~8 to 10 kHz. The free amplitude of the cantilever was ~25 nm, and
the tapping amplitude was set at 70% of this free amplitude. For SPAM
experiments, 5 x 1.25 µm images were captured with 256 x 64 pixel resolution.
Using a signal access module (Veeco, Santa Barbara, CA) and CompuScope
14100 data acquisition card (Gage, Lachine, Quebec) cantilever deflection
trajectories were captured at 2.5 MS/s and 14-bit resolution with a range of 2 V.
The captured cantilever trajectory was filtered using a Fourier transform based
harmonic comb filter.40 The second derivative of the resulting filtered cantilever
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deflection trajectory was taken and multiplied by the effective mass, meff, of the
cantilever to obtain the time-resolved based tapping force between the tip and
sample. The meff was determined using a thermal tuning method,47 performed in
solution, to obtain the spring constant and resonance frequency of the cantilever,
which can be used to determine meff based on the following equation:
meff =

k
ω2

(1)

€ of complete AFM experiment.
2.2.4 Numerical simulations
The cantilever motion was described as a single degree of freedom
damped driven harmonic oscillator.48,49

meff ˙z˙ + bz˙ + k [ z − D0 + a0 sin(ωt )] = Fext

(2)

where meff is the effective mass of a cantilever, b is the damping coefficient, k is

€ spring constant, a is the drive amplitude, ω is the drive frequency,
the cantilever
0
D0 is the resting position of the cantilever base, Fext is the tip/sample force, and z
is the position of the cantilever with respect to the surface. In tapping mode, the
tip/surface separation distance changes as the cantilever oscillates. While the tip
and surface are not in contact for the majority of the oscillation cycle (non-contact
regime), the tip intermittently contacts (or taps) the surface during each cycle. In
solution, the AFM tip in close proximity of a surface would experience van der
Waals forces and electric double layer forces, which can be described by the
Derjaguin–Landau–Verway– Overbeek (DLVO) theory.50 Our experimental
system, however, has a high salt concentration in the buffer, resulting in a short
Debye length and negligible forces arising from the electric double layer.51 As a
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result, the external force associated with the noncontact regime was
approximated using the van der Waals interaction between a sphere and flat
surface:52!
Fext = −

ARtip

for

6z 2

z > aDMT

(3)

where A is the Hamaker constant, Rtip is the tip radius, and aDMT is the
€
interatomic distance parameter of a Derjaguin-Muller-Toporov (DMT) potential.53
When the separation distance between the tip and surface is less than or equal
to aDMT, the tip is in contact with the surface, and the external force was modeled
with a DMT potential,
Fext

4
=
3πκ eff

3
2

R ( aDMT − z) −

ARtip
6aDMT 2

for

z ≤ aDMT

(4)

€
with
(5)
where Etip, νtip and Esample, νsample are, respectively, the Young’s modulus and
Poisson coefficient of the tip and the sample.
To simulate the entire scanning process, a feedback loop containing an
integral gain was implemented in the model. In practice, the cantilever deflection,
rather than the position with respect to the surface, is monitored experimentally.
As a result, the feedback loop in the model monitored the oscillation amplitude of
the deflection (y) of the cantilever, which is related to the position by:
y = z − D0 + a0 sin(ωt )
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The measured amplitude of the deflection signal was compared to a specified set
point amplitude, and the cantilever position relative to the surface was adjusted
to maintain the set point. The feedback loop feature can be used to simulate the
process of acquiring an AFM scan line in which the surface topography is
variable. The resulting model is capable of capturing several features of the
cantilever deflection signal and tip/sample force (Figure 2.7B).54,55

2.3 Results
2.3.1 Amyloidogenic proteins alter membrane morphology.
To determine the impact of exposing lipid membranes to amyloid-forming
proteins, supported TBLE bilayers were used as a model surface. TBLE is
comprised of a physiologically relevant ratio of membrane components
(cholesterol, gangliosides, sphingolipids, isoprenoids and both acidic and neutral
phospholipids), providing a relevant model surface. The supported bilayers were
formed by vesicle fusion on freshly cleaved mica56 and systematically exposed to
a variety of amyloid-forming proteins (Aβ1-40, htt exon1-51Q, synthetic polyQ
peptide, or amylin). Observations were limited to 40 x 40 µm patches of bilayer
that were defect-free, at a scale determinable by AFM analysis, prior to exposure
to amyloid-forming proteins. A freshly prepared bilayer was used in each
experiment, and the addition of protein indicated our zero time-point for
exposure. No additional protein was added after the initial injection. Each protein
was freshly prepared and was in a predominately monomeric state upon initial
injection; although, some small aggregates may have been present. Control
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Figure 2.5: Amyloid-forming proteins disrupt TBLE bilayers. Representative 2D
and 3D in situ AFM images of TBLE bilayers that were exposed to (A) control buffer,
(B) 20 µM Wild Type Aβ1-40, (C) 20 µM htt exon1-51Q, (D) 20 µM synthetic htt peptide,
(E) 50 µM amylin, and (F) 20 µM bovine serum albumin (as a control) are presented.
The green lines in the 2D images correspond to the height profiles below the AFM
images. Arrows indicate discrete oligomeric aggregates. The scale bar in a-d
represents 500 nm, and the scale bar in e-f represents 1000 nm.

experiments were performed by exposing TBLE bilayers to protein-free solutions
that were identical to vehicle solvents used for each protein. None of these
vehicle solutions altered the morphology or mechanics of the TBLE bilayer as
assessed by AFM.
A freshly formed bilayer had a smooth appearance with an RMS
roughness of 0.06 ± 0.03 nm. Initially, upon exposure to freshly prepared
2. Amyloid-forming proteins alter the nanoscale mechanical
properties of lipid membranes
!

47!

solutions of Aβ1-40 (20 µM), htt exon1-51Q (20 µM), synthetic polyQ peptide (20
µM), or amylin (50 µM), patches of increased surface roughness developed on
the lipid bilayer, indicating disruption of the bilayer structure (Figures 2.5 and
2.6). When the RMS roughness of these regions was measured (excluding the

Figure 2.6: Exposure to amyloid-forming proteins causes increased surface
roughness in TBLE bilayers. (A) Root mean square (RMS) surface roughness
analysis of TBLE bilayers before (TBLE) and after exposure to Aβ1-40, htt exon1-51Q,
synthetic polyQ peptide, and amylin induced significant (* indicates p<0.01)
roughening of the TBLE bilayer, as assessed by a t-test with n = 5. RMS roughness
measurements were restricted to disrupted regions of the surface. (B) Height
histograms of every pixel contained in the AFM images presented in Figure 2.6.
Exposure to BSA served as a control.

unperturbed regions of the image to normalize for the surface area actually
occupied by roughened morphology), the increased roughness induced in the
bilayer by all four amyloid-forming proteins was statistically significant (p < 0.05)
(Figure 2.6A). Histograms of the height values associated with every pixel within
the region also demonstrate that the bilayer morphology was significantly altered
upon exposure to the amyloid-forming proteins (Figure 2.6B). TBLE not exposed
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to any protein or TBLE exposed to BSA had tight distributions of height values
centered around zero nm, as zero height corresponds to the top of the
unperturbed bilayer. When exposed to amyloid-forming proteins, the histogram
deviates from zero to larger values of height, indicating the extent of the bilayer
roughness. Small aggregate complexes, were often observed within these
roughened domains for each protein, but fibrils were not observed (Figure 2.5
blue arrows). These aggregate complexes were globular in morphology. While
these complexes are most likely comprised of both peptide and lipid components,
they may represent discreet oligomers. The concentrations used in this study are
much larger than is typically observed in vivo for these proteins. This was done to
allow for observations over an experimentally feasible length of time. As
aggregation is highly dependent on concentration, this must be taken into
consideration when interpreting these results.
The disrupted regions of bilayers exposed to Aβ1-40 took ~12-18 hours to
develop and exhibited the largest surface roughness (RMS = 1.95 ± 0.38 nm)
(Figure 2.5B). Aβ1-40 formed larger aggregate complexes (4-16 nm in height) than
those formed by the other amyloid-forming proteins in the presence of the
bilayer. Such aggregate complexes are defined as being a mixture of aggregates
(oligomers, protofibrils, fibrils) and lipid components. Other reported globular
aggregates of Aβ tend to be smaller than the observed aggregate complexes.
Amyloid-derived diffusible ligands (ADDLs) have been observed to be 3-5 nm in
height,57 which is on the small end of the range of aggregates observed in this
study. Much smaller Aβ oligomers are commonly observed, such as Aβ*56 which
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correlates with memory loss,58 and has been reported to be ~1 nm in height.59
The larger size of the observed complexes may indicate that either lipid
components are indeed accumulated within the complex or that the TBLE lipid
environment is promoting the formation of a larger globular aggregate.
Bilayer disruption occurred within 10-25 minutes of exposure to htt exon151Q (Figure 2.5C). Despite the apparent more aggressive interaction of htt
exon1-51Q with the bilayer, the associated RMS roughness with disruption was
smaller (0.66 ± 0.15 nm), and the size of observed aggregate complexes was
typically smaller (2-10nm in height) compared to Aβ1-40. While these aggregate
complexes associated with htt exon1-51Q may contain some lipid components,
they were similar in size to oligomers observed for a htt exon1 construct with 53Q
repeats60 and to htt exon1 purified from transgenic mice.61 While the rate of
interaction with the bilayer appeared to be slower (1-3 hours), the synthetic polyQ
peptide interacted with the membrane in a similar fashion to htt exon1-51Q, with
an RMS roughness of 0.54 ± 0.13 nm and aggregate complex heights ranging
between 2-5 nm (Figure 2.5D). The slower apparent rate of aggregation on the
bilayer of the synthetic polyQ peptide compared to the htt exon1-51Q protein was
potentially due to the length of the polyQ domain, which has been shown to alter
the rate of aggregation.60
As amylin interacted with the bilayer with the slowest apparent rate, the
concentration was increased to 50 µM, which resulted in membrane disruption
within 3 hours (Figure 2.5E). The RMS roughness of the amylin-induced
disrupted bilayer regions was 0.94 ± 0.36 nm, and the observed aggregate

2. Amyloid-forming proteins alter the nanoscale mechanical
properties of lipid membranes
!

50!

complexes were ~2-7 nm in height. Similar sized oligomers of amylin (3.6 nm)
were reported from aggregation studies performed in the presence of a
DOPC/DPPC/Chol lipid bilayer system, but this was observed at a much lower
concentration (1 µM) and after a longer incubation time (30 hours).62 These
aggregate complexes that formed on the TBLE bilayer were also much larger
than oligomers of amylin that are commonly observed during the lag-phase of
aggregation in the absence of a lipid membrane.62,63
Complicating the comparison of these observed aggregates with those
reported in the literature is that the heights of the aggregate complexes
associated with each protein were measured with respect to the bilayer surface.
As a result, the actual heights of the aggregate complexes associated with the
exposure to all four peptides may be larger than measured here if the complex is
fully or partially inserted into the bilayer. As a control, bilayers were exposed to
50 µM BSA, and no bilayer disruption (RMS roughness of 0.07 ± 0.01 nm) or
protein aggregation was observed over 24 hours (Figure 2.5F).
The differences in the magnitude of roughening caused by each protein
may be attributable to the mechanism of lipid binding associated with each
protein. The random coil in the transmembrane and extracellular domains of Aβ
can result in deeper insertion into the bilayer, resulting in a larger roughness
measurement. The amphiphilic α-helix in htt exon1-51Q, synthetic polyQ peptide,
and amylin allow for lipid binding with less insertion into lipid membranes when
compared with Aβ1-40.20 Partial insertion of amylin into lipid membranes,
stabilizing its a-helical character, has been suggested by molecular dynamic
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simulations.64 Correspondingly, solid-state nuclear magnetic resonance (NMR)
studies of the first 17 amino acids of htt exon1 show this domain to be partially
inserted into lipid membranes.65 The lateral morphology of the disrupted regions
of the bilayer associated with the different amyloid-forming proteins varied. The
disrupted regions of the bilayer associated with Aβ1-40 were often interconnected
by meandering, elongated regions. Htt exon1-51Q and amylin were associated
with round regions of increased surface roughness that were typically between
300-500 nm in diameter. The synthetic polyQ peptide also formed these round
regions of disruption, but often these regions were as large as 1-2 mm in
diameter and generally were fewer in number.
Collectively, these observations suggest that the disruption of membrane
structure is a common feature of the interaction between amyloid-forming
proteins and lipid bilayers. This disruption should alter the local mechanical
properties of the bilayer, compromising its ability to function properly as a
membrane. Mechanical properties of lipids have long been thought to correlate
with dysfunction and disease66-68 since it is hypothesized that elasticity and
adhesion of membranes directly influence cell stability. Cell and/or lipid
permeability correlating with dysfunction has previously been suggested with
Aβ,69,70 mutant htt,27,71 and amylin.72,73 As a result, analysis of the tip/sample
tapping forces were conducted to determine the impact of these amyloid-forming
proteins on the mechanical properties of the bilayer.
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2.3.2 Features of the time-resolved tip/sample tapping forces can be used to
measure mechanical properties.
It has been established that features of the time-resolved tip/sample force
associated with tapping mode AFM are dependent on the mechanical properties
of the sample.40,51,74-81 While obtaining AFM topography images of protein/lipid
bilayer systems, the cantilever deflection signal was captured and used to
recover the time-resolved tip/sample tapping force. Features of the force
associated with tapping events changed during the imaging processes,
suggesting differences in mechanical properties along the surface. In particular,
the maximum tapping force (Fmax) and minimum tapping force (Fmin) per
oscillation cycle varied. Fmax is defined as the peak or largest positive force
experienced between the tip and surface during one tapping event, and Fmin is
defined as the largest negative force experienced between the tip and surface
(Figure 2.7A). To demonstrate the impact of surface properties on the tip/sample
force interaction associated with tapping mode AFM in fluids and to aid in
interpretation of these force interactions, numerical simulations of the entire
imaging process were performed as described in the materials and
methods.40,54,55
For changes in the tip/sample force to be useful in determining the
mechanical properties of lipid bilayers disturbed by amyloid-forming proteins, the
tip/sample tapping force must be independent of the surface roughness. To
determine the role of surface roughness on tip/sample tapping forces,
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Figure 2.7: Based on numerical simulations, time-resolved tip/sample tapping
forces can be used to measure local surface properties of surfaces,
independent of morphology. (A) The time-resolved tip/sample force trajectory
associated with imaging a lipid bilayer exposed to amyloid-forming proteins. Example
force interaction for one oscillation cycle are shown, with Fmax and Fmin indicated. (B)
Experimental (left) and simulated (right) cantilever deflection and tapping force
trajectories are shown. (C) Simulated height profiles are shown with regions of
increased root-mean-square (RMS) roughness (indicated by gray shading) ranging
from 0.5 to 2.0 nm. (D) A representative, simulated force trajectory associated with
imaging a surface in which the RMS roughness increased in the variable region of the
model surface (from 0.1 to 2.0 nm). (E) Fmax and (F) Fmin plotted as a function of RMS
roughness. (G) Simulated force trajectories associated with imaging a surface with the
Young’s modulus changing from 5.5 GPa to 3.0 GPa or 1.0 GPa (shaded in gray)
respectively. (H) Tip/sample force for one oscillation cycle for simulations with different
values of Young’s modulus as indicated. (I) Fmax and (J) Fmin plotted as a function of
Young’s modulus. (K) Simulated force trajectories associated with imaging a surface
with the Hamaker constant changing from 1.0 a J to 1.75 a J or 0.1 a J (shaded in
gray) respectively. (L) Tip/sample force for one oscillation cycle for simulations with
different values of the Hamaker constant as indicated. (M) Fmax and (N) Fmin plotted as
a function of the Hamaker constant.
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simulations were performed using 500 nm long model surfaces that consisted of
two regions of RMS roughness of 0.1 nm (similar to the undisturbed bilayer)
flanking a region in which the RMS roughness was varied (0.5 to 2.0 nm) in
successive simulations (Figure 2.7C-D). The range of RMS roughness used in
these simulations was comparable to that observed for bilayers disrupted by
amyloid-forming proteins. As there is an inherit response time associated with the
ability of the feedback loop to restore the tapping amplitude when the tip
encounters an abrupt change in surface morphology, the tapping force trajectory
appears choppier when the RMS roughness increases. However, the average
Fmax and Fmin do not change as a function of RMS roughness (Figure 2.7E-F).
This indicates, that as long as the feedback loop is optimized, changes in tapping
forces are not dependent on sample topography.
After establishing that changes in Fmax and Fmin are independent of surface
topography, simulations were performed to determine how the relative rigidity of
the surface and its adhesion to the AFM probe altered features of the tip/sample
force interaction. Changes in the rigidity of a surface can be modeled by
changing the Young's modulus of the sample (Esample in equation (5)). As the
surface free energy (and adhesive force) between the tip and surface are related
to the Hamaker constant by:
(7)
the adhesive interaction between the tip and surface can be modeled by
changing the value of the Hamaker constant. For these simulations, 500 nm long
model surfaces were used that contained a region in which the mechanical
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properties of the surface could be changed in successive simulations. This
variable region was flanked by regions that had a Young's modulus of 5.5 GPa
and a Hamaker constant of 1.0 aJ. First, a series of simulations were run with the
Young's modulus systematically increasing from 0.5 to 5 GPa in the variable
region (the Hamaker constant was not changed) (Figure 2.7G-H). Increasing the
Young's modulus results in a less compliant surface and a reduction in the
constant, keff, in equation (5). As a result, Fmax increased in magnitude with larger
values of sample Young's modulus with a power law dependence (Figure 2.7I).
Fmin was independent of changes in the surface Young's modulus (Figure 2.7J).
Next, a series of simulations were run with various values of Hamaker constant
(0.1 to 1.75 aJ) in the variable region of the model surface, and changes in Fmax
and Fmin were observed (Figure 2.7K-L). As the Hamaker constant was
increased, the attractive component of the tip/sample force became larger, and
the magnitude of Fmin increased (became more negative) in a linear fashion
(Figure 2.7M). The larger attractive force also caused the tip to push deeper into
the surface. As a result, the Hertzian portion of the tip/sample force during
contact increased, causing Fmax to increase in magnitude linearly with larger
Hamaker constants (Figure 2.7N). Collectively, the simulations with varying
values of the Hamaker constant or Young's modulus demonstrated that unique
features of the tip/sample tapping force can be used to determine relative
changes in the mechanical properties of the bilayer surface.
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2.3.3 Amyloidogenic proteins alter mechanical properties of lipid bilayers
To elucidate the impact of amyloid-forming proteins on lipid bilayers,
mechanical properties of the membranes were spatially analyzed based on the
time-resolved tip/sample imaging forces associated with tapping mode AFM. To
accomplish this, the entire tip deflection trajectory was captured while obtaining
an entire AFM image and converted into the force interaction by SPAM. This
allowed for specific tapping events to be correlated with morphological features
of the surface. Spatially resolved maps of Fmin (Figure 2.8) and Fmax (Figure 2.9)

Figure 2.8: Lipid bilayers exposed to amyloid-forming proteins adhere less to
the AFM probe, based on changes in the minimum tapping force. A series of Fmin
images and histograms of every tapping event associated with capturing AFM imaging
of TBLE bilayers exposed to (A) Aβ1-40, (B) htt exon1-51Q, (C) synthetic polyQ
peptide, and (D) amylin are shown. These Fmin images correspond to the
topographical images presented in Figure 2.5. The scale bar in a-c represents 500
nm, and the scale bar in d represents 1000 nm.
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were generated that correspond to each topography image in Figure 2.5 of lipid
bilayers exposed to amyloid-forming proteins. The force images have distinct
contrast between the unperturbed regions of the bilayer and the disrupted
regions of the bilayer associated with all of the tested amyloid-forming proteins.
Histograms of Fmin and Fmax for every tapping event can be sorted based on
topography image so that every individual tapping event can be associated with
specific regions in the surface. The domains where proteins have associated with

Figure 2.9: Exposure to amyloid-forming proteins soften lipid bilayers, based on
changes in the maximum tapping force. A series of Fmax images and histograms of
every tapping event associated with capturing AFM imaging of TBLE bilayers exposed
to (A) Aβ1-40, (B) htt exon1-51Q, (C) synthetic polyQ peptide, and (D) amylin are
shown. These Fmax images correspond to the topographical images presented in
Figure 2.5. The scale bar in A-C represents 500 nm, and the scale bar in d represents
1000 nm.
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lipid, resulting in disruption, were associated with smaller magnitudes of both Fmin
and Fmax compared to the unperturbed lipid domains. Based on simulations, there
are several potential implications of these changes in the tip/sample force
interaction associated with disrupted regions of the bilayer. The shifts in Fmin and
Fmax were independent of the rougher morphology caused by the amyloid-forming
proteins. As Fmin was not altered by changes in the Young's modulus of the
surface in simulation, the observed shifts in Fmin associated with exposure to
amyloid-forming proteins were primarily due to a decreased adhesive interaction
between the disrupted regions of the bilayer and the AFM tip. The shift in Fmax
associated with disrupted regions of the bilayer are potentially related to both
changes in the bilayer's Young's modulus and/or the Hamaker constant
associated with the interaction between the tip and surface. Simulations
suggested that shifts in Fmax due to changes in the surface free energy can be
estimated from the observed change in Fmin. When comparing the results
associated with Fmin and Fmax, the observed shift in Fmax could not be completely
accounted for by what would be expected based on the observed shift in Fmin. As
a result, a portion of the observed decrease in Fmax associated with disrupted
regions of the bilayer can be associated with a decreased Young's modulus.
Collectively, these results indicate that interaction between lipid bilayers and
amyloid-forming proteins results in regions of altered membrane morphology
(increased roughness) and mechanical properties (decreased Young's modulus
of the bilayer and a reduced adhesive interaction between the tip and surface).
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2.4 Discussion
A potential explanation for these observed changes in bilayers exposed to
amyloid-forming proteins is a decrease in the efficiency of the packing of the lipid
components within the bilayer in response to protein insertion/binding and
aggregation. This would lead to a rougher bilayer that is more easily compressed
and a decrease in the number of potential hydrogen bonds formed between the
tip and bilayer surface, leading to the lower adhesive interaction. Previous
studies highlight the effects lateral tension has on lipid structure and stability.82,83
These studies suggest that due to the material properties of the lipid bilayer
(thickness, intrinsic curvature, and Young’s moduli), the membrane can serve as
an allosteric regulator of membrane protein function. Furthermore, lipids naturally
compress and/or stretch in order to minimize the interaction between
hydrophobic domains of a transmembrane protein and the aqueous environment.
Thus, once the amyloid-forming proteins associate with the bilayer, the bilayer
may stretch itself in order to minimize the hydrophobic effect, allowing more
space between the two tail ends of the lipid leaflets. A larger space between the
two leaflets would be consistent with our results since this would result in greater
compressibility.
Presented results and simulations demonstrate that Fmin and Fmax of the
tip/sample tapping force can be directly related to material properties of the
surface. As a result, the mechanical properties of biological surfaces, such as
lipid bilayers, can be mapped with nanoscale spatial resolution while
simultaneously obtaining the surface topography in a tapping mode AFM
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experiment. Taking advantage of this, the morphological and mechanical
changes associated with exposing lipid bilayers to amyloidogenic proteins were
determined in this chapter. The similar physical impact on bilayers of these
amyloid-forming proteins suggests that this may represent an intrinsic
amyloid/lipid interaction with potential implication for a common toxic mechanism.
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3. Point mutations in Aβ induce polymorphic aggregates at
liquid/solid interfaces and in the presence of lipid bilayers

The ability of Aβ to display aggregate polymorphism may contribute to
variations in AD, and a potentially important environmental factor in determining
aggregate structure is the interaction of Aβ with surfaces, as conformational
changes can be stimulated in proteins encountering surfaces. There are also
several mutations clustered around the central hydrophobic core of Aβ near the
α-secretase cleavage site (E22G Arctic mutation, E22K Italian mutation, D23N
Iowa mutation, and A21G Flemish mutation). These point mutations are
associated with hereditary diseases ranging from almost pure cerebral amyloid
angiopathy (CAA) to typical AD pathology with plaques and tangles. The goal of
this study was to determine how point mutations in Aβ, which alter peptide
charge and hydrophobic character, influence the morphology of Aβ aggregates
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under free solution conditions, at a solid/liquid interface, and in the presence of
supported lipid membranes of total brain lipid extract. Brain lipid extract bilayers
were used as a physiologically relevant model of a neuronal cell surface. While
the rate of formation of specific aggregate types was altered by mutations in Aβ
under free solution conditions, the respective aggregate morphologies were
similar. However, aggregation occurring directly on a negatively charged mica
surface resulted in distinct aggregate morphologies formed by different mutant
forms of Aβ. Intact lipid bilayers were exposed to predominantly monomeric
preparations of Wild Type or different mutant forms of Aβ, and AFM was used to
monitor aggregate formation and morphology as well as bilayer integrity over a
12 h period. While fibril morphology did not appear to be significantly altered
when mutants were prepped similarly and incubated under free solution
conditions, aggregation in the lipid membranes resulted in a variety of
polymorphic aggregates in a mutation dependent manner. The mutant peptides
also had a variable ability to disrupt bilayer integrity. These studies provide
insight into the potential role surfaces play in dictating the formation of specific
Aβ polymorphic aggregate structures.

3.1 Introduction: Point mutations in AD
There are several point mutations in APP that are associated with a
variety of familial forms of AD.1 Of particularly interest are the point mutations
clustered around the central hydrophobic core of Aβ at positions 21-23 (E22G
Arctic mutation, E22K Italian mutation, D23N Iowa mutation, and A21G Flemish
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mutation) (Figure 3.1). With only the Flemish mutation being an exception, these
missense mutations are not associated with increased Aβ secretion2-7 and have
a greater propensity of the peptide to aggregate into protofibrils and/or fibrils than

Figure 3.1: Experimental systems. Schematic representation of the Aβ peptide with
point mutations used in this study and occurring between the 21-23 amino acid
sequence of Aβ1-40 indicated. These mutations include Arctic, Italian, Iowa, and
Flemish.

Aβ Wild Type (WT).4,8-11 The Arctic, Italian and Iowa mutations of Aβ1-40 are
reported to be more toxic to neuroblastoma cells in vitro.1,5,12-16 Interestingly,
these mutations are located at the end of or directly adjacent to a sequence in Aβ
(residues 16-21) that has been identified to have amyloidogenic properties.17
Each mutation has its own unique pathology ranging from severe cerebral
amyloid angiopathy (CAA) to AD-like plaque formation, as well as varying ages of
onset (Table 3.1). Due to their clustering around positions 21-23, these mutations
offer a unique opportunity to correlate toxicity to specific aggregate conformers,
as point mutations alter the rates of Aβ aggregation, fibril formation, interaction
with surfaces, and insertion into lipid bilayers by changing the hydrophobicity or
charge following substitution.
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Mutation

Familial AD Disease Pathology

Age of
Onset

Arctic

58

(E22G)

Early onset-AD without small, localized area of dead
tissue resulting from failure of blood supply. High
protofibril and fibril levels. Very fast aggregation.18-20

Italian

Extensive CAA with cerebral hemorrhagic episodes21

57

Early onset, AD-like dementia with cerebral atrophy,
and severe CAA and deposition of plaques and
tangles.22,23

69

Abundance of large, dense AD-like plaques linked to
CAA. Progressive dementia and cortical atrophy. Very
slow aggregation.24-26

40-60

(E22K)
Iowa
(D23N)
Flemish
(A21G)

Table 3.1: Aβ mutation disease pathology. Each missense mutation studied in this
chapter has a distinct disease pathology and age of onset. These mutations are a key
aspect of familial AD.

The altered charge of mutant Aβ peptides can influence their interactions
with surfaces, resulting in an altered aggregation process both kinetically and
morphologically. Such changes would potentially impact the deposition,
proteolytic susceptibility, clearance rates, and cellular toxicity of Aβ. In this
chapter, the role point mutations in the central region of Aβ play in determining
aggregate morphology, kinetics of formation, and interactions with an anionic
surface and supported lipid bilayers was determined. For these studies,
aggregation of Wild Type Aβ1-40 with Aβ1-40 containing the E22G Arctic, E22K
Italian, D23N Iowa, or A21G Flemish mutations was compared. Because
traditional light and electron microscopic approaches have important limitations
for studying heterogeneous mixtures of Aβ aggregates, AFM was used to
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characterize the morphology of the assembly states of the different Aβ peptides.
AFM is uniquely well suited to study amyloidogenic proteins, as it is capable of
obtaining three-dimensional surface maps with nanometer spatial resolution in
solution in the absence of artifacts from sample processing.

3.2 Materials and methods
3.2.1 Sample preparation
Synthetic Wild Type, Arctic, Iowa, Italian, and Flemish Aβ1-40 peptides
(AnaSpec Inc., San Jose, CA) were used for all studies. The same lot of peptide
for each variant of Aβ was used for all experiments. These peptides were
prepared exactly the same based on previously reported protocols.31 In short,
peptides were treated with HFIP to dissolve pre-existing aggregates and seeds
present in the lyophilized stocks. The solutions of Aβ in HFIP were placed under
vacuum in a Vacufuge concentrator (Eppendorf) to remove the HFIP completely,
resulting in a small film of Aβ. The attained Aβ films were resuspended in 10.0 µL
DMSO and thoroughly vortexed to make a 2000 µM stock solution. These stock
solutions were then dissolved directly into 37°C PBS (pH 7.3) to a final peptide
concentration of 20-40 µM depending on the required experimental conditions
final DMSO concentration of 1%). TBLE was purchased from Avanti Polar Lipids
(Alabaster, AL) in a lypholized state and was resuspended in PBS (pH 7.3) at a
concentration of 1 mg/ml. Using an acetone/dry ice bath, bilayers and multilayer
lipid sheets were formed by five cycles of freeze-thaw treatment.36,64 The lipid
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suspensions were sonicated for 15 min to promote vesicle formation. All
experiments were performed with the same lot of lipids.

3.2.2 Ex situ AFM imaging conditions (free solution)
For experiments aimed at elucidating the aggregation of Aβ peptides
under free solution conditions, 20 µM solutions of each peptide was prepared
and incubated at 37oC and 1400 RPM for the duration of the experiment. At 1, 3,
5, 8, and 24 h after the final dilution of the peptide into buffer, 5 µL aliquots of
each incubation was spotted on freshly cleaved mica, washed with 200 µL of
HPLC grade water, and dried under a gentle stream of Nitrogen. Three separate
incubations were performed for each type of Aβ, and each of these were
sampled twice at each time point. Aβ aggregates deposited on mica were imaged
ex situ using a Nanoscope V MultiMode scanning probe microscope (Veeco,
Santa Barbara, CA) equipped with a closed-loop vertical engage J-scanner and
operated in the tapping mode. Images were taken with a diving board shaped
silicon cantilever with a nominal spring constant of 40 N/m. Scan rates were set
at 2 to 3 Hz with cantilever drive frequencies of approximately 300 kHz.

3.2.3 In situ AFM imaging conditions
In situ AFM experiments were performed with a Nanoscope V MultiMode
scanning probe microscope (Veeco, Santa Barbara, CA) equipped with a
sealable fluid cell and a closed-loop vertical engage J-scanner operated in the
tapping mode. Images were obtained with V-shaped oxide-sharpened silicon
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nitride cantilever with a nominal spring constant of 0.5 N/m (Budget Sensors,
Bulgaria). Scan rates were set between 1 to 2 Hz with cantilever drive
frequencies ranging from ~8-10 kHz.
For in situ experiments on a mica surface, 25 µL filtered PBS buffer was
added to the cell, and background images were obtained to ensure cleanliness of
the cell before the addition of Aβ. Next, a 25 µL aliquot of freshly prepared 40 µM
Aβ1-40 peptide solution in PBS was injected via channels on the fluid cell, resulting
in a final peptide concentration of 20 µM. After injection of the peptide, the
surface was continuously imaged in order to track the aggregation of Aβ on the
mica surface. Intermittently, the scan area was offset to compare aggregate
morphologies of previously un-imaged portions of the mica surface to the
aggregates forming under continual imaging. This was done to ensure that the
imaging process itself was not significantly altering the aggregation process on
the surface. Typical scan size was 10 by 10 µm with resolution 1024 x 1024
pixels.
For experiments on a supported lipid bilayer, concentrated TBLE vesicle
solution was added to the cell in 40 µL aliquots by the hanging drop method and
allowed to fuse in situ. Once a 40 × 40 µm patch of defect-free bilayer was
formed, the cell was flushed to remove vesicles remaining in solution. Only
defect-free bilayers that were 40 × 40 µm were used for studies with Aβ. Next, 40
µL of 20 µM of freshly prepared Aβ1-40 solution in PBS was added via the
channels in the fluid cell.
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3.2.4 Quantitative image analysis
AFM image analysis was performed using MATLAB equipped with the
image processing toolbox (MathWorks, Natick, MA). Physical dimensions of most
aggregates were measured automatically in this way: 1) Images were imported
into MATLAB. 2) Images were flattened to correct for curvature due to the
imaging process. 3) Flattened images were converted into binary maps of
aggregate locations by using a height threshold (set at ~1 nm). This was
accomplished by assigning values of 1 to any pixel of the image that represented
a height above the threshold and assigning a value of 0 to any pixel
corresponding to a height below the threshold. 4) The binary map was used to
locate aggregates within the original AFM image using pattern recognition
algorithms. 5) Once a discreet aggregate was located, dimensions were
automatically measured. Each aggregate was also assigned an individual
number so that aggregates chosen based on specific measured properties could
be located, allowing for verification that chosen dimensions corresponded to
specific aggregate types. In this way large data sets were automatically
constructed that could be used to keep track of thousands of individual
aggregates and sorted based on specific dimensional characteristics. Two
dimensional fast Fourier transform (FFT 2D) analysis was performed on in situ
AFM images using the NanoScope v7.30 AFM processing software (Veeco,
Santa Barbara, CA).
Based on inspection of individual representative aggregate types and
verified using our tracking system, specific dimensional characteristics to specific
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aggregate types were assigned. Oligomers were defined as 2–10 nm in height
with an aspect ratio (longest distance across to shortest distance across) less
than 2, indicating a globular structure. Fibrils were defined as aggregates greater
than 3 nm in height that had an aspect ratio greater than 2.5. For determination
of fibril contour length and end to end distance, individual objects in an AFM
image were identified by height thresholding and filtering based on aspect ratio.
The software then incorporated a fast parallel thinning algorithm66 to create a
pixel skeleton for each object present in the AFM image. Once the fibril skeleton
was obtained, the endpoints of each skeleton were determined and used to
calculate end to end distance. The pixel skeleton was used to determine contour
length and average height along contour of the fibril.

3.2.5 Determining the number of peptides per oligomer from AFM images
Volume measurements were partially corrected for error associated with
the finite size of the AFM probe based on geometric models.40 The volume of an
individual Aβ peptide was estimated based on its molecular weight and the
average density of proteins.67,68 By dividing the observed corrected volume of
each individual aggregate by the estimated volume of a single monomer, the
number of molecules per each oligomer was calculated. This calculation
assumes perfect packing of individual monomers within the oligomer and that the
density of the proteins is the same in aggregated and unaggregated forms.

3. Point mutations in Aβ induce polymorphic aggregates at liquid/solid
interfaces and in the presence of lipid bilayers
!

76!

3.3 Results
3.3.1 Point mutations in the central region of Aβ result in variable rates of
aggregation
To determine how point mutations in the central region of Aβ alter
aggregation under free solution conditions (without the presence of a surface),
separate incubations of Wild Type, Italian, Arctic, Flemish, and Iowa Aβ at 20 µM
were prepared. After dilution into PBS, these solutions were incubated at 37oC
and sampled for ex situ AFM analysis at 1, 3, 5, 8, and 24 h (Figure 3.2). For
analysis, aggregate types were defined strictly by morphological features (Figure
3.3). Oligomers were defined as aggregates that were at least 1 nm in height and
had an aspect ratio (longest distance across to shortest distance across) of less
than 2.5, which indicated a predominantly round, globular structure. Protofibrils
and fibrils were defined as aggregates with heights larger than 1 nm and an
aspect ratio greater than 2.5. A height filter further separated these elongated
aggregates. Protofibrils were defined as being 1-4 nm in height, whereas, fibrils
were larger than 4 nm in height anywhere along their contour. The characteristic
morphological features associated with these distinct aggregate types were
justified by measurements performed on representative aggregates in images.
When fibrils grew long enough to intertwine and be detected as a single
aggregate, the number of fibrils bundled together was estimated visually by
counting. The incubations were performed in triplicate. To quantify the
relationship between oligomer, protofibril, and fibril formation, the number of each

3. Point mutations in Aβ induce polymorphic aggregates at liquid/solid
interfaces and in the presence of lipid bilayers
!

77!

!

Figure 3.2: Point mutations in Aβ alter the temporal appearance of distinct
aggregate forms. AFM images demonstrate the aggregation of Wild Type, Arctic,
Italian, Iowa, or Flemish Aβ1-40. Incubations with protein concentration of 20 µM were
imaged at different time points after the dilution of DMSO stocks into PBS buffer.
Examples of oligomers, the larger subpopulation oligomers, protofibrils, and fibrils are
indicated by black, magenta, blue, and green arrows, respectively. At 1 h, Wild Type
and mutant Aβ peptides all formed predominately oligomeric aggregates. However,
heterogeneous mixtures of aggregate types appeared at later times for all incubations.

respective aggregate type per µm was determined by use of automated image
analysis software (Figure 3.4). Five 25 µm images of different areas of the mica
substrate were taken and analyzed at each time-point for every replicate (a total
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Figure 3.3: Representative ex situ AFM images demonstrate the classification of
Aβ aggregates. Representative AFM images and aggregate profiles that compare
basic dimensions of (A) oligomers, (B) protofibrils, and (C) fibrils are shown. Height
profiles under each image are indicated by colored lines. The blue arrows in (A)
indicate the appearance of smaller oligomers. By using a combination of height and
aspect ratio, relative populations of aggregates types can be distinguished and
quantified in a heterogeneous mixture. Oligomers can be distinguished from
protofibrils and fibrils by aspect ratio. Protofibrils and fibrils can be distinguished from
each other by height, as indicated by the yellow shading in the height profiles.

of 15 images per data point in Figure 3.4). It should be noted that at some time
points, annular aggregates were observed (Figure 3.5). There were two types of
annular aggregates: larger rings with inner diameter greater than 100 nm smaller
rings with inner diameter smaller than 25 nm. The larger annular aggregates
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possessed heights similar to those of fibrils; meanwhile, the smaller annular
aggregates were similar to protofibrils in height. However, as annular aggregates
were rare, they were not included in further analysis.
Oligomeric

structures

were observed for all forms of Aβ
within 1 h. The appearance of
protofibrillar

and

fibrillar

aggregates depended on the
specific form of Aβ, with these
structures

appearing

different
Images

after

incubation
(Figure

quantification

times.

3.2)
of

and
distinct

aggregate types per unit area
(Figure 3.4) demonstrated that
aggregation
Figure 3.4: Quantification of the temporal
appearance of distinct Aβ aggregate forms
with respect to mutation. Quantification of
aggregate types observed in AFM images for
20 µM incubations of Wild Type, Arctic, Italian,
Iowa, or Flemish Aβ1-40. The numbers of (A)
oligomeric, (B) protofibrillar, and (C) fibrillar
aggregates per µm were calculated from AFM
images taken at discreet time points for each
incubation (for examples of images see Figure
3.2). The appearance of protofibrillar and
fibrillar aggregates varied for the different Aβ
peptides.

results

heterogeneous
aggregate

forms

in

a

mixture

of

(under

free

solution conditions at any given
time), which is influenced by the
presence of disease-related point
mutations in Aβ. The number of

oligomers per unit area in Wild Type incubations gradually increased, reaching a
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maximum population at the 5 h time point. After this initial increase, the
population of Wild Type oligomers decreased as protofibrils (8 h) and fibrils (24
h) appeared. There was also a subpopulation of larger oligomer (i.e. globular)
species observed throughout the Wild Type Aβ aggregation experiment. Due to
their “bumpy” morphology, these larger oligomers were most likely accumulations
of smaller globular aggregates.
Fibrils of Wild Type Aβ at the 24 h time-point were typically a few hundred
nm to a micron in length. The same aggregation pattern emerged for the Italian
form of Aβ. However, the maximum population of oligomers occurred at an
earlier time-point (3 h) that corresponded with the appearance of protofibrils at
3h. Fibrils of Italian Aβ also appeared (5 h) more quickly in comparison to Wild
Type, which is compatible with previous reports indicating that Italian Aβ
aggregates with faster kinetics.27 Despite appearing at a much earlier time-point,
fibrils of Italian Aβ observed after 24 h of incubation were similar in length to
those observed by Wild Type at the same time-point. The population of oligomers
peaked at the 1 h time-point for incubations of Arctic Aβ. Protofibrils and fibrils
appeared after 3 h of incubation for Arctic Aβ, with protofibrils being the more

Figure 3.5: A small number of
annular aggregates were
observed in incubations of
Wild Type and mutant Aβ. (A)
Large ring structures with inner
diameters on the order of 100
nm and (B) small ring
structures with inner diameters
on the order of 25 nm were
observed.

3. Point mutations in Aβ induce polymorphic aggregates at liquid/solid
interfaces and in the presence of lipid bilayers
!

81!

abundant of the two aggregate forms. With time, the number of protofibrils of
Arctic Aβ decreased as the fibril population grew. Arctic Aβ demonstrated the
most prolific fibril formation, eventually resulting in fibrils that extended over
several microns in length and formed inter-tangled meshes or bundles of fibrils.
While the initial reports on the aggregation kinetics of Arctic Aβ indicated that the
mutation increases protofibril formation but not fibril formation,4 subsequent
reports are more consistent with our observations that the Arctic mutation
increased the rate of fibril formation.14,28-30 A potential source for this discrepancy
is the well documented observations that preparatory conditions have an impact
on the types of aggregates formed by Aβ31 and can lead to distinct polymorphic
aggregates.32 The Iowa mutation resulted in a steady population of oligomers, in
comparison to the other Aβ forms. Similar to Wild Type, a subpopulation of larger
oligomeric (globular morphology) also formed in incubations of Iowa Aβ.
Protofibrils appeared after 3 h of incubation for Iowa Aβ, which was faster
compared to Wild Type but similar to Italian and Arctic Aβ. Despite the early
appearance of protofibrils, fibrils of Iowa Aβ were not observed until 24 h of
incubation, yet these fibrils were very long, extending several microns in length.
Flemish Aβ formed oligomers with a peak population appearing after 3 h of
incubation, but unlike the other forms of Aβ, this peak did not correspond with the
appearance of protofibrils (appeared at 8 h) or fibrils (not observed during the 24
h incubation). A subpopulation of larger oligomers comprised of Flemish Aβ,
similar to that observed for Wild Type, was observed. Overall, the observations
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are consistent with reports that the Flemish mutant reduces the rate of Aβ
aggregation and fibril formation.11,27,33

3.3.2 Aggregation of Wild Type or mutant forms of Aβ1-40 results in similar
aggregate morphologies under free solution conditions
While the populations of aggregate forms based on morphological criteria
were automatically quantified, in order to determine if once formed, there were
more subtle morphological differences within these aggregate categories as a
function of these specific point mutations in Aβ. Representative AFM images and
size analysis of oligomers are presented in Figure 3.6. The morphological
dimension chosen for this comparison was aggregate height because this
measurement contains the least amount of distortion associated with the finite
size and shape of the AFM probe tip. Due to the large numbers of oligomers
observed at each time-point, height histograms were constructed of all
aggregates that met the morphological requirements to be considered oligomers
as a function of time. While the majority of oligomers formed from Wild Type Aβ
were ~4-6 nm tall at all time points, after 5 h a second, larger subpopulation of
oligomers appeared, as evidenced by a shoulder or secondary peak in the height
histograms. While larger oligomers were observed for the other mutant forms of
Aβ, only with the Flemish and Iowa mutation did the population of these larger
oligomers become high enough to result in a distinct second peak in the
histograms. The majority of oligomers formed by Italian Aβ were slightly smaller
compared to Wild Type. The Italian Aβ oligomers were predominately 2-4 nm tall
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Figure 3.6: Oligomers formed by Wild Type or mutant Aβ peptides displayed a
variety of sizes. (A) Representative ex situ AFM images of oligomeric aggregates of
Wild Type, Arctic, Italian, Iowa, or Flemish Aβ1-40 after 8 h of incubation. Arrows
indicate examples of larger oligomeric (globular) aggregates. (B) Height histograms of
oligomeric aggregates for each type of Aβ for different incubation time points.

at 1, 3 and 5 h; however, Italian Aβ oligomers were significantly smaller (~1-2
nm) after 8 and 24 h of incubation. Oligomers formed from Arctic Aβ gradually
transitioned to larger aggregate forms based on height before becoming smaller
at later time points (2-3 nm at 1 h; 2-4 nm at 3 h; 3-4 nm at 5 h; 2-4 nm at 8 h;
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and 1-2 nm at 24 h). Iowa Aβ formed oligomers that were consistently 1-3 nm in
height; however, at the 24 h time-point, the size of the oligomers shifted to 3-5
nm. At all time points except 3 h, oligomers of Flemish Aβ were predominately
smaller than 2 nm; however, there was the previously mentioned subpopulation
of larger oligomeric aggregates.
Next, the morphologies of elongated aggregate structures, i.e., protofibrils
and fibrils, formed by Wild Type and mutant forms of Aβ were compared (Figure
3.7). As there were much fewer observed elongated aggregates and the height
along the contour of these aggregates was quite variable, representative height
profiles across these aggregates are presented (Figure 3.7A). As defined by our
morphological criteria, protofibrils were defined to be 1-4 nm tall; however, most
(> 90% for all Aβ forms) of the observed protofibrils were 1.5-2.5 nm tall. Once
formed, protofibrils of Wild Type, Italian, Arctic, Flemish, or Iowa were
morphologically indistinguishable from each other. All of the protofibrils displayed
various degrees of curvature along their contour and often had an appearance of
being a series of connected globular blobs. As fibrils were rare or not observed at
all for some of the Aβ peptides, some of the incubations were sampled at a 48 h
time point to obtain aggregates that satisfied the sorting criteria for fibrils to
facilitate morphological comparison (Figure 3.7B). Fibrils were defined as having
a height anywhere along their contour greater than 4 nm, with no upper limit.
Despites this lack of no upper restriction in the criteria, fibrils were seldom
observed (for Wild Type and all mutant forms of Aβ) containing a height larger
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Figure 3.7: Comparison of protofibrillar and fibrillar aggregates formed from
Wild Type or mutant Aβ. Representative ex situ AFM images of (A) protofibrils and
(B) fibrils of Wild Type, Arctic, Italian, Iowa, or Flemish Aβ1-40. Height profiles under
each image are indicated by colored lines.

than 10 nm along its contour unless there was a bundling of fibrils or
accumulation of other aggregates associated with the fibril. While the criteria for
a fibril required at least a portion of the fibril to be taller than 4 nm, there were
also regions along fibrils that would be shorter than this limit. However, a fibril
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region shorter than 3 nm was never observed. Once abundantly formed, fibrils of
Wild Type Aβ tended to form bundles. Despite this bundling, regions of Wild Type
fibrils not bundled closely resembled fibrils formed from Arctic and Iowa Aβ
morphologically, with fibril heights varying from ~4-10 nm along the fibril contour.
Fibrils of Italian Aβ tended to not be as tall, seldom having regions taller than 5-6
nm. The fibrils formed form Flemish Aβ were often obscured by accumulation of
particulate aggregate forms; however, fibrillar morphologies often extended out
from these large structures. These regions of Flemish fibrils were also very
similar to those formed by Wild Type.

3.3.3 Point mutations in the 21st-23rd amino acid of Aβ result in polymorphic
aggregates at solid/liquid interfaces
Previous studies with Aβ and other amyloid forming peptides have
demonstrated that fibril formation may be driven by interactions at the interface of
aqueous solutions and surfaces.34 Here, the determination if such a solid/liquid
interface could invoke polymorphic aggregate structures in a mutant dependent
manner was studied. If mutations exert influence on the interaction of Aβ with
surfaces, this would have consequences for a variety of biophysical phenomenon
related to Aβ cellular binding, aggregation, and ultimately mechanisms of toxicity,
potentially playing a factor in mutation related alterations in disease pathology.
For these studies, the aggregation of Wild Type and mutant Aβ peptides in real
time by in situ AFM using hydrophilic mica (which can be considered a mimic of
an anionic lipid membrane) as a model surface was characterized. Based on
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recent studies indicating that Aβ oligomers have a higher affinity for lipid
membranes with an increased net negative charge,35 the negatively charged
mica surface seems to be an appropriate choice for a simple model surface. For
these studies, Wild Type or the mutant forms of Aβ were all freshly prepared by
the same procedure, to eliminate variance associated with these conditions.
The aggregation of Wild Type Aβ1-40 on a mica surface at 20 µM using in
situ AFM was first tracked (Figure 3.8). For the first 20-30 min, several oligomers
appeared on the surface, and with time, the number of oligomers increased.
Some small putative, protofibrillar aggregates were present on mica after ~35
min. These elongated protofibrils were highly curved and often displayed
morphology of connected globules. As they were fully hydrated, these protofibrils
were taller than observed in ex situ AFM experiments with Wild Type (Figure
3.8C). Furthermore, these protofibrillar aggregates displayed varying stability.
That is, some of these protofibrils disappeared after a few minutes, while others
remained and grew in size for the remainder of the experiment. With time several
oligomers moved together to form protofibrils (Figure 3.8A yellow arrows, while
other migrating oligomers joined the ends of established protofibrillar aggregates
(Figure 3.8A blue arrows). These phenomenons of oligomers nucleating and
adding onto protofibrils most likely underlie the observations that they were
similar in height (Figure 3.8C). Histograms of all aggregates formed at 123 min,
which contained a large population of oligomers and protofibrils, displays a tight
population of aggregate height of ~3-5 nm (Figure 3.8D). However, many of the
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Figure 3.8: Wild Type Aβ1-40 aggregates into a variety of structures on mica. (A)
Freshly prepared Wild Type Aβ was imaged continuously in solution on mica at a
concentration of 20 µM. 5 by 5 µm images are presented as 3D reconstructions with
indicated zoomed in 1 by 1 µm areas are presented in 2D. The yellow arrow indicates
an oligomer that coalesced with other oligomers to form a fibrillar aggregate. The blue
arrow indicates a fibrillar aggregated that elongated with time and eventually had two
discrete oligomers incorporate into its structure. (B) 2D Fourier analysis performed on
a representative image (shown to the upper left) demonstrated that Wild Type
aggregates did not display long range order along the mica surface. (C) Height profiles
of Wild Type Aβ aggregates on mica (corresponding to the lines indicated in the
adjacent images) (D) and height histograms of all aggregates after 123 min of
aggregation are presented. Collectively, these demonstrate that the typical Wild Type
Aβ aggregate appearing on mica was ~ 3-5 nm tall.

protofibrillar structures did not appear to have oligomeric precursors. These
protofibrils probably formed in solution before depositing on the mica surface. As
protofibrils grew into larger aggregate structures, they often accumulated great
amounts of Aβ that amorphously clumped around the extended structure. 2D
Fourier analysis of a representative image (Figure 3.8B) demonstrates that there
does not appear to be any long range lateral organization of Wild Type Aβ
aggregation on a mica surface. These observations were similar to previous
reports 34.
3. Point mutations in Aβ induce polymorphic aggregates at liquid/solid
interfaces and in the presence of lipid bilayers
!

89!

When tracking the aggregation of Arctic Aβ on the mica surfaces using in
situ AFM (Figure 3.9), a distinctly different aggregation pattern compared to Wild
Type was observed. For the first ~50-60 min of observation, oligomers of Arctic
Aβ appeared on mica. However, the formation of distinct, extended (fibrillar)
aggregates soon dominated the aggregation process (blue and yellow arrows in
Figure 3.9A). Several of the oligomers of Arctic Aβ eventually nucleated or were
incorporated into these elongated structures. In contrast to the extended
protofibril aggregates formed by Wild Type Aβ on mica, the extend Arctic
aggregates displayed a more rigid morphology (less curvature), were often highly
branched, and formed highly ordered arrays along the crystallographic lattice of
the mica surface. 2D Fourier analysis of these images (Figure 3.9B)
demonstrates that these aggregates grew predominately in three directions
rotated by 60o with respect to each other, supporting an epitaxial patterning of
Arctic aggregation by the mica surface. Once formed these fibrillar aggregates
rapidly extended and branched along these three directions. The height along the
extended Arctic aggregates was quite variable, ranging from ~2-5 nm along their
contours (Figure 3.9C). While the height of these Arctic fibril-like aggregates are
quite variable (Figure 3.9D), these structures are primarily comprised of thinner
~2.5 nm tall regions or thicker ~5 nm tall regions (Figure 3.9D).
In order to understand the epitaxial growth of Arctic Aβ on mica, the
details of the structure of the underlying substrate and the changes in the peptide
associated with the mutation are necessary. These studies were performed on
the muscovite form of mica, which belongs to the class of dioctahedral
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Figure 3.9: Arctic Aβ1-40 forms polymorphic distinct aggregates on mica
compared to Wild Type. (A) Freshly prepared Arctic Aβ was imaged continuously in
solution on mica at a concentration of 20 µM. 5 by 5 µm images are presented as 3D
reconstructions with indicated zoomed in 1 by 1 µm areas are presented in 2D. In
contrast to Wild Type Aβ, Arctic Aβ formed a highly ordered network of elongated
fibrillar aggregates on mica. The yellow and blue arrows indicate the formation and
growth of these elongated aggregates with time. (B) 2D Fourier analysis performed on
a representative image (shown to the upper left) demonstrated that Arctic Aβ
aggregation occurred predominately along three directions rotated by 60o with respect
to each other. This suggests a role of the mica surface in patterning the aggregation of
Arctic Aβ. (C) Height profiles of these Aβ aggregates on mica (corresponding to the
lines indicated in the adjacent images) (D) and height histograms of all aggregates
after 221 min of aggregation are presented. Collectively, these demonstrate that the
typical fibrillar aggregates of Arctic Aβ were of approximately two height regimes, ~2.5
and 5 nm.

phyllosilicates. Mica has a sheetlike structure consisting of tetrahedral and
octahedral layers. The tetrahedral unit consists of SiO4 or AlO4; the octahedral
unit is AlO6 or MgO6. A sheet consists of an octahedral layer sandwiched
between two tetrahedral layers. An uncompensated charge within the sheetlike
structure is caused by a partial substitution of Al

3+

for Si

4+

in the tetrahedral

layers, resulting in the need for an interlayer of potassium cations that leads to
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the ability to easily cleave mica. Upon cleavage, the tetrahedral layer is the
exposed surface, with the tetrahedral subunits being arranged in a slightly
distorted hexagonal pattern, providing the epitaxial interface, resulting in the
specific orientation of the Arctic Aβ aggregates. The hexagonal pattern of the
mica interface does not completely explain why Arctic Aβ formed these
orientated extended aggregates while Wild Type Aβ did not. The Arctic mutation
replaces a polar, negatively charged glutamic acid with a nonpolar, neutral
glycine. The Arctic mutation also results in a shift in the hydropathy index at the
22nd amino acid of Aβ from −3.5 to −0.4, indicating a significant reduction in the
hydrophilic nature of the peptide at this region. Furthermore, the side chain of
glycine in comparison to glutamic acid is much smaller. All three of these
features associated may contribute to the observed unique morphology and
epitaxial growth pattern observed for the aggregation of Arctic Aβ on mica. The
resulting removal of the negative charge should alter the interaction of Arctic Aβ
with the negatively charged mica surface, which may partially contribute to the
distinct morphological pattern observed. However, the rate of absorption of
peptide to the mica surface, as measured by the surface area covered by protein
(Figure 3.10), was not appreciably different between Wild Type and Arctic Aβ
during the first 100 min. Then, despite having a reduced negative charge, the
absorption of Arctic Aβ lagged behind Wild Type until the elongated aggregates
began to steadily elongate. It appears the reduction in the hydrophilic character
of the peptide compensates for the loss of the negative charge with respect to
the initial rate of absorption to mica. The average height of 2.5 nm of these
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fibrillar aggregates is approximately twice that which would be observed for a
fully extended peptide, as was observed for Wild Type Aβ on graphite in other
studies.34 This height indicates that the individual Arctic Aβ peptides that
comprise these structures contain a turn, which can be facilitated by the smaller
glycine removing steric hindrance to the required conformation.
Next, the aggregation of Italian Aβ on
mica using in situ AFM was studied
(Figure

3.11A).

Initially,

small

oligomers (1-2 nm in height) of Italian
Aβ were the predominate aggregate
form to appear on the mica surface
for ~ the first 50 min. While some
Figure 3.10. Wild Type and mutant
forms of Aβ absorb to mica with
variable rates. Quantification of the
percent of the surface covered by
aggregates of the different forms of Aβ as
a function of time is presented. While the
absorption of Wild Type, Arctic, Italian, and
Iowa Aβ was performed at 20 µM, Flemish
Aβ experiments were performed at a
higher concentration (40 µM) as very little
Flemish Aβ aggregation was observed at
20 µM within 400 min.

smaller oligomers were observed in
Wild Type aggregation on mica, these
small oligomers were much more
abundant for Italian Aβ at early time
points in comparison. With time,
these smaller oligomers coalesced

into larger oligomers and highly curved fibrillar structures reminiscent of
protofibrils (blue arrow in Fig 11A), similar to the curved structures observed
during in situ AFM experiments with Wild Type. These Italian Aβ aggregates
continued to move together, creating larger aggregates. At ~ 100 min, some
more rigid (straight morphology) elongated aggregates appeared on the surface
3. Point mutations in Aβ induce polymorphic aggregates at liquid/solid
interfaces and in the presence of lipid bilayers
!

93!

!

Figure 3.11: Italian Aβ1-40 forms a variety of aggregate morphologies on mica. (A)
Freshly prepared Italian Aβ was imaged continuously in solution on mica at a
concentration of 20 µM. 5 by 5 µm images are presented as 3D reconstructions with
indicated zoomed in 1 by 1 µm areas are presented in 2D. Initially, the mica surface
was covered by a dense number of small oligomers. With time, these small oligomers
of Italian Aβ came together to form highly curved, elongated aggregates (as indicated
by the blue arrows). These fibrillar aggregates, having a connected globule-like
morphology, were the predominate aggregate type at later time points; however, a
small number of fibrillar aggregates had a distinct morphology (yellow arrow) similar to
that observed for Arctic Aβ. (B) Despite these small patches of aggregates similar to
those observed for Arctic Aβ, 2D Fourier analysis performed on a representative
image (shown to the upper left) demonstrated that the majority of Italian Aβ
aggregates did not display long range order along the mica surface. (C) Height profiles
of Italian Aβ aggregates on mica (corresponding to the lines indicated in the adjacent
images) for the “Arctic-like” (top) and “Wild Type-like” (bottom) aggregates are shown
to be ~2.5 nm and ~5 nm in height respectively. (D) Height histograms of all
aggregates after 275 min of aggregation show that, although there is a small
population of ~2.5 nm tall aggregates, the majority of Italian aggregates are ~5 nm in
height.

(yellow arrows in Figure 3.11A) which had similar morphology in comparison to
those formed by Arctic Aβ on mica. Specifically, these aggregates appeared to
be growing in specific directions influenced by the underlying substrate.
However, these extended aggregates were never the dominate aggregate
form for Italian Aβ, and the vast majority of Italian Aβ aggregates did not exhibit
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any long range ordering on mica based on 2D Fourier analysis of larger areas of
the in situ AFM images (Figure 3.11B). The majority of the Italian aggregates
after ~150 min of aggregation were predominately 4.5-5.0 nm tall with a very
narrow distribution compared to Wild Type (Figure 3.11C-D); however, there
were some smaller aggregates still present within the size range of 23 nm. These
smaller aggregates include the “Arctic-like” extended aggregates of Italian Aβ as
demonstrated by height profiles (Figure 3.11C top), demonstrating that these
structures are morphologically indistinguishable to their Arctic counterparts.
The Italian mutation replaces a polar, negatively charged glutamic acid
residue with a polar, positively charged lysine, with a corresponding small
increase in hydrophilic character (hydropathy index changes from 3.5 to 3.9). The
positive charge associated with the Italian mutation resulted in a significantly
increased rate of absorption onto the mica surface compared to Wild Type
(Figure 3.10). While the negative charge is removed from position 22 for both
Arctic and Italian mutations in Aβ, Italian Aβ had a much lower propensity to form
the epitaxial oriented fibril-like structure, but it was observed. The removal of the
negative charge at position 22 appears to promote the formation of laterally
ordered, elongated aggregates on mica, as this morphology was only observed
for the Arctic and Italian mutations that replace this residue. As this structure is
not the dominant aggregation product on mica for the Italian mutation, the
additional positive charge, and resultant increased absorption on mica, makes
the formation of this morphology less efficient. As the laterally ordered
aggregates did not form from Italian Aβ until after approximately 100 min
3. Point mutations in Aβ induce polymorphic aggregates at liquid/solid
interfaces and in the presence of lipid bilayers
!

95!

!

compared to within 30 min for Arctic Aβ, another potential explanation for this
observation is that the conformational freedom associated with the glycine of the
Arctic mutation lowers the barrier for Aβ to rearrange into this, presumably,
ordered structure that contains a turn within the peptide. The bulk of the lysine
residue would make such a structure less favorable compared with glycine.
Another unique morphology was formed from the aggregation of Iowa Aβ
on mica, as observed by in situ AFM (Figure 3.12A). For the first 30-40 min,
small oligomers (2-3 nm tall) of Iowa Aβ were the predominate aggregate form to
appear on the mica surface, but these oligomers quickly coalesced into larger
structures. After this initial period, the oligomers gave way to elongated
protofibrillar-like aggregates with highly curved morphologies (Figure 3.12A blue
and yellow arrows). Within 130-160 min, these elongated aggregates covered the
surface and became highly interconnected, forming a large network of
aggregated Iowa Aβ. Despite this large network of aggregation, the elongated
aggregates of Iowa Aβ did not appear to have any long range order in the lateral
dimension on mica (Figure 3.12B). This extended, meandering network was not
observed for Wild Type or any other mutant form of Aβ. Accumulations of
amorphous protein clumps around these extended protofibrillar-like aggregates
of Iowa Aβ did not appear, further distinguishing Iowa aggregation from Wild
Type. These Iowa Aβ aggregates (both oligomeric and elongated) formed at later
time points and had heights that were slightly larger on average (~4-6 nm)
compared to Wild Type (Figure 3.12C-D).
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Figure 3.12: Iowa Aβ1-40 forms a dense network of elongated aggregates on
mica. (A) Freshly prepared Iowa Aβ was imaged continuously in solution on mica at a
concentration of 20 µM. 5 by 5 µm images are presented as 3D reconstructions with
indicated zoomed in 1 by 1 µm areas are presented in 2D. Similar to Italian and Wild
Type Aβ, a large population of oligomers of Iowa Aβ were initially observed on mica.
With time, these small oligomers of Iowa Aβ came together to form highly curved,
elongated aggregates. However, these fibrillar aggregates quickly formed a dense
mesh of interconnected aggregates (as indicated by the blue and yellow arrows). (B)
Despite the formation of this highly interconnected mesh of aggregates, the growth of
Iowa Aβ fibrillar aggregates did not appear to have any long range order along the
mica surface (as was observed for Arctic Aβ), based on 2D Fourier analysis. (C)
Height profiles of Iowa Aβ aggregates on mica (corresponding to the lines indicated in
the adjacent images) (D) and height histograms of all aggregates after 83 min of
aggregation are presented. Collectively, these demonstrate that the typical Iowa Aβ
aggregate appearing on mica was ~ 3-5 nm tall, which is slightly larger than those
observed for Wild Type.

The Iowa mutation replaces a polar, negatively charged aspartic acid with
a polar, neutral asparagine, but there is no change in the hydropathy index. The
absorption of Iowa Aβ on the mica surface occurred at a faster rate than that of
Wild Type (Figure 3.10). The absorption of Italian Aβ to mica was initially similar
to that of Italian Aβ, and after ∼100 min more Iowa absorbed to the surface
despite not having the extra positive charge associated with Italian. Removal of a
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negative charge must also be accompanied without an increase in hydrophobicity
to result in an increased rate of peptide absorption compared to Wild Type. While
the Iowa and Italian mutations did not change or slightly decreased the
hydrophobic character of Aβ, the removal of the negative charge in the Arctic
mutation was accompanied by an increased hydrophobic character, resulting in
no increase in the rate of absorption to mica. The absence of this negative
charge at position 23 of Aβ did not lead to the laterally ordered aggregation
associated with removal of a negative charge at position 22. This may be due to
the importance of residue 22 in forming these elongated aggregates or remaining
conformational barriers associated with the large asparagines side group.
However, the Iowa mutation did promote increased aggregation on the negatively
charged mica surface, resulting in a unique morphology compared to Wild Type.
Finally, the aggregation of Flemish Aβ on mica using in situ AFM was
studied (Figure 3.13A). Due to the slow aggregation of Flemish Aβ on mica at 20
µM, experiments presented here were performed at a higher concentration (40
µM) so that observation on aggregate morphology could be observed in an
experimentally accessible time frame. At this elevated concentration, two types of
oligomers (smaller oligomers ~2-4 nm in height and larger oligomers ~ 5-7.5 nm
in height) of Flemish Aβ appeared on the mica surface throughout the experiment
(Figure 3.13A, C-D). The larger oligomers, however, were the dominant form
observed for the entirety of the experiment (353 min). These taller oligomers of
Flemish Aβ were the largest oligomers observed in situ for any of the varieties of
Aβ. Both the smaller and larger oligomers moved together and coalesced into
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Figure 3.13: Flemish Aβ1-40 predominately forms a variety of oligomeric
aggregates on mica. (A) Freshly prepared Flemish Aβ was imaged continuously in
solution on mica at a concentration of 40 µM. The increased concentration was used
because the Flemish aggregation was much slower compared to Wild Type and the
other mutants. 5 by 5 µm images are presented as 3D reconstructions with indicated
zoomed in 1 by 1 µm areas are presented in 2D. Throughout the experiment, a large
population of stable oligomers were observed. Often times, two oligomers could be
seen to coalesce into a slightly larger oligomer (yellow arrows). There were a few
cases of what appeared to be short, slightly elongated aggregates that were stable
(blue arrows). (B) 2D Fourier analysis performed on a representative image (shown to
the upper left) demonstrated that Flemish aggregates did not display long range order
along the mica surface. (C) Height profiles of Flemish Aβ aggregates on mica
(corresponding to the lines indicated in the adjacent images) (D) and height
histograms of all aggregates after 362 min of aggregation are presented. Collectively,
these demonstrate that the Flemish Aβ formed a variety of oligomers of different
heights. There were two major populations with aggregate height of ~2-4 nm and ~5-7
nm.

larger aggregates, most often forming larger, globular oligomers (Figure 3.13A
yellow arrow). Some of these interacting oligomers formed putative protofibrils
similar in morphology to those observed for Wild Type and Italian Aβ (Figure
3.13A yellow arrow); however, these often remained quite short in comparison.
Overall, the Flemish Aβ aggregates did not exhibit any long range ordering on
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mica based on 2D Fourier analysis of larger areas of the in situ AFM images
(Figure 3.13B).
The Flemish mutation replaces a nonpolar, neutral alanine residue with a
nonpolar, neutral glycine at position 21, leading to a large decrease in
hydrophobic character (a change of 1.8 to 0.04 in the hydropathy index). Despite
a doubling of the concentration (40 µM compared to 20 µM), the absorption of
Flemish Aβ to mica initially increased quickly but stabilized to a percent of
surface area coverage similar to that of Wild Type (Figure 3.10). Despite
potentially gaining some conformational freedom associated with the glycine
compared to alanine, Flemish Aβ did not form extensive, elongated aggregates.
As the Flemish mutation does not change the local charge of Aβ, the lack of
these extended morphologies on mica further implicate the importance of
removing the negative charge of the adjacent amino acid at position 22.

3.3.4 Wild Type Aβ1-40 forms distinct aggregates on lipid membranes leading to
membrane disruption
Experiments exposing defect-free TBLE bilayers to freshly prepared Wild
Type Aβ1-40 verified previously reported observations.36 These experiments also
served as controls for comparison with experiments conducted with mutant forms
of Aβ1-40. To control for any influence of the AFM tip on Aβ aggregation and Aβinduced bilayer disruption, small areas of bilayer were only intermittently
scanned. Initially when TBLE bilayers were exposed to freshly prepared aliquots
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of a 20 µM solution of Wild Type Aβ1-40 via injection into the fluid cell, there was
little if any discernable deposition of protein onto the bilayer. With time (2-4 h),
discrete oligomeric aggregates of Wild Type Aβ1-40 appeared on, or possibly in,
the bilayer (Figure 3.14A). These aggregates were stable and appeared to be
relatively immobile, as they appeared unchanged in several successive AFM
images taken over several hours. After ~9-12 h of exposure to Wild Type Aβ1-40,
the bilayer developed large regions of increased bilayer roughness, indicating
disruption of the bilayer’s structural integrity induced by the presence of Wild
Type

Aβ1-40

3.14B-D).
areas

(Figure
These

of

increased

roughness

were

predominately
associated

with

presence

of

elongated,
Figure 3.14: Representative in situ AFM images of Wild
Type Aβ1-40 aggregate formation on supported TBLE
lipid bilayers. (A) 2-4 h after injection of freshly prepared
Wild Type Aβ1-40, discrete oligomeric aggregates of Wild
Type Aβ1-40 appeared on the bilayer. Zoomed in examples
of oligomers are shown. (B-D) After ~9-12 h, fibrils
associated with vast regions of bilayer disruption were
observed.

the

rigid

fibrillar aggregates as
evidence

by

their

straight

morphology.

While

the

vast

majority (~95%) of observed fibrils were co-localized with distinctly disrupted
bilayer surfaces, some fibrillar aggregates of Wild Type Aβ1-40 were not
associated with obvious adjacent areas of bilayer roughening.
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3.3.5 Point mutations in Aβ1-40 alter the aggregate forms observed on lipid
bilayers
When TBLE bilayers were exposed to freshly prepared aliquots of 20 µM
solution of Arctic Aβ1-40, small oligomeric aggregates similar in morphology to
those associated with Wild Type Aβ1-40 (Figure 3.15A) appeared on the lipid
surface. These oligomers typically were observed within 1-2 h after injection,
exhibiting
comparable
and
those
Wild

stability

immobility
formed
Type.

to
from

These

oligomers

also

increased in number
with time. Within ~6-8
Figure 3.15: Representative in situ AFM images of Arctic
Aβ1-40 aggregate formation on supported TBLE lipid
bilayers. (A) When TBLE bilayers were exposed to freshly
prepared aliquots of 20 µM solution of Arctic Aβ1-40, small
oligomeric aggregates were observed within 1-2 h. (B) After
~6-8 h, large regions of increased bilayer roughness were
observed that appeared to be co-localized with discrete
oligomeric aggregates. (C-D) Elongated fibrillar aggregates
were also observed within 6-8 h. (C) Many of these fibrils
displayed straight morphologies. (D) These fibrillar
aggregates often displayed enhanced curvature, forming
large circular structures with many branching points.

h

of

Arctic

exposure
Aβ1-40,

to
vast

areas of increased
bilayer

roughness

were

observed;

however, these areas

were not associated with the co-localized rigid fibrillar aggregates as was the
case with Wild Type (Figure 3.15B). While these areas did appear to be
populated by discrete oligomeric aggregates, there was a large number of
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morphologically indistinguishable oligomers that were not associated with
disrupted bilayer structure. Elongated fibrillar aggregates were also observed
within 6-8 h of addition of Arctic Aβ1-40 to the lipid bilayer. While many of these
fibrils displayed straight morphologies reminiscent of those observed for Wild
Type Aβ1-40 (Figure 3.15C), elongated aggregates displaying enhanced curvature
were frequently observed for Arctic Aβ1-40 (Figure 3.15D). These highly curved
extended aggregates often circled back upon themselves, forming large (100’s of
nm) ring-like structures that were not associated with the formation of holes
within the bilayer. These curved fibrillar structures also contained many
branching points, which could also rejoin, resulting in the formation of small ringlike structures contained within the contour of the fibril itself. It is speculated that
the increased hydrophobic nature of Arctic Arctic Aβ1-40 increases the insertion
once bound to the bilayer surface leading to enhanced bilayer disruption. The
observed enhanced bilayer disruption at micromolar concentrations is consistent
with recent coarse-grained molecular dynamic simulations of fibril-forming
amphipathic peptides in the presence of lipid vesicles suggesting that the
ongoing process of aggregation leads to the development of defects in the
bilayer surface, underlying the ability of mutations that enhance fibrillogenesis to
appear more toxic 38.
The interaction of Italian Aβ1-40 with supported TBLE bilayers was next
investigated (Figure 3.16). Upon exposure of a 20 µM solution of Italian Aβ1-40 to
the TBLE bilayer, oligomeric aggregates of similar morphology compared to
those described for Wild Type and Arctic were observed on the bilayer surface
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within 2-4 h (Figure 3.16A). Again, these oligomers were stable and initially
increased in number with time. After ~10-12 h of exposure to Italian Aβ1-40, the
bilayer developed large patches of increased bilayer roughness, corresponding
to disruption of the bilayer’s structural integrity (Figure 3.16B). Similar to Arctic
Aβ1-40 as opposed to Wild Type, these areas of increased bilayer roughness were
not clearly associated with rigid fibrils. However, elongated fibrillar aggregates
were observed within 8-10 h of addition of Italian Aβ1-40 to the lipid bilayer (Figure
3.16B-D). As was the case with Arctic Aβ1-40, these fibrillar aggregates displayed
a variety of morphologies. While several of these elongated aggregates of Italian
Aβ1-40 appeared rigid
and

lacking
discernable

curvature,
majority

the
of

fibrillar

aggregates

formed

by Italian Aβ1-40 had
curled
Figure 3.16: Representative in situ AFM images of Italian
Aβ1-40 aggregate formation on supported TBLE lipid
bilayers. (A) Upon addition of a 20 µM solution of Italian
Aβ1-40 to the TBLE bilayer, oligomeric aggregates appeared
within 2-4 h. (B) After ~10-12 h of exposure to Italian Aβ1-40,
the bilayer developed large patches of increased bilayer
roughness that often contained oligomeric aggregates. (B-D)
Elongated fibrillar aggregates were observed within 8-10 h of
addition of Italian Aβ1-40 to the lipid bilayer. These fibrillar
aggregates displayed a variety of morphologies,
predominantly displaying large curvature and branching.
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often highly branched and contained a variety of large ring-like structures
contained within their contour. Despite the Italian mutation being associated with
an increased rate of Aβ aggregation,1 the extent of lipid bilayer disruption did not
significantly change in comparison with Wild Type Aβ1-40. However, it is important
to note that fibril morphologies observed for the Italian mutation in the presence
of the lipid bilayer were morphologically distinct compared to Wild Type fibrils.
Upon exposure of a supported TBLE bilayer to a 20 µM solution of Iowa
Aβ1-40, a large number of discrete oligomeric aggregates appeared on the lipid
surface within 2-3 h (Figure 3.17A). Like oligomers formed by Wild Type and
other mutant Aβ1-40 peptides, these oligomers were extremely stable and could
be imaged for several hours. In some experiments with Iowa Aβ1-40, hole forming
annular aggregates were observed with a lip protruding ~0.5 nm above the
bilayer surface and an inner diameter of 32.7 ± 4.5 nm (Figure 3.17B). However,
the inner diameters of these annular aggregates were much larger than would
traditionally be considered a pore. While smaller, pore-like structures of Aβ have
been reported in other studies,30,39 these were the smallest annular structures
observed in the studies. After ~10-12 h of exposure to Iowa Aβ1-40, the bilayer
developed small, discrete areas of disrupted lipid morphology (i.e. enhanced
roughness). These areas of enhanced roughness were much smaller than had
previously been observed for Wild Type, Arctic, or Italian Aβ1-40 (Figure 3.17C).
While these small areas of disrupted bilayer often had oligomeric
structures contained within them, there was not a significantly larger number of
oligomers associated with disruption areas compared to the number of oligomers
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on intact bilayer. Many short putative fibrillar structures of Iowa Aβ1-40 were
observed (Figure 3.17C). A few larger fibrils also appeared that were
morphologically very similar to the fibrils formed by Wild Type Aβ1-40 (Figure
3.17D). These fibril structures did not appear to be associated with changes in
bilayer integrity. In spite of the appearance of fibrils and oligomers, abundant
larger

amorphous

aggregates

formed

from Iowa Aβ1-40 were
also present on the
bilayer (Figure 3.17B).
While

these

large

amorphous
aggregates

extended

higher

above

bilayer

surface

the
in

comparison with the
previously

described

oligomers,

they

appeared
(round)

still

globular
in

nature,

Figure 3.17: Representative in situ AFM images of Iowa
Aβ1-40 aggregate formation on supported TBLE lipid
bilayers. (A) Upon exposure of a supported TBLE bilayer
to a 20 µM solution of Iowa Aβ1-40, a large number of
discrete oligomeric aggregates appeared on the lipid
surface within 2-3 h. (B) Hole forming annular aggregates
were observed after ~6 h. Larger amorphous aggregates
formed from Iowa Aβ1-40 were also present on the bilayer.
(C) After ~10-12 h the bilayer developed small, discrete
areas of disrupted lipid morphology. Many short putative
fibrillar structures of Iowa Aβ1-40 were also observed. (D)
There were some larger fibrils formed on the bilayer that
were morphologically very similar to the fibrils formed by
Wild Type Aβ1-40.

making them distinct from fibrils. Despite this distinctly round morphology, these
amorphous aggregates often had many smaller protofibril-like structures
protruding from their periphery. As the Iowa mutation does not alter the
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hydrophobic character of Aβ1-40, the reduced ability of the Iowa mutation to
disrupt supported lipid bilayers appears to be related to eliminating a negative
charge from the peptide. The Arctic mutation also resulted in the elimination of a
negative charge from Aβ1-40; however as previously stated, the Arctic mutation
resulted in increased bilayer disruption due to its increased hydrophobic
character.
When TBLE bilayers were exposed to freshly prepared aliquots of 20 µM
solutions of Flemish Aβ1-40 via injection into the fluid cell, oligomeric aggregates
were not typically observed for 3-5 h (Figure 3.18A). Once oligomers appeared
on the surface, they
were

stable

for

several hours. Often
small bilayer defects
developed
3.18B),
defects

(Figure

but
did

these
not

appear to have any
Figure 3.18: Representative in situ AFM images of
Flemish Aβ1-40 aggregate formation on supported TBLE
lipid bilayers. (A) Within 3-5 h after the injection of Flemish
Aβ1-40 into the fluid cell, oligomeric aggregates appeared on
the bilayer surface. (B) Often small defects in the lipid bilayer
that did not appear to be associated with aggregates would
develop. There were also many large amorphous
aggregates on the bilayer. (C) After ~10-12 h of exposure to
Flemish Aβ1-40, a few small patches of increased bilayer
roughness associated with a high density of very short
putative fibrillar aggregates developed. (D) Not all fibrils
were associated with bilayer disruption.

Flemish
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annular
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for Iowa Aβ1-40. After ~10-12 h of exposure to Flemish Aβ1-40, supported bilayers
developed a few small patches of increased bilayer roughness (Figure 3.18C).
These areas of increased roughness were predominately associated with a high
density of very short putative fibrillar aggregates. However, not all fibrillar
aggregates of Flemish Aβ1-40 were associated with adjacent areas of bilayer
disruption (Figure 3.18D). The fibrils not associated with bilayer disruption tended
to be isolated from other aggregate structures. In some experiments with Flemish
Aβ1-40, larger amorphous aggregates, similar to those formed by Iowa Aβ1-40,
were observed (Figure 3.18B). Unlike those larger aggregates observed for Iowa
Aβ1-40, these amorphous aggregates did not appear to have smaller protofibrillike structures protruding from their periphery. As there is no net change in
peptide charge, the decreased extent of aggregation and bilayer disruption
observed for the Flemish mutation is most likely a result of its increased
hydrophilic nature.

3.3.6 Comparison of mutant Aβ aggregate size in the presence of lipid bilayers
Measurable morphological features of oligomer and fibrillar aggregates of
Wild Type and mutant forms of Aβ1-40 formed in the presence of supported TBLE
bilayers were compared (Figure 3.19). To obtain data sets of physical
dimensions of only globular oligomers using our image analysis software,
oligomers were defined as any feature protruding at least 2 nm above the bilayer
surface with an aspect ratio (longest distance across to shortest distance across)
less than 2.0, indicating a globular structure. Fibrils were defined as aggregates
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that protruded at least 3 nm above the bilayer surface with an aspect ratio
greater than 2.5, indicating an elongated structure. These criteria were based on
measurements of representative examples of each respective aggregate type.
Measurements of oligomers and fibrils were compiled from multiple experiments
and time points. The height (measured from the bilayer surface) distributions of
globular oligomeric aggregates were not significantly different (based on a
Spearman’s rank correlation coefficient), when comparing Wild Type with each
mutant form of Aβ1-40, suggesting that oligomers formed from each mutation are
structurally indistinguishable from those formed by Wild Type (Figure 3.19A). The
similarity between oligomer aggregates formed by Wild Type and the different
mutant Aβ1-40 peptides was further illustrated by comparison of the average
height of oligomers formed by each type of Aβ1-40 peptide (Figure 3.19B). Using
an independent analysis, the corrected volume distributions of oligomers

40

was

used to estimate the number of protein molecules per oligomer and the
corresponding mass of oligomers formed by Wild Type, Arctic, Italian, Iowa, and
Flemish Aβ1-40. One caveat of this analysis is that it does not take into account
any portion of the globular oligomer that may be inserted into the bilayer. Despite
this limitation, the majority of oligomers formed by Wild Type and each mutant
were in the range of 10-15 peptides per oligomer with a mass ranging from 47-70
kDa (Figure 3.19C). These measured dimensions were within the range of a
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Figure 3.19: Quantification of morphological features of aggregates formed in
the presence of supported TBLE lipid bilayers by Wild Type or mutant forms of
Aβ1-40. (A) Histograms of height above the bilayer surface for oligomers formed by
Wild Type, Arctic, Italian, Iowa, or Flemish Aβ1-40 are shown. (B) When the average
height above the bilayer surface of oligomers formed by Wild Type and the mutant
forms were compared, oligomers were not significantly different as a function of
mutation. (C) Based on corrected volume measurements and the molecular mass of
Aβ1-40, the numbers of peptides per oligomer and apparent mass of oligomers
comprised of Wild Type, Arctic, Italian, Iowa, or Flemish Aβ1-40 were calculated. The
plots are color coded such that darker colors represent a greater abundance of
oligomers composed of that number of molecules. Black arrows indicate where 10-15
peptides and 47-70 kDa oligomers would be observed. (D) The average height above
the bilayer surface along the contour of elongated fibril aggregates comprised of Wild
Type, Arctic, Italian, Iowa, or Flemish Aβ1-40 are shown. Fibrils formed from Arctic (*
indicates p < 0.01) and Italian (** indicates p < 0.05) Aβ1-40 were significantly shorter
compared to fibrils comprised of Wild Type Aβ1-40. (E) Plots correlating the contour
length to the end to end distance of fibrils formed from Wild Type, Arctic, or Italian Aβ140 are shown. The dashed line represents the theoretical correlation for infinitely rigid
rod-like structures.
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specific oligomeric structure (Aβ*56) that correlates with memory loss,41 and
been imaged by AFM.28 Despite the majority of these oligomers being similar in
size to Aβ*56, there was still a significant number of larger globular aggregates,
particularly for the Italian and Iowa mutants, demonstrating that the population of
oligomeric aggregates formed in the presence of lipid bilayers display
considerable heterogeneity (Figure 3.19C).
The average height above the surface along the contour of elongated,
fibrillar aggregates was also determined (Figure 3.19D). Unlike the average
height of oligomers, when comparing the height of fibrils formed by mutant Aβ1-40
peptides with those formed by Wild Type, fibrils comprised of Arctic (p < 0.01) or
Italian (p < 0.05) Aβ1-40 were significantly shorter based on a student’s T-test
(Figure 3.19D). This suggests that fibrils formed by these two mutant forms of
Aβ1-40 are structurally different or are further inserted into the lipid bilayer when
compared to those formed by Wild Type. Fibrils observed for Arctic and Italian
Aβ1-40 often appeared morphologically distinct to Wild Type fibrils as described
above, which supports the notion that the fibrils are structurally unique. The
primary morphological difference between fibrils formed by these different
versions of Aβ1-40 was an apparent increased curvature (or reduced persistence
length) of the fibril structure. Therefore, the contour and end to end distance of
individual fibrils formed from Wild Type, Arctic, and Italian Aβ1-40 on the TBLE
bilayer were measured. The data was analyzed by constructing correlation plots
of individual fibril contour length as a function of their end to end distance (Figure
3.19E). For rigid structures with an infinitely large persistence length, the contour
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length would be equal to the end to end distance. For these infinitely rigid
structures, the corresponding correlation plots would produce a line with a slope
of 1, which is represented by the dashed line. As elongated fibril structures
become less rigid (shorter persistence length), correlation between the contour
length and end to end distance will deviate from this line. As the contour length
increases, the spread of the correlation with end to end distance will increase
with a decrease in persistence length. For the more rigid fibril structures
observed for Wild Type Aβ1-40 in the presence of lipid bilayers, the majority of
data points for the correlation between contour length and end to end distance
fell near the theoretical line for an infinitely rigid rod-like structure with very little
spread (Figure 3.19E). The correlation between contour length and end to end
distance for fibrils comprised of Arctic Aβ1-40 or Italian Aβ1-40 formed in the
presence of the bilayer deviated much more from the theoretical line with a large
spread of data points with increased contour length. These features in the
correlation plots indicate that fibrils formed from these two mutant Aβ1-40 peptides
were less rigid than their Wild Type counterparts, further supporting that these
fibrils are structurally distinct. A feature of these plots is that for very short fibrils
(contour length < persistence length) the data points fall very closely to the
theoretical line of infinitely rigid rods. Due to this feature, analysis of fibrils formed
from Iowa and Flemish Aβ1-40 was inconclusive (data not shown) because the
observed fibrils formed from these peptides tended to be very short (less than
200 nm in contour length).
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3.3.7 Comparison of induced lipid roughness by different point mutations of Aβ
Using image processing software the extent of bilayer disruption was
analyzed. A freshly formed bilayer had a RMS surface roughness of 0.24 ± 0.09
nm measured over a total of 148 µm2 (Figure 3.20A). To prevent error associated
with the size of the regions of disrupted bilayer structure, RMS roughness
measurements of areas that had been destabilized by Aβ1-40 and mutant Aβ1-40
peptides were restricted only to portions of the images containing disrupted
regions, excluding regions of the bilayer not altered by the presence of Aβ1-40
from the analysis.

Figure 3.20: Quantification of bilayer roughening. (A) Quantitative assessment of
bilayer disruption by analysis of root mean square (RMS) roughness of images taken
before and after exposure to various Aβ1-40 peptides is shown. Control corresponds to
RMS roughness measurements taken on supported TBLE lipid bilayers that had not
been exposed to any Aβ1-40 peptides. Exposure to Wild Type, Arctic, Italian, Iowa, or
Flemish Aβ1-40 induced significant (* indicates p < 0.01) roughening of the supported
TBLE lipid bilayer. RMS roughness measurements of disrupted areas were restricted
to areas that displayed enhanced roughness to prevent biased based on the extent of
disruption. (B) The percent area of TBLE bilayers containing increased roughness
induced by exposure to Wild Type, Arctic, Italian, Iowa, or Flemish Aβ1-40 was
measured from images obtained 10-12 h after the initial injection of Aβ1-40 peptides.
Exposure to Arctic Aβ1-40 resulted in a significantly larger area of the bilayer being
disrupted in comparison to Wild Type (* indicates p < 0.01). The extent of bilayer
disruption was significantly reduced when bilayers were exposed to Iowa or Flemish
Aβ1-40 in comparison to Wild Type (** indicates p < 0.05).
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RMS roughness measurements are also highly dependent on the
coverage of Aβ1-40 aggregates present on the surface; therefore, aggregate
structures were filtered out of the analysis. All RMS measurements were taken
from images representing at least 10-12 h of bilayer exposure to Wild Type or
mutant forms of Aβ1-40. After 10 h of exposure to Wild Type Aβ1-40, disrupted
portions of the bilayer surface displayed significantly (p > 0.01) enhanced RMS
surface roughness increasing to 1.18 ± 0.46 nm measured over a total of 56.7
µm2 (Figure 3.20A). Likewise, significant (p > 0.01) bilayer roughening occurred
after 10 h of exposure to all mutant Aβ1-40 peptides (1.55 ± 0.19 nm measured
over 1,579 µm2, 1.41 ± 0.24 nm measured over 896 µm2, 1.86 ± 0.46 nm
measured over 117 µm2, 1.60 ± 0.27 nm measured over 381 µm2 for Arctic,
Italian, Iowa, and Flemish respectively). Despite different aggregate types (or
lack thereof) being associated with regions of bilayer disruption for Wild Type or
mutant forms of Aβ1-40, there was no significant differences in the measured RMS
roughness of these regions when comparing each mutant peptide to Wild Type.
Although the resulting surface roughness associated with bilayer
disruption by Wild Type or mutant forms of Aβ1-40 was similar in magnitude after
10 h of exposure, the fraction of the bilayer surface area exhibiting some amount
of increased roughness varied (Figure 3.20B) (which is one reason why the RMS
roughness measurements reported above were taken over different sized areas).
For Wild Type Aβ1-40, 25.4 ± 9.0% of the bilayer surface area exhibited increased
surface roughness. The Arctic mutation significantly (p < 0.01) increased the
percent area of bilayer disruption (41.0 ± 10.9%) after 8 h of co-incubation.
3. Point mutations in Aβ induce polymorphic aggregates at liquid/solid
interfaces and in the presence of lipid bilayers
!

114!

Despite resulting in morphologically distinct fibrillar aggregates, the Italian
mutation did not result in a significantly different percent of bilayer surface area
with increased roughness (24.3 ± 9.4%) in comparison to Wild Type. Both the
Iowa (14.32 ± 10.0%) and Flemish (11.2 ± 9.4%) mutations resulted in a
significantly (p < 0.01) smaller percentage of the bilayer being disrupted in
comparison to Wild Type.

3.4 Discussion
In recent years, the focus of many studies of Aβ aggregates associated
with AD has predominately been on nonfibrillar intermediates;28,41-46 however, the
relative importance for disease of different aggregates forms of Aβ has not been
fully elucidated. A complicating factor for understanding the role of different
aggregate forms is the ability of Aβ to form a large array of polymorphic fibril
structures.32,47-50 For example, it has been shown with investigating just eight
different preparatory conditions that five distinct fibrillar polymorphs of Aβ can
result.32 The effects of preparatory conditions on aggregate formation are further
discussed in Chapter 5. The existence of different polymorphic fibril structures
may also indicate that there are a variety of soluble intermediate structures.
Indeed, several distinct oligomeric forms of Aβ have been reported.41,51 The
ability of Aβ to form a variety of polymorphic aggregate structures may underlie
the variations observed in AD pathology. While the chemical environment of Aβ
appears to have a profound effect on Aβ aggregation,31,32 the interaction of
proteins with solid surfaces is a fundamental phenomenon with potential
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implications for protein misfolding associated with neurodegenerative diseases.
Kinetic and thermodynamic studies indicate that significant conformational
changes can be induced in proteins encountering surfaces.52 Such surface
induced conformational changes can play a critical role in nucleating or inducing
Aβ aggregate formation.
Point mutations have been shown to promote protein aggregation by
destabilizing the native, globular state of a protein.53 Interestingly, these
mutations are located at the end of or directly adjacent to a sequence in Aβ
(residues 16-21) that has been identified to be highly amyloidogenic,17 indicating
that this region may be a viable target for preventing Aβ aggregation for
therapeutic purposes. In this regard, several antibodies and single chain variable
fragments specific for this region of Aβ appear to prevent aggregation and in
some cases reduce toxicity.54-56 EPR studies of Aβ fibril structure using sitedirected spin-labeling demonstrated that this central region is sandwiched
between two more highly ordered regions in the fibril structure.57 Observations
reported here support the notion that this region plays a role in lipid/Aβ
interactions that can influence aggregate morphology and the ability of Aβ to
disrupt bilayer integrity. In particular, the propensity to form polymorphic fibrillar
structures on lipid bilayers appears to be heavily influenced by point mutations in
this region. Furthermore, it has been reported that toxic forms of Aβ contain a
turn at positions 22 and 23,58,59 precisely where the mutations (Arctic, Italian, and
Iowa) that increased aggregation occur. More recently, an antibody has been
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reported that is specific for the turn at position 22 and 23 associated with toxic
forms of Aβ aggregates.58
Studies presented here demonstrate that mutations in this region not only
change the rates of formation of Aβ aggregates in free solution but also the
morphology of aggregates formed at surfaces. As each mutation alters
aggregation kinetics as well as AD phenotype, each may have different
propensities to form various abnormal structures like spherical oligomers, and
this may be heavily influenced by the chemical environment or the surface (i.e.
liquid/solid interfaces, supported lipid bilayers). While it has already been
demonstrated that these specific point mutations alter the rate of Aβ
aggregation,2-7,15,28 here these mutations influence the interaction of Aβ at a
negatively charged surface, resulting in the formation of several polymorphic
aggregate forms, and on a supported TBLE lipid bilayer resulting in a
heterogeneous mixture of aggregate species and polymorphic fibrillar structures
and bilayer disruption. The aggregate morphologies of the mutant forms of Aβ
can be drastically different than those formed in the absence of a surface (free
solution conditions). Furthermore, the ability of Aβ to disrupt the structural
integrity of bilayers is notably modulated by these mutations. Such results
indicate that surfaces influence Aβ self-assembly, and these surface effects in a
physiological environment may dictate whether specific aggregates with potential
roles in disease pathology form and/or are stable. Interestingly, it has often been
observed that exogenously added Aβ will selectively bind a subset of
hippocampal neurons and neuroblastoma cells in culture.60,61 The selective
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interactions of the point mutations with supported lipid bilayers could potentially
be regulated by not only the composition of the cellular membrane but also by
the electrostatic and hydrophobic properties of Aβ, which is supported by the
altered aggregation patterns observed for different mutant peptides.
Previous reports using in situ AFM to study the aggregation of Wild Type
forms of Aβ indicated that chemically diverse surfaces significantly influence
aggregate morphology. Small, highly mobile, globular aggregates of both Aβ1-4062
and Aβ1-4234 were observed on mica. The results of both studies are similar to
those reported here for Wild Type Aβ on mica. However, aggregation of Aβ1-42 on
graphite resulted in markedly different aggregated morphology than those
observed on mica.34 In that study, Aβ1-42 formed extended nanoribbons with
heights of 1–1.2 nm and widths of ~18 nm, which suggested that peptide chains
adopted fully extended β-sheet conformation and were perpendicular to the long
axis of nanoribbons. Comparison of the dimension of aggregates of Aβ forming
on graphite with the expected dimensions of a β-sheet provides a strong
indication that the elongated aggregates indeed correspond to single β-sheets
(parallel or antiparallel) with fully extended peptide chains perpendicular to the
long axis of the aggregate. These putative β-sheets elongated over time and
preferentially organized into parallel “rafts” while maintaining preferential
alignment along three equivalent directions, most likely pointing to a templating
effect of the graphite lattice. This lateral association of aggregates is similar to
that observed here for Arctic Aβ (and to a lesser extent Italian Aβ) on mica.
Despite similar lateral aggregation patterns, the aggregates formed by Arctic Aβ
3. Point mutations in Aβ induce polymorphic aggregates at liquid/solid
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on mica had heights approximately twice as tall as those reported for Wild Type
aggregates on graphite, indicating that these extended aggregates were
structurally unique.
The fibrillar aggregates formed by the Arctic and Italian Aβ1-40 peptides in
the presence of the supported lipid bilayers appeared to be distinct polymorphs
compared to those formed by the Wild Type peptide. This observation suggests
that electrostatic and hydrophobic interactions with membrane surface can
induce polymorphic aggregates structures of Aβ. In the case of the Arctic
mutation, it has been reported that aggregates (oligomer, protofibrils, and fibril)
formed by this mutation are indistinguishable to those formed by Wild Type under
free solution conditions.28 However, the aggregation process and resulting
aggregate morphology of Arctic differed dramatically in comparison to Wild Type
in the presence of the anionic surface of mica, pointing to the ability of surfaces
to influence aggregate structure.28 This ability of surfaces to alter aggregate
morphology of amyloidogenic peptides has been well documented for a variety of
systems.34,63 It appears that the chemical environments provided by lipid
membranes have the ability to structurally influence the aggregation of Aβ into
elongated structures. The two mutations that led to shorter, less rigid fibril
structures both occur at the 22nd residue of Aβ. In both cases, a negative charge
is removed, indicating that this residue may experience specific electrostatic
interactions with lipids that influence its ability to form specific fibrillar
polymorphs. However, it appears that the exact composition of the bilayer and
the peptide preparation protocol could also play a role in this interaction, as the
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more highly curved fibril structures have been observed for Wild Type Aβ1-40 on
TBLE bilayers by other investigators.64 The Iowa and Flemish mutations did not
appear to result in different morphologies of fibrils compared to Wild Type;
however, the extent of fibril formation appeared to be reduced in the presence of
the bilayer by both of these mutations.
The central domain of Aβ, containing the point mutations studied here,
appears to play an important role in Aβ’s interaction with negatively charged
surfaces and lipid bilayers. As it has been proposed that different polymorphs
may be associated with variations in AD phenotype,65 it is tempting to speculate
that local chemical environments of lipid membranes may influence the
aggregate state of Aβ which will be studied in Chapter 5. Furthermore, the
propensity of mutant Aβ to form different polymorphic aggregates may underlie
the phenotypic variations associated with these mutations.
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4. Specific domains of Aβ facilitate aggregation on and
association with lipid bilayers

Understanding the role that specific regions of Aβ play in regulating its
aggregation and interaction with lipid membranes may provide insights into the
fundamental interaction between Ab and cellular surfaces. The interaction and
aggregation of several Aβ fragments (Aβ1-11, Aβ1-28, Aβ10-26, Aβ12-24, Aβ16-22, Aβ2235,

and Aβ1-40) in the presence of supported model TBLE bilayers was

investigated. These fragments represent a variety of chemically unique domains
within Aβ, i.e., the extracellular domain, the central hydrophobic core, and the
transmembrane

domain.

Using

scanning

probe

techniques,

aggregate

morphologies were elucidated for these different Aβ fragments in free solution
and in the presence of TBLE bilayers. These fragments formed a variety of
oligomeric and fibrillar aggregates under free solution conditions. Exposure to
TBLE bilayers resulted in distinct aggregate morphologies compared to free
solution and changes in bilayer stability dependent on the Aβ sequence. Aβ10-26,
Aβ16-22, Aβ22-35, and Aβ1-40 aggregated into a variety of distinct fibrillar aggregates
and disrupted the bilayer structure, resulting in altered mechanical properties of
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the bilayer. Aβ1-11, Aβ1-28, and Aβ12-24 had minimal interaction with lipid
membranes, forming only sparse oligomers.

4.1 Introduction: Interaction of Aβ fragments with supported lipid bilayers
As Aβ is a cleavage product of APP, it contains a hydrophobic
transmembrane domain and a predominately hydrophilic extracellular domain,
imparting amphiphilic character to Aβ (Figure 4.1). Furthermore, based on a
variety of structural and computational studies, several domains have been
identified in Aβ. The N-terminal region of Aβ has been shown to form a-helical or
β-sheet structure dependent on solution conditions, such as pH.1,2 The
hydrophobic C-terminal end of Aβ has a high propensity to aggregate into βsheet rich structures independent of solvent conditions.1,2 Despite the
appearance of various polymorphs, Aβ fibrils are comprised of bundled β-sheets

Figure 4.1: Schematic representation of Aβ and specific domains. Using the
hydropathy index, each sequence has hydrophilic amino acids (red), hydrophobic
(blue) and slightly hydrophobic (light blue). The aggregation of Aβ1-11, Aβ1-28, Aβ10-26,
Aβ12-24, Aβ16-22, Aβ22-35, and Aβ1-40 was investigated here.
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with backbones orthogonal to the fiber axis creating a cross-β structure.3 Sitedirected spin labeling electron paramagnetic resonance (EPR) studies of Aβ
fibrils identified two β-strand forming domains (residues 11-21 and 29-39
respectively) separated by turn/bend region (around residues 23-26).4 NMR
studies on a variety of Aβ fragments support the notion of two β-strand regions
separated by a β-turn in different fibril structures.5-7 The appearance of a β-turn
between two β-strands is further supported by computational studies of Aβ
fibrils.8 The central region of Aβ (residues 16-21) has been shown to form a
hydrophobic core with enhanced amyloidogenic properties9 and is contained
within one of the β-strand forming regions. A variety of NMR studies of Aβ in
solution indicate that the monomer is predominately unstructured with fluctuating
residual structure.10,11 Although, a more recent NMR study has demonstrated
that this central hydrophobic domain of Aβ can form a 310 helix, resulting in a
compact structure as other hydrophobic residues cluster against the helix.12 The
variations in Aβ monomer and aggregate structure associated with these different
studies may be partially attributed to the variation in preparation protocols that
lead to polymorphic aggregates.
Here, the role specific domains of Aβ play in its aggregation under free
solution conditions and in the presence of TBLE bilayers were determined. The
aggregation of seven different Aβ fragments (Aβ1-11, Aβ1-28, Aβ10-26, Aβ12-24, Aβ1622,

Aβ22-35, and Aβ1-40) was investigated. These Aβ fragments represent a variety

of chemically unique regions, i.e., the extracellular domain, the central
hydrophobic core, different β-strand forming sequences, and the transmembrane
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domain (Figure 4.1). AFM was used to characterize the Aβ fragment aggregate
morphology and to monitor the degree of interaction with a model lipid bilayer
system. In addition, the mechanical impact of exposure to the different Aβ
fragments on TBLE bilayers was determined.

4.2 Materials and methods
4.2.1 Peptide preparation
Synthetic fragments of Aβ1-11, Aβ1-28, Aβ10-26, Aβ12-24, Aβ16-22, Aβ22-35, and
Aβ1-40 (AnaSpec Inc., San Jose, CA) were prepared in the same manner
according to published protocols.13 Briefly, peptides were treated with HFIP to
dissolve seeds and pre-existing aggregates within the lyophilized stock. HFIP
was evaporated off in a Vacufuge concentrator (Eppendorf), resulting in peptide
films. These peptide films were dissolved in 10 µL DMSO to make a 2000 µM
stock solution. To achieve a final concentration of 20 µM, the stock solutions
were dissolved directly into 37°C PBS buffer (pH 7.3). The molecular weights of
these fragments are 1.33 kDa for Aβ1-11, 3.26 kDa for Aβ1-28, 2.01 kDa for Aβ10-26,
1.57 kDa for Aβ12-24, 0.85 kDa for Aβ16-22, 1.40 kDa for Aβ22-35, and 4.33 kDa for
Aβ1-40.

4.2.2 Preparation of defect free bilayers
Lyophilized porcine TBLE (Avanti Polar Lipids, Alabaster, AL) was resuspended in PBS (pH 7.3) at a concentration of 1 mg/ml. Using an acetone/dry
ice bath, bilayers and multilayer lipid sheets were formed by five cycles of freeze4. Specific domains of Aβ facilitate aggregation on and association
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thaw treatment.14 Lipid suspensions were then sonicated for 15 minutes to
promote vesicle formation. Next, 15 µL of a 1:1 TBLE/PBS (pH 7.3) solution was
injected directly into a prepared AFM fluid cell. A defect free bilayer (40 x 40 µm)
was formed via vesicles fusion on a freshly cleaved mica substrate. Once
formed, 2-3 washes with PBS were performed to remove excess lipid vesicles
from the fluid cell. All experiments were performed with the same lot of lipids.

4.2.3 Lipid/polydiacetylene (PDA) assay
PDA assay was prepared using previously reported protocols.15,16 In
short, the diacetylene monomers 10,12-tricosadiynoic acid (GFS Chemicals,
Columbus, OH) and TBLE (2:3 molar ratio) were dissolved in a solution of 1:1
chloroform/ethanol. The solution was rotovapped off leaving a thin, dry film. 1X
Tris buffered saline (TBS) heated to 70°C was added to the film and sonicated
for 5 min at 100 w using a sonic dismembrator (FisherSci). To ensure selfassembly of the vesicles, the suspension was stored at 4°C overnight. The
suspension was polymerized by irradiation at 254 nm with 7 lumens for 10 min
(room temperature with stirring) turning a brilliant blue. The assay included
polymerized PDA + 1X TBS (negative control), polymerized PDA + 1X TBS +
NaOH (pH 12) (positive control), and polymerized PDA + 1X TBS + Aβ for each
individual Aβ sequence with a final protein concentration of 20 µM. Colorimetric
response over 24 h for each well was recorded using an Infinite M1000 Pro plate
reader (TECAN, Switzerland) at 37°C measuring both the blue component (640
nm) and the red component (500 nm) of the spectrum.
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4.2.4 AFM imaging conditions
For ex situ AFM imaging, 20 µM solutions of each sequence were
prepared and incubated at 37°C with no shaking for the duration of the
experiment. 2 µL aliquots of each incubation were spotted onto freshly cleaved
mica for 30 s at various time points, washed with 200 mL of HPLC grade water,
and dried under a gentle stream of nitrogen. Deposited peptide aggregates were
imaged with a Nanoscope V MultiMode scanning probe microscope (Veeco,
Santa Barbara, CA) equipped with a closed-loop vertical engage J-scanner and
operated in tapping mode. Ex situ images were acquired with diving board
shaped silicon cantilevers with a nominal spring constant of 40 N/m and
resonance frequency of ~300 kHz.
For in situ AFM experiments, the Nanoscope V MultiMode scanning probe
microscope (Veeco, Santa Barbara, CA) was operated in tapping mode,
equipped with a fluid cell sealed with an O-ring. In situ images were obtained with
V-shaped oxide-sharpened silicon nitride cantilevers with a nominal spring
constant of 0.5 N/m (Budget Sensors, Bulgaria). Scan rates were set at 1–2 Hz
with cantilever drive frequencies ranging from ~8 to 10 kHz. 35 µL of filtered PBS
buffer was added to the fluid cell, and background images were obtained to
ensure cleanliness of the cell before direct injection of 15 µL of TBLE solution.
Once formed, only defect-free TBLE bilayers that were 40 x 40 µm were exposed
to Aβ fragments at a final concentration of 20 µM. Upon injection of the
sequence, a 10 x 10 µm image of the surface with 1024 x 1024 pixel resolution
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was taken before sealing the fluid cell to prevent evaporation. The bilayer was
imaged again 16-20 h after exposure to the Aβ fragments.
For SPAM experiments, 10 x 2.5 µm images were captured with 512 x 128
pixel resolution. Cantilever deflection trajectories were captured at 2.5 MS/s and
14-bit resolution with a vertical range of 2 V via a combination of a signal access
module (Veeco, Santa Barbara, CA) and CompuScope 14100 data acquisition
card (Gage, Lachine, Quebec). A Fourier transform based harmonic comb filter
was applied to the deflection signal, and the second derivative of the filtered
cantilever deflection was used to obtain the time-resolved tip acceleration. By
use of the effective mass, meff, of the cantilever, the time-resolved tapping force
between the tip and sample was recovered.17 meff was determined using a
thermal tuning method by obtaining the spring constant and resonance frequency
of the cantilever.

4.2.5 Quantitative image analysis
AFM image analysis was performed using the image processing toolbox of
MATLAB (MathWorks, Natick, MA) as described elsewhere.18 Briefly, the
physical dimensions of aggregates were measured automatically by: 1) importing
images into MATLAB; 2) flattening the images to correct for background
curvature; 3) using a height threshold to create a binary map of the surface that
can be used to locate individual aggregates; 4) implementing pattern recognition
algorithms to the binary map to locate aggregates and measure specific features
(height, volume, contour length, etc.) of each individual aggregate. To determine
fibril contour length and end to end distance, a fast parallel thinning algorithm19
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was used to create a pixel skeleton of each object present in the AFM image.
Once the pixel skeletons of fibrils were obtained, crossing over points of slightly
entangled fibrils were removed, and the endpoints of each skeleton was
determined.20 Highly entangled skeletons were removed from the analysis. The
end to end length between the endpoints connected by a pixel skeleton was
calculated, and the contour length was calculated based on the length of the
entire pixel skeleton.

4.3 Results
4.3.1 Aβ fragments form distinct oligomeric and fibrillar aggregates in free
solution
To compare oligomers and fibrils formed by different Aβ fragments under
free solution conditions (i.e. no surface present), 20 µM solutions of Aβ1-11, Aβ1-28,
Aβ10-26, Aβ12-24, Aβ16-22, Aβ22-35, or Aβ1-40 were incubated at 37°C and sampled at
different time points, deposited on mica, and imaged by AFM in air. Each Aβ
fragment was prepared via the same protocol13 to ensure that observed
differences in aggregate morphology were not attributable to sample preparation,
which has been shown to profoundly influence Aβ aggregate morphology.21 Each
fragment was capable of forming discrete, globular oligomers within an hour of
incubation (Figure 4.2A). These oligomers were present for the entire length of
the incubation (up to 72 h); although, the relative abundance decreases when
fibrils appeared for each respective fragment. Oligomers were defined as having
an aspect ratio (longest distance across to shortest distance across) of less than
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Figure 4.2: Aβ fragments form oligomers under free solution conditions.
Oligomers formed by Aβ1-11, Aβ1-28, Aβ10-26, Aβ12-24, Aβ16-22, Aβ22-35, and Aβ1-40 formed a
variety of oligomers. (A) Representative AFM images of oligomeric aggregates formed
by different Aβ fragments. The scale bar is applicable to all images. Representative
oligomers are indicated by yellow arrows. (B) Height histograms for oligomers formed
by the different Aβ fragments. The total number (n) of measured oligomers used to
construct each histogram is indicated for each fragment. The histograms were
compiled from a minimum of six images taken from at least three independent
experiments. (C) Based on corrected volume measurements, the molecular mass of
oligomers formed by each Aβ fragment was calculated. The darker colors represent a
greater population of oligomers at that molecular mass.
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2, indicating a round, globular structure, allowing us to distinguish them from
fibrils and other aggregates via image processing software.
Height analysis of oligomers suggested that the Aβ fragments formed
different oligomeric species (Figure 4.2B). The height of an individual oligomer
was defined as the largest height value (pixel in the image) contained within the
globular structure constituting one oligomer in the AFM image. While one could
predict that the height of oligomers would correlate with the size of the individual
fragments, this was not necessarily the case. Aβ1-40, being the largest fragment,
did form the largest oligomers (average height of 7.8 ± 3.5 nm and a mode of ~58 nm). Fragments that predominately contained the extracellular domain
aggregated into the smallest oligomers with Aβ1-11 and Aβ1-28 having average
oligomer heights of 3.8 ± 3.3 nm and 3.3 ± 1.9 nm respectively. Due to the
distribution of oligomer height being skewed toward larger values for both Aβ1-11
and Aβ1-28, the modes of the height were smaller (0.5-1.5 nm for Aβ1-11 and 2-3
nm for Aβ1-28). The relatively small height was observed despite Aβ1-28 being the
second largest fragment studied. Aβ1-11 aggregated into a more heterogeneous
population of oligomers compared to Aβ1-28. Two of the three fragments
containing the central hydrophobic/amyloidogenic core of Aβ (Aβ10-26 and Aβ12-24)
formed similar sized oligomers, suggesting that the core region may organize to
form specific oligomeric species. Aβ16-22, being a much smaller fragment, formed
a smaller oligomer. The height of oligomers for these three fragments were 4.1 ±
2.5 nm for Aβ10-26, 4.2 ± 2.4 nm for Aβ12-24, and 2.9 ± 1.1 nm for Aβ16-22. The
modes of oligomer height comprised of Aβ10-26 or Aβ12-24 were 3-4 nm, and it was
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2-3 nm for Aβ16-22. Aβ22-35, which does not contain the amyloid core region but
does have a portion of the transmembrane domain, formed smaller (average
height of 2.5 ± 1.0 nm and a mode of 2-3 nm) oligomers with a very tight
distribution compared to the other fragments.
To further characterize the size of oligomers formed by the different Aβ
fragments, volume distributions of individual oligomers (obtained via an aspect
ratio filter) were used to estimate the approximate molecular weight of oligomers.
As the measured volume of each oligomer is exaggerated due to the size and
shape of the AFM tip, a partial correction based on geometric models was
applied to the volumes observed for individual oligomers.22 The volume of
individual oligomers was converted to an approximate molecular weight based on
the average density of proteins.23,24 Following this protocol, molecular weight
distributions of oligomers formed by each fragment were obtained (Figure 4.2C).
Unsurprisingly, Aβ1-40 formed the largest oligomers with a broad distribution. Aβ
fragments that contained the extracellular domain formed the smallest oligomers;
although, oligomers of Aβ1-11 were smaller (~20 kDa) than those formed by Aβ1-28
(~40-60 kDa). The oligomers formed by Aβ10-26, Aβ12-24, or Aβ16-22 (the three
fragments that contained the hydrophobic core) systematically decreased in
mass in a manner consistent with the size of each respective monomer (~125150 kDa for Aβ10-26, ~90-120 kDa for Aβ12-24, and ~75-100 kDa for Aβ16-22). This
suggests that these oligomers are comprised of a similar number of peptides. As
the common sequence between these three fragments was the hydrophobic
core, it is likely that this sequence is driving the formation of oligomers of these
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three fragments. Aβ22-35 aggregated into smaller oligomeric structures (~70-80
kDa) compared to fragments containing the hydrophobic core, but larger than
those formed by fragments containing the extracellular domain.
All of the Aβ fragments aggregated into fibrils (Figure 4.3A); however, the
time needed to observe fibrils and their morphology was fragment specific. Aβ1-40
aggregated into fibrils within 24 h of incubation. The Aβ1-11 took 72 h of
incubation for fibrils to appear, and this extended incubation time needed for fibril
formation was most likely due to the lack of a β-strand region within this
fragment. Fibrils were observed for the other fragment predominately comprised
of the extracellular domain, Aβ1-28, within 48 h. The shorter time of fibril formation
for Aβ1-28 in comparison with Aβ1-11 was most likely aided by the inclusion of a βstand region in the longer fragment. Aβ10-26, Aβ12-24, and Aβ16-22, despite
aggregating

into

similar

sized

oligomers,

assembled

into

fibrils

after

approximately 24 h, 48 h, and 72 h of incubation. The time required for these
three fragments containing the hydrophobic core of Aβ to aggregate into fibrils
roughly correlated with the length of the fragment, with fibrils appearing earlier for
longer fragments. For these three fragments (Aβ10-26, Aβ12-24, and Aβ16-22), the
longer sequences have more sites where β-sheet formation can nucleate,
leading to earlier fibril formation. Fibrils of Aβ22-35 formed most quickly, within 8 h
of incubation. The formation of Aβ22-35 fibrils was likely facilitated by the β-strand
forming sequence associated with the transmembrane domain and the tight
distribution of oligomers that may be on pathway to fibril formation. The relatively
quick formation of fibrils for Aβ22-35 and Aβ1-40, both of which contain at least a
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portion of the transmembrane domain, indicates that the transmembrane portion
of Aβ plays an important role in nucleating fibril formation.
It is important to note, however, that the morphology of the fibrils formed
by the different fragments varied (Figure 4.3A). As a result, a variety of image
analyses were performed to investigate these morphological differences. The
average height (or thickness perpendicular to the long axis of the fibril) along the
entire contour of each fibril was determined because height can vary along the
extended morphology of a fibril (note: this is a different method of determining the
height than was used for analysis of oligomers). This average height along the
contour varied for fibrils comprised of the different Aβ fragments (Figure 4.3B).
As expected, Aβ1-40 formed the thickest fibrils (average height of 7.3 ± 2.4 nm
and a mode of ~5-8 nm) with a highly entangled morphology. Unlike the case
with

oligomers,

fragments

containing

the

extracellular

domain

formed

intermediate sized fibrils with Aβ1-11 and Aβ1-28 having average fibril heights of 3.5
± 2.3 nm and 3.2 ± 1.9 nm along the fibril contour respectively. The three
fragments containing the hydrophobic core formed very similar sized fibrils (1.5 ±
2.5 nm for Aβ10-26, 1.2 ± 2.4 nm for Aβ12-24, and 1.9 ± 1.1 nm for Aβ16-22) that were
smaller than fibrils formed by other fragments. The similarity between these
average heights along the fibril contour suggests that the hydrophobic core is
dictating the fibril structure. The mode of fibril heights comprised of Aβ10-26 was
~1-2 nm, and the mode was ~0.5-1.5 for fibrils of both Aβ12-24 and Aβ16-22. It
should also be noted that of these three fragments, only Aβ12-24 formed a
subpopulation of annular aggregates. Aβ22-35 formed slightly thicker fibrils
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Figure 4.3: Aβ fragments form fibrils in free solution with distinct morphologies.
(A) Ex situ AFM images of fibrils for Aβ1-11, Aβ1-28, Aβ10-26, Aβ12-24, Aβ16-22, Aβ22-35, or Aβ140. The images were taken at the time points when fibrils first formed, as indicated. The
scale bar is applicable to all images. Arrows indicate annular aggregates (pink) and
fibrils (blue). (B) Histograms of average height along the contour of the fibril for fibrils
formed by each Aβ fragment are presented. Total number (n) of measured fibrils used
to construct each histogram is indicated for each fragment. Histograms were compiled
from a minimum of three images taken from at least three independent experiments.
(C) Plots correlating contour length to end to end distance of fibrils formed from
different Aβ fragments are shown. Dashed lines represent the theoretical correlation for
rigid rod-like structures with infinite persistence lengths.
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compared to those containing the hydrophobic core (average height of 2.5 ± 1.0
nm and a mode of 2-3 nm).
The fibrils formed by the different fragments displayed varying amounts of
curvature (or persistence length) along their long axis. In an effort to more clearly
demonstrate this feature, the relationship between the contour length and end to
end distance were compared (Figure 4.3C). Rigid structures that have an
infinitely large persistence length would have equal contour lengths and end to
end distances. Such a scenario would result in a correlation plot with a slope of 1
(represented by the dashed line seen in each correlation plot in Figure 4.3C).
Deviations from this theoretical dashed line indicated that the fibril structure has a
smaller persistence length, and the further the deviation, the lower the
persistence length. Trends in the relative rigidity of the fibril structure along its
long axis can be seen based on the specific domains contained in each
fragment. Based on these correlation plots, Aβ1-11 formed a large population of
highly curved fibrillar aggregates, which can be seen as half ring-like structures in
the corresponding AFM image (Figure 4.3A). This ability to form highly curved
fibrils of Aβ1-11 may be due to the lack of any known β-strand forming domains
within this fragment. In comparison, Aβ1-28 and Aβ10-26 formed fibril structures with
relatively large persistence lengths, both of which contain a large portion of the
first β-strand forming domain in Aβ. Aβ22-35, which contained a portion of the
second β-strand forming domain, also formed fibrils with large persistence
lengths. Reducing the size of the β-strand forming domain appeared to reduce
the persistence length of the fibrils, as Aβ12-24 and Aβ16-22 aggregated into highly
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curved fibrils that deviated from the theoretical rigid line in the correlation plot
between contour length and end to end distance (Figure 4.3C). Aβ1-40, despite
containing both β-strand forming domains, aggregated into fibrils that had
intermediate persistence lengths.

4.3.2 Aβ fragments form distinct aggregates in the presence of supported
bilayers
To investigate the interaction between specific Aβ fragments and lipid
membranes, supported TBLE bilayers were exposed to each fragment and
imaged using in situ AFM. TBLE bilayers contain a physiologically relevant mix of
lipid components, i.e., cholesterol, gangliosides, sphingolipids, isoprenoids and
both acidic and neutral phospholipids, making these bilayers an appropriate
model surface. Defect-free bilayers (as determined by AFM) were produced via
vesicle fusion, and such supported lipid bilayers have been shown to maintain
many properties of free membranes.25,26 The defect-free TBLE bilayers were
stable for at least 24 h and had a RMS surface roughness of 0.21 ± 0.07 nm.
Originally, the aggregation of Aβ fragments on TBLE bilayers was to be
tracked continuously while imaging the surface. During these experiments, AFM
images were zoomed out and bilayer morphology that had not been imaged was
compared with bilayer area that had been continuously imaged. The process of
imaging with the AFM was found to block the interaction of Aβ fragments with the
bilayer. From this, discrete time points were chosen and imaged. At time points
ranging from 5-6 h, no noticeable interaction of Aβ fragments with the bilayer was
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seen (Figure 4.4). Therefore, later time points were chosen for these experiments
at ~16-20 h.
Figure 4.4: In situ AFM images
of TBLE bilayer exposed to Aβ
fragments are intermediate time
points (5-6h). Aβ1-28, Aβ16-22, and
Aβ22-35 are shown at intermediate
time points. No appreciable
interaction with the TBLE bilayer
is seen. Later time points resulted
in noticeable bilayer interaction
and Aβ aggregation.

TBLE bilayers were exposed to 20 µM (final concentration) solutions of
each Aβ fragment (Aβ1-11, Aβ1-28, Aβ10-26, Aβ12-24, Aβ16-22, Aβ22-35, or Aβ1-40) at
~21-22 oC (Figure 4.5A) by direct injection of the peptides into the AFM fluid cell.
As continual imaging by the AFM tip was found to interfere with the interaction of
some of the Aβ fragments with the bilayer, an image was taken directly after
injection to ensure no damage to the bilayer due to the injection process, and
then the imaging process was stopped. After 16 h of co-incubation, AFM imaging
was resumed; therefore, all presented AFM images were taken between 16-20 h
after the injection of peptide (Figure 4.5A). As has been previously observed in
the literature,14,27 Aβ1-40 readily aggregated into fibrils and oligomers on the TBLE
bilayer, creating regions of increased surface roughness (RMS roughness of 6.9
± 0.5 nm) that can be associated with disruption of lipid packing within the
bilayer. The large surface roughness is partially due to a combination of the large
size of aggregates associated with these regions and holes that span the entire
bilayer. For Aβ sequences predominately containing the extracellular domain
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Figure 4.5: Aβ fragments have varying levels of interaction with lipid
membranes. (A) Representative in situ AFM images of TBLE bilayers exposed to Aβ111, Aβ1-28, Aβ10-26, Aβ12-24, Aβ16-22, Aβ22-35, or Aβ1-40 for 16-20 h. Scale bar is applicable
to all images. Arrows indicate oligomers (yellow), fibrils (blue) and areas of exposed
mica (green). (B) Percent area of the TBLE bilayer surface occupied by Aβ fragment
aggregates or increased bilayer disruption was measured from images obtained after
16-20 h of bilayer exposure to different Aβ fragments. (C) %CR of PDA vesicles
exposed to different Aβ fragments as a function of time are presented. Exposure to
Tris and NaOH acted as negative and positive controls respectively. %CR values were
averaged over three samples.

(Aβ1-11 and Aβ1-28), a small number of oligomers appeared on the TBLE bilayer,
with no discernible effect on the bilayer integrity or roughness. Presumably, the
hydrophilic nature of the extracellular domain does not provide an adequate
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driving force for substantial association between Aβ and the lipid bilayer. Of the
peptides containing the hydrophobic core, Aβ12-24 only formed oligomeric
aggregates on the bilayer, resulting in limited changes in the bilayer's stability
and morphology. However, Aβ10-26 and Aβ16-22 both extensively aggregated into
oligomers and fibrils in the presence of the bilayer, and these aggregates were
often associated with regions of the TBLE bilayer displaying increased surface
roughness (~1.6 ± 0.1 nm for Aβ10-26 and ~5.9 ± 0.5 nm for Aβ16-22) or holes
spanning the entire membrane. Aβ22-35 aggregated predominately into fibrils (with
some oligomers present), and aggressively disrupted the TBLE bilayer (RMS
roughness ~ 3.8 ± 0.2 nm) to expose large areas of mica, suggesting the
transmembrane

domain

mediates

the

interaction between Aβ and lipid bilayers. As
both mica (Figure 4.6) and unperturbed TBLE
bilayers (Figure 4.5A) appear smooth in AFM
images, the creation of holes in the bilayer that
exposed the underlying mica substrate was
evident by ~4-5 nm step features in the AFM
Figure 4.6: Representative in
situ tapping mode AFM image
of a freshly cleaved mica
surface in PBS buffer. The
flat, aggregate free surface acts
as a model substrate for bilayer
formation.

images (Figure 4.5A).
The extent of interaction of the different
fragments with the bilayer was determined by
calculating the percent surface area that

contained aggregates or increased surface roughness (Figure 4.5B). Based on
this analysis, the fragments that contained a portion of the transmembrane
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domain (Aβ22-35 and Aβ1-40) had the strongest interaction with the TBLE bilayer as
at least half of the available bilayer surface was typically disrupted after 16 h of
exposure. Peptides that contained the hydrophobic core typically disrupted 5-

Figure 4.7: Colorimetric response
with lipid/PDA vesicles occurs in
conjunction
with
the
structural/colorimetric
transformations of PDA (blue)
induced
by
protein
(green
rectangles) interaction with the
lipid bilayer domains (grey). The
lipid components in the mixed
vesicles form distinct bilayer domains
with
biosensing
abilities.
The
interactions of proteins with the lipid
domains give rise to blue-red
transformations of the polymer. (A)
Lipid/PDA vesicles with no protein
interaction do not undergo a blue-red
transformation and the vesicle stays
blue. (B) Due to external pertubations
(protein
interaction)
Lipid/PDA
vesicles undergo rapid blue-red
colorimetric transitions and the
vesicle becomes red. (C) Protein
insertion causes lipid/PDA vesicles to
undergo a slight blue-red transition
causing the vesicle to become
purple.

15% of the surface, with Aβ10-26 being the most aggressive of these three
fragments. Aβ1-11 and Aβ1-28 minimally interacted with the TBLE bilayer, as only a
small fraction of the surface was occupied by discrete oligomers.
To verify the observed magnitude of the interaction of the different Aβ
fragments with the TBLE bilayers as measured by in situ AFM and gain some
time-resolved information about this interaction, a series of colorimetric
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membrane binding assays using lipid/polydiacetylene (PDA) vesicles were
performed. Lipid/PDA vesicles have varied colorimetric responses when exposed
to proteins depending on the extent of the protein/lipid interaction.15,28 The
colorimetric response (CR) in the lipid/PDA vesicles is related to transitions of the
PDA polymer backbone structure, which is affected by changes in tension
associated with protein interaction with and/or insertion into the vesicle (Figure
4.7).15 By measuring absorbance of both the blue (640 nm) and red (500 nm)
wavelengths of TBLE/PDA vesicles upon exposure to different Aβ fragments, the
percent colorimetric response (%CR) was obtained, which directly corresponds
to the protein/lipid interaction (Figure 4.5C). Exposure to Tris or NaOH was used
as negative and positive controls. NaOH acts as a positive control for vesicle
perturbation because, as a strong base, it can decompose lipids, changing the
tension in the vesicle and inducing a colorimetric response. These PDA/TBLE
experiments correspond well with the AFM observations (the 16 and 20 h time
points can be directly compared to Figure 4.5B). Aβ1-11 and Aβ1-28 had induced
the smallest colorimetric response. A larger colorimetric response was observed
for the Aβ fragments containing the hydrophobic core, and the relative magnitude
of this response was consistent with the AFM data. The largest colorimetric
response was observed when the vesicles were exposed to Aβ22-35 and Aβ1-40,
verifying that the transmembrane domain play a key role in the interaction of Aβ
with lipid membranes. Despite both invoking a large colorimetric response, there
were differences in the time-dependent interaction of Aβ22-35 and Aβ1-40 with the
PDA/TBLE vesicles. While Aβ1-40 quickly interacted with the vesicles, the
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colorimetric response quickly leveled off. Aβ22-35 did not initially invoke a large
colorimetric response; however, the interaction with the vesicles steadily
increased with time.
Next, analysis of the aggregate morphologies observed for each Aβ
fragment upon exposure to the TBLE bilayer via AFM image analysis (Figure 4.8)
was conducted. Each Aβ fragment formed oligomers (aggregates with an aspect
ratio less than 2) on the TBLE bilayer, and the height of these oligomers was
analyzed (Figure 4.8A). Small oligomers of Aβ1-11 associated with the bilayer
(mode ~ 0.5 nm; average height of 2.6 ± 2.4 nm) were similar in morphology to
the smaller population of Aβ1-11 oligomers that formed under free solution
conditions; however, the population of larger oligomers that were observed in
free solution was absent in the presence of the bilayer, suggesting that the
bilayer either preferentially binds the smaller oligomers or promotes their
formation. Oligomers of Aβ1-28 were smaller in the presence of the TBLE bilayer
(mode ~ 1-2 nm; average height of 1.8 ± 0.8 nm) compared to oligomers formed
under free solution conditions, suggesting either that the bilayer promotes the
formation of smaller oligomers or that the oligomers are partially inserted into the
bilayer. The fragments that contained the hydrophobic core of Aβ formed smaller
oligomers (mode ~ 0.5-2 nm for Aβ10-26, 0.5-2 nm for Aβ12-24, and 1.0-2.5 nm for
Aβ16-22) compared to those observed under free solution conditions. Again, a
plausible explanation for this observation is that these oligomers are partially
inserted into the bilayer. Due to the appearance of some larger oligomers, the
average heights of oligomers were larger than the mode for these three
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fragments (4.0 ± 1.9 nm for Aβ10-26, 2.4 ± 1.7 nm for Aβ12-24, and 4.6 ± 3.1 nm for
Aβ16-22). Aβ22-35 oligomers were similar in size (mode ~ 1.0-2.5 nm) in the
presence of the bilayer compared to their free solution counterparts, but the
Figure 4.8: Aβ fragments form
a variety of oligomers and
fibrils on TBLE bilayers. (A)
Height histograms of oligomers
formed by Aβ1-11, Aβ1-28, Aβ10-26,
Aβ12-24, Aβ16-22, Aβ22-35, or Aβ1-40 in
the presence of TBLE bilayers
are shown. (B) Histograms of the
average height along the contour
of the fibril for fibrils formed by
each Aβ10-26, Aβ16-22, Aβ22-35, or
Aβ1-40 in the presence of TBLE
bilayers are presented. The total
number
(n)
of
measured
oligomers and fibrils used to
construct each histogram is
indicated for each fragment. The
histograms were compiled from a
minimum of six images taken
from at least three independent
experiments. (C) Plots correlating
the contour length to the end to
end distance of fibrils formed
from Aβ10-26, Aβ16-22, Aβ22-35, or
Aβ1-40 in the presence of TBLE
bilayers are shown. The dashed
lines represent the theoretical
correlation for rigid rod-like
structures with infinite persistence
lengths.

distribution was much broader with some larger oligomers being observed. Aβ1-40
oligomers were on average smaller compared to those observed in free solution
(5.2 ± 3.1 nm), also suggesting partial insertion into the bilayer. However, the
distribution of sizes of Aβ1-40 oligomers became much broader.
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The appearance of fibrils on TBLE bilayers was only observed for Aβ10-26,
Aβ16-22, Aβ22-35, and Aβ1-40, and these fibrils varied morphologically (Figure 4.8B
and C). The time frame for fibrils of these four fragments to form on the bilayer
was reduced in comparison to free solution conditions, suggesting that the lipid
environment facilitates the formation of fibrils for these specific fragments. As
there was a limited time period in which to observe the TBLE bilayers, we can not
rule out that Aβ1-11, Aβ1-28, and Aβ12-24 would form fibrils on the bilayer given more
time, especially considering that it took at least 48 h for fibrils to be observed for
these three fragments under free solution conditions. Fibrils of Aβ10-26 that formed
on the bilayer were similar in height (1.8 ± 1.1 nm) (Figure 4.8B) but appeared to
have a smaller persistence length (Figure 4.8C) compared to fibrils formed in free
solution. Due to these characteristics and the appearance of the fibrils, it
appeared that Aβ10-26 aggregated into a distinct polymorphic fibril on the bilayer
compared to those observed from free solution. Aβ16-22 aggregated into a much
longer, thicker (average height of 5.4 ± 2.4 nm), and rigid (high persistence
length) fibrillar polymorph than was observed in free solution. Aβ22-35 formed
thicker (2.5 ± 1.9 nm) and more rigid fibrillar aggregates on the bilayer in
comparison to free solution, and these fibrils were predominately associated with
complete disruption of the membrane, exposing mica. Based on appearance,
Aβ1-40 formed a different fibril structure on the bilayer compared with free
solution. The height of these Aβ1-40 fibrils on the bilayer was slightly smaller (5.2
± 3.1 nm) with higher curvature than their free solution counterparts.
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4.3.3 Aβ fragments alter the local mechanical properties of TBLE bilayers
Next, how exposure to the different Aβ fragments altered the local
compressibility and adhesive properties of a TBLE bilayer was determined. To
accomplish this, a technique called SPAM (explained in Chapter 1 and 2 in
detail) was used,17 which recovers the time-resolved tip/sample force associated
with every tapping event during the acquisition of a tapping mode AFM image
taken in solution. Specific features of the tapping forces, the maximum tapping
force (Fmax) and minimum tapping force (Fmin) per oscillation cycle, are sensitive
to changes in the sample's mechanical properties and can be used to map these
properties with high spatial resolution during regular AFM operation.29,30 Fmax is
defined as the largest positive (or repulsive) force experienced between the tip
and sample during one tapping event and is responsive to the sample's
compression modulus. Fmin is defined as the largest negative (or attractive) force
between the tip and sample during one tapping event and is indicative of the
adhesion properties of the surface with respect to the probe. Topography, Fmax,
and Fmin images were generated of TBLE bilayers exposed to the different Aβ
fragments for 16-20 h (Figure 4.10 and 11). Control topography, Fmax, and Fmin
images are presented in (Figure 4.9). These control images appear featureless,
as the TBLE bilayer represents a relatively homogenous surface. As the
topography and force data are obtained simultaneously, the tapping forces can
be

associated

with

specific

topographical

features,

allowing

for

the

deconvolution of the tapping force distributions. The fragments Aβ1-11, Aβ1-28, and
Aβ12-24, which only formed oligomeric aggregates on the TBLE bilayer, did not
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cause extensive mechanical changes in the bilayer (Figure 4.10). However, the
oligomers of these three fragments were typically less adherent to the probe, and
tended to be slightly more compressible.

Figure 4.9: Undisturbed TBLE
bilayers display specific local
mechanical properties. AFM
topography, Fmax, and Fmin images
of TBLE bilayer were obtained
using SPAM. Histograms of every
tapping event (right of images) for
Fmax and Fmin illustrate the
unperturbed bilayer region.

The Aβ fragments that significantly altered the bilayer morphology and
formed a larger variety of aggregates had a much larger impact on the
mechanical properties (Figure 4.11). For experiments performed with Aβ10-26,
Aβ16-22, Aβ22-35, or Aβ1-40, portions of the bilayer were unaffected, and the forces
associated with these areas can be used as an internal reference to determine
the relative mechanical properties associated with different features of the
surfaces. Whenever mica was exposed, those areas of the surface were
associated with the highest magnitudes of Fmax and Fmin, consistent with mica
being a hard substrate that is relatively more adherent to the probe. Based on
Fmax, the aggregates of Aβ10-26, Aβ16-22, Aβ22-35, or Aβ1-40 were more compressible
compared with the bilayer, and Fmin indicated that these aggregates were the
features with the least amount of adhesion to the AFM tip. Regions of the bilayer
that had disrupted bilayer morphology (for example in Aβ1-40) were consistently
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more compressible (softer) than unperturbed regions of bilayer; however, these
regions were not as soft as the actual aggregates. This is consistent with Aβ
fragments reducing the ordering and packing efficiency of the bilayer,31,32
resulting in a more compressible membrane.

Figure 4.10: Minimal changes in
local mechanical properties of
TBLE bilayers are associates
with exposure to Aβ 1-11, Aβ 1-28,
or Aβ 12-24. As Aβ1-11, Aβ1-28, and
Aβ12-24 only formed oligomeric
aggregates on TBLE bilayer,
extensive bilayer disruption was
not observed. AFM topography,
Fmax, and Fmin images of TBLE
bilayer exposed to (A) Aβ1-11, (B)
Aβ1-28, and (C) Aβ12-24, were
obtained using SPAM. Histograms
of every tapping event (right of
images) for Fmax and Fmin illustrate
the various regions of interest:
bilayer and oligomer, which were
sorted based on the topography
image. The insets zoom to show
the
data
associates
with
oligomers, as a significantly fewer
tapping events are associated
with these regions.
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4.4 Discussion
A variety of Aβ fragments have been investigated in this chapter in an
effort to understand how specific regions of Aβ regulate its interaction with lipid
membranes. In particular, the interaction of Aβ1-11, Aβ1-28, Aβ10-26, Aβ12-24, Aβ16-22,
Aβ22-35, and Aβ1-40 with TBLE bilayers were investigated. These Aβ fragments

Figure 4.11: Aβ 10-26, Aβ 16-22, Aβ 22-35, and Aβ 1-40 disrupt TBLE bilayers, altering the
mechanical properties of the bilayer. AFM topography, Fmax, and Fmin images of
TBLE bilayers exposed to (A) Aβ10-26, (B) Aβ16-22, (C) Aβ22-35, and (D) Aβ1-40 were
obtained using SPAM. Histograms of every tapping event (right of images) for both
Fmax and Fmin illustrate the various regions of interest: Aβ10-26, Aβ16-22 and Aβ22-35 the
regions include undisrupted bilayer, mica and aggregates, whereas Aβ1-40 showed
regions of undisrupted bilayer, disrupted bilayer, mica, and aggregates. These regions
were sorted based on the topography image. The insets zoom to show regions of the
surface that have significantly fewer tapping events associated with them.
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represent a variety of chemically unique regions along the peptide i.e., the
extracellular domain, β-strand, β, turns, the central core, and a portion of the
transmembrane domain. While these studies using these Aβ fragments can
provide insights into the interaction of specific domains with lipid membranes,
care must be used in extrapolating these results in understanding the dynamic
aggregation of full-length Aβ in solution or at lipid interfaces. Specifically, studies
with these fragments exclude the potential of the interaction between protein
domains to facilitate aggregation or binding to lipid membranes. Furthermore, the
Aβ concentrations used in this study are large compared to those typically
observed in vivo. While this was done to allow for observations within an
experimentally feasible time period, this increased concentration must be taken
into consideration when interpreting these results, as amyloid formation is highly
dependent on protein concentration.
Exposure of the model lipid membrane to fresh preparations of these Aβ
fragments resulted in distinct aggregation patterns and changes in bilayer
stability associated with each fragment. Aβ10-26, Aβ16-22, Aβ22-35, and Aβ1-40
caused disruption of the lipid bilayer structure upon exposure and resulted in a
variety of distinct fibrillar aggregates. Exposure to these fragments resulted in
altered mechanical properties of the lipid bilayer. Interestingly, in the
corresponding force images, the rigidity associated with individual aggregates of
Aβ fragments bound to the membrane was able to be determined. The
aggregates were more compressible than the surrounding lipid bilayer, indicating
that the aggregate may form a local weak spot within the membrane that may
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lead to fragmentation of the membrane structure. Conversely, Aβ1-11, Aβ1-28, and
Aβ12-24 had minimal interaction with lipid membranes, forming only oligomers that
were weakly adhered to the surface. These studies provide insight into the
potential role of specific amino acid sequences within Aβ on aggregation and
interactions with lipid membranes. As a result, residues 16-23 and 30-35 were
determined to play a major role in Aβ binding to model membranes and the
subsequent changes in mechanical properties of the membrane. Similar
sequences (Aβ17-20 and Aβ30-35) have been found to be critical facilitating cellular
toxicity and Aβ aggregation,33 and portions of these regions (10 residues of the
C-terminus and Aβ17-21) have the greatest hydrophobic character of Aβ.34
While it would have been desirable to have a fragment representing just
the transmembrane domain of Aβ, the preparatory protocol used in this study
was unable to completely solubilize lyophilized stocks of such a fragment (Aβ2939).

As it is well established that chemical history of Aβ influences the aggregation

pathway,21,35 using a different preparation to solubilize Aβ29-39 would have biased
any

comparisons

with

the

other

fragments.

Presumably,

the

entire

transmembrane domain would interact strongly with the hydrophobic core of a
lipid membrane, as the Aβ25-35 fragment, which only contains a portion of the
transmembrane domain, interacted the most aggressively with TBLE in both the
AFM and PDA assays. Observations from the literature further support this
notion. Experiments with the same Aβ25-35 fragment alters the structure and
dynamic nature of a variety of phospholipid membranes.36-38 An Aβ25-40 fragment,
which contains the entire transmembrane domain, preferentially localized within
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the hydrophobic core of DMPC/DPPG liposomes.39 Interestingly, fragments of
Aβ31-35 and Aβ25-35 can induce toxicity in PC12 cells, although, by apparently
different mechanisms as Aβ31-35 toxicity is associated with biochemical features
of apoptosis that are not detected in studies with Aβ25-35.40
Surfaces have long been established as potential modifiers of amyloid
formation, and these studies further demonstrate that lipid surfaces, in particular,
can influence the aggregation of Aβ. It has been shown that chemically distinct
surfaces influence the aggregation rate of Aβ, as well as the morphology.41-43
Lateral mobility of Aβ appears to be critical in the formation of fibrils on solid
surfaces and lipid bilayers,44 and this could be important as single molecule
studies performed on Aβ inserted into anionic lipid membranes demonstrated
high lateral mobility until aggregating into oligomers.45 The affinity of Aβ for the
surface also plays a role in creating local areas of high concentration that can
lead to aggregation.44 This factor is supported by the observations suggesting
that Aβ fragments containing the transmembrane domain, with presumably a
higher affinity for lipid membranes, aggregated more aggressively on TBLE
bilayers.
The pathological action of Aβ and its aggregate forms appears to be at
least partially attributable to interaction with cellular membranes.46 Detrimental
effects of Aβ on lipid membranes can occur via several potential mechanisms.
Several studies have indicated that Aβ can form pore-like structures in lipid
membranes, resulting in increased membrane permeability.47-51 Studies using
lipid vesicles that contained self-quenching dyes have demonstrated that Aβ can
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disrupt the integrity of lipid bilayers, making them leaky,52 and the disruption of
bilayer morphology by Aβ has been observed by AFM for a variety of lipid
systems.14,48,53,54 The observed morphological changes in bilayers associated
with Aβ fragments that aggressively interacted with the TBLE surface suggest
that the aggregation process plays a role in altering the integrity of membranes.
The physical properties of lipid bilayers, such as phase state, bilayer
curvature, elasticity and modulus, surface charge, and degree of hydration, can
influence modulate protein aggregation at membrane surfaces.55 The lipid
composition of a bilayer has been shown to exert substantial influence on the
aggregation of amyloid-forming proteins.56 TBLE bilayers were chosen to study
the aggregation of Aβ in the presence of a physiologically relevant mixture of lipid
components. While this complicates the ability to determine the importance of
specific Aβ/lipid interactions, other studies have indicated that the interaction of
Aβ with membranes is highly dependent on the abundance of specific lipid
components, i.e., cholesterol,27,57,58 sphingolipids,59 gangliosides,60 and neutral or
charged phospholipids.61-63 Neutral phosphatidylcholine (PC) lipids extend the
lag time needed to initiate Aβ aggregation in concentration dependent manner.63
a variety of lipids have been shown to induce structural transition in Aβ, from ahelical to β-sheet, using circular dichroism.61 The charge of the lipid membrane,
which is determined by phospholipid headgroups, is a major factor controlling the
extent of Aβ/membrane association, as the affinity of monomeric Aβ is stronger
for membranes comprised of negatively charged 2-oleoyl-1-pamlitoyl-sn-glyecro3-glycerol (POPG) compared with membranes of neutral 1-palmitoyl-24. Specific domains of Aβ facilitate aggregation on and association
with lipid bilayers

157!

oleoylphosphatidylcholine (POPC).64,65 However, aggregation can modulate
these interactions as fibrillization reduces the affinity for negatively charged
membranes to a greater extent than that for neutral membranes.65 Other studies
demonstrate that Aβ binding to gangliosides accelerates fibril formation in the
presence of vesicles.66,67 Incorporation of gangliosides in membranes also
facilitates the formation of Aβ pores and membrane fragmentation.68 Ganglioside
GM1 and sphingomyelin can destabilize mature Aβ fibrils, stabilizing intermediate
protofibrillar aggregates.69 Furthermore, altering the composition of supported
TBLE bilayers by exposing them to apoE-containing lipoprotein particles was
shown to reduce Aβ binding to the lipid surface, resulting in decreased
membrane disruption.54
While previous studies using Aβ1-40 mutants demonstrated that lipid
membrane association of Aβ is driven by electrostatic and hydrophobic
interactions,70 the results indicate that specific domains also play an important
role, leading to various degrees of lipid interaction and disruption. Understanding
the interaction of specific Aβ residues with lipid membranes is important because
Aβ may exert its cytotoxic effect at cellular membranes, not in free solution,
changing the effectiveness of potential therapeutics that target Aβ. This concept
has been demonstrated by studies on the aggregation of human islet amyloid
polypeptide at phospholipid surfaces that showed a known inhibitor of amyloid
formation, (−)-EGCG, was less effective at a phospholipid interface.71
While the physical/chemical properties of bilayers may dictate the
susceptibility of a membrane to Aβ binding, once Aβ binds the membrane, it can
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destabilize

membrane

structure,

compromising

membrane

integrity.

Aβ

fragments that aggressively aggregated on TBLE bilayers created regions of
disrupted bilayer morphology that were associated with a softer elastic modulus
and reduced adhesion to the AFM probe tip in comparison to unperturbed
bilayer. A potential explanation for these observed changes in bilayers exposed
to specific Aβ fragments is a decrease in the efficiency of the packing of the lipid
components within the bilayer in response to protein insertion/binding and
aggregation. This would lead to a rougher bilayer that is more easily compressed
and a decrease in the number of potential hydrogen bonds formed between the
tip and bilayer surface, leading to the lower adhesive interaction. This scenario is
consistent with NMR studies that indicate that Aβ induces greater packing
disorder in model lipid bilayers 31,32,68 and morphological changes associated with
membrane exposure to Aβ observed here and elsewhere by AFM.54,70,72
Furthermore, exposure to Aβ has been demonstrated to reduce the force
necessary to puncture lipid membranes.53 Rearrangement of lipid orientation
should have profound effects on the mechanical integrity of membranes. While
anisotropy studies with single component lipid membranes demonstrated that
monomeric Aβ had minimal impact on bilayer fluidity, oligomers decreased the
lateral mobility of lipid components.73 Evidence also suggests that polymorphic
oligomeric structures have varying abilities to alter membrane fluidity,73 and a
reduction in membrane fluidity due to Aβ has been demonstrated in rodent
brains.74 Even at nanomolar concentrations, the lysis tension of unilamellar
vesicles containing oxysterols can be altered by exposure to Aβ.75 Here, specific
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Aβ fragments are demonstrated to locally increase the compressibility of TBLE
bilayers, and in some cases even generate holes spanning the entire membrane.
Collectively, these results suggest Aβ can negatively impact the mechanical
integrity of lipid membranes.
Aβ can also induce membrane curvature in 1,2-dioleoyl-sn-glycero-3phosphocholine (DOPC) lipid vesicles, inducing several different vesicle
shapes.76 These changes in vesicle curvature were highly dependent on the
aggregation state of Aβ, and the mechanical strain associated with Aβ-induced
curvature of lipid membranes could lead directly to their disruption. Such a
mechanism has also been demonstrated for the interaction of IAPP with lipid
vesicles.77-79 However, due to the AFM studies being performed on bilayers
supported by a solid substrate, to see if the fragments studied here preferentially
induced large-scale changes in membrane curvature was unable to be
determined.
Aβ1-11, Aβ1-28 and Aβ12-24 did not extensively aggregate on TBLE bilayers
(only oligomers were observed) and did not result in detectable membrane
disruption. This is easily explained for Aβ1-11, which represents the N-terminus of
the hydrophilic extracellular domain and contains no β-sheet forming sequences.
However, both Aβ1-28 and Aβ12-24 contain extensive hydrophobic residues that
have been associated with β-strand formation. Presumably, these should have
interacted with the lipid bilayer. However, the addition of the first 11 residues of
Aβ in Aβ1-28 may impede the lipid/protein interaction. This notion is supported by
circular dichroism (CD) studies demonstrating that the random structure of Aβ1-28
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is unchanged in the presence of a TBLE bilayer.14 It is not entirely clear,
however, why Aβ12-24 did not interact extensively with the bilayer when Aβ10-26
and Aβ16-22 did.
Based on morphological and mechanical observations, three scenarios for
the impact of Aβ and its aggregate forms on bilayer structure are proposed
(Figure 4.12). Due to the lack of structural information at the molecular level,

Figure 4.12: Aβ fragments can interact with lipid bilayers via several potential
scenarios. (A) Monomeric or small oligomeric species (i.e., dimers) can insert into
bilayers, creating disorder within the membrane. (B) Oligomers of Aβ fragments can
be loosely adhered to the surface of the bilayer (green arrows), or partially inserted
into the bilayer (yellow arrows). When oligomers insert into the bilayer, they displace
lipid components. (C) Fibril formation at the membrane surface leads to lipid
disordering and eventual fragmentation of the membrane, exposing the underlying
mica substrate.

these scenarios are somewhat speculative. Monomers or small oligomers (i.e.,
dimers) can penetrate into the bilayer structure, resulting in disordering of the
bilayer structure that manifest as increased surface roughness observed in AFM
images (Figure 4.12A). This insertion into the bilayer by the Aβ fragments is
facilitated by the presence of the central hydrophobic core and/or the
transmembrane domain. Depending on the specific fragment studied, oligomers
are located within regions of increased bilayer roughness, or not associated with
changes in bilayer morphology (Figure 4.12B). Presumably, the oligomers that
perturbed the bilayer morphology were partially inserted into the membrane,
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forcing the rearrangement of lipid components to accommodate the presence of
the oligomer. Oligomers that minimally inserted into the bilayer would not cause
observable bilayer roughening. The bilayer roughening associated with
monomers and oligomers can potentially lead to membrane leakage and
dysfunction. The formation of fibrils of the Aβ fragments on the bilayer was often
associated with fragmentation of the membrane, exposing bare mica substrate
(Figure 4.12C). Collectively, the ability of Aβ and its aggregate forms to bind lipid
membranes and impact their structural integrity can potentially play a role in a
variety of toxic mechanisms associated with AD.
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5. Aβ 1-40 preparation modulates lipid bilayer interaction by
forming aggregate polymorphisms

The peptide sequence of Aβ has the ability to grow into a variety of stable
fibrillar aggregates. Commonly referred to as polymorphs, such distinct
aggregate species have been recently shown to play a role in AD pathology, as
well as form a basis for strain effects in prion biology. It has been well
demonstrated that polymorphic aggregates of Aβ can be produced by changes in
the chemical environment and peptide preparations. The goal of this study was to
determine how various preparations of Aβ that lead to distinct polymorphs in free
solution influence interactions between a model lipid membrane and Aβ. The Aβ
preparations in this study varied temperature, agitation, and buffer composition.
Distinct fibril morphologies were present in free solution based upon the various
preparations of Aβ. Upon exposure of model lipid membranes to different Aβ
preparations, polymorphic aggregates formed on the bilayer surface and the
roughness of the bilayer was altered in a preparation dependent manner.
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5.1 Introduction: Aβ forms morphologically distinct aggregates or
polymorphs
An interesting feature associated with the aggregation of many amyloid
forming peptides, in particular Aβ, is the ability to form a variety of
morphologically distinct and stable fibril structures, commonly referred to as
polymorphs.1-4 Aβ also forms a variety of aggregate structures on and off
pathway to fibril formation, including distinct oligomers and protofibrils.3,5 The
ability of Aβ to form distinct polymorphic fibril structures is well known and highly
dependent on the chemical environment of the peptide during the aggregation
process.1,4 Recent studies demonstrated variations in Aβ1-40 sample preparation
result in at least five structurally-distinct fibrillar aggregates in vitro.3 Polymorphic
aggregates of Aβ induced by different aggregation conditions are toxic to cells to
a varying degree. For example, subtle alterations in fibril growth conditions
results in two structurally distinct polymorphic fibrils of Aβ1-40 with significantly
different levels of toxicity to neuronal cell cultures.6 Fibrillar polymorphs of Aβ
have been extracted from AD patient brains, and these polymorphs had the
ability to seed further aggregation.7
In this chapter, four distinct preparations of Aβ (Prep A, B, C, and S)
(Table 5.1) based upon established Aβ preparation protocols are investigated.
The preparations vary from the method of Aβ monomer disaggregation to the
buffer used to initiate Aβ aggregation, leading to distinct fibril morphologies in
free solution. Here, model lipid bilayers will be exposed to Aβ prepared by these
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different protocols to determine how the chemical environments of Aβ fibril
formation alters Aβ interaction with lipids.

5.2 Materials and methods
5.2.1 Peptide preparation
Four distinct preparations of synthetic Aβ1-40 (AnaSpec Inc., San Jose,
CA) were prepared. In Preps A and C, Aβ was initially disaggregated using a
standard protocol.8 In short, the lyophilized peptide was suspended in 1 mL TFA
and sonicated for 10 min, and dried under a gentle stream of nitrogen to obtain a
thin film. The peptide film was dissolved in 1 mL HFIP and incubated at 37°C for
1 h. The peptide was dried under a gentle stream of nitrogen. The film was
dissolved in 2 mL HFIP for a second time in order to remove all TFA. The peptide
was again dried under nitrogen and once dried, immediately was further dried
under vacuum in a Vacufuge concentrator (Eppendorf) for 60 min to ensure all
HFIP and TFA was removed. 0.5 mL of fresh 2 mM NaOH was added to each
tube and let stand undisturbed for 5 min. 0.5 mL 2X PBS (pH 7.3) with 0.1%
sodium azide was slowly added to each sample without agitation. Each sample
tube was centrifuged at 386,000 g overnight at 4°C in an ultracentrifuge. After 24
h, the supernatant was carefully removed and the disaggregated monomer was
snap-frozen in liquid nitrogen and stored at -80°C. To obtain fibrils in free
solution, Prep A underwent a non-agitated incubation at 37°C in PBS (pH 7.3),
while Prep C underwent an agitated incubation at 24°C in PBS (pH 7.3).
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In Prep B, Aβ was initially non-disaggregated and prepared by directly
adding the lyophilized peptide powder to 2 mM NaOH, sonicated for 5 min and a
10mM phosphate buffer (pH 7.4) was added to make a solution of 250 µM. Prep
B underwent a non-agitated incubation at 24°C to obtain fibrils in free solution.3
For Preps A, B, and C, all PBS and phosphate buffers both contained 0.05%
(w/v) sodium azide. Prep S was prepared using another published protocol.9 Aβ140

peptide was treated with HFIP to dissolve seeds and pre-existing aggregates

within the lyophilized stock. The peptide sample was placed in a Vacufuge
concentrator (Eppendorf) to remove all HFIP, resulting in a peptide film. To make
a 2000 µM stock solution, the peptide film was dissolved in 10 µL DMSO. The
stock solution was directly dissolved into PBS buffer (pH 7.3) to obtain a final
concentration of 20 µM. In free solution, Prep S underwent an agitated incubation
at 24°C in PBS buffer. Agitation for Prep C and S was conducted using a
thermomixer (Eppendorf) at 400 rpm. For in situ experiments on lipid bilayers,
Preps B, C, and S were prepared as indicated above and added to the lipid
bilayer to undergo incubation.

5.2.2 Preparation of defect free bilayers
At a concentration of 1 mg/mL, lyophilized porcine TBLE (Avanti Polar
Lipids, Alabaster, AL) was re-suspended in PBS (pH 7.3). All experiments were
performed with the same lot of lipids. Bilayers and multilayer lipid sheets were
formed by five cycles of freeze-thaw treatment using an acetone/dry ice bath,10,11
and lipid suspensions were sonicated for 15 min. 15 µL of a 1:1 TBLE/PBS (pH
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7.3) solution was injected directly into the AFM cell and via vesicle fusion, a near
defect free 40 x 40 µm bilayer was formed on freshly cleaved mica. Three
washes with 15 µL PBS were performed to remove excess lipid vesicles from the
fluid cell once the bilayer was fully formed.

5.2.3 AFM imaging conditions
For ex situ AFM imaging, 2 µL aliquots of each Aβ incubation was spotted
onto freshly cleaved mica for 30 s at various time points, washed with 200 µL of
HPLC grade water, and dried under a gentle stream of nitrogen. For each Aβ
preparation, three separate incubations were performed, and each sampled twice
at each time point. Peptide aggregate depositions were imaged with a
Nanoscope V MultiMode scanning probe microscope (Veeco, Santa Barbara,
CA) operated in tapping mode and equipped with a closed-loop vertical engage
J-scanner. Images were acquired with diving board shaped silicon cantilevers
with a nominal spring constant of 40 N/m, scan rates of 2-3 Hz, and a resonance
frequency of ~300 kHz.
In situ AFM images on lipid bilayers were also imaged with a Nanoscope
V MultiMode scanning probe microscope (Veeco, Santa Barbara, CA). Operated
in tapping mode with scan rates of 1-2 Hz and cantilever drive frequencies of ~810 kHz, the microscope was also equipped with a fluid cell sealed with an O-ring.
In situ images were obtained with V-shaped oxide-sharpened silicon nitride
cantilevers with a nominal spring constant of 0.5 N/m (Budget Sensors, Bulgaria).
35 µL of filtered PBS buffer was added to the fluid cell, and background images
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were obtained to ensure cleanliness of the cell before direct injection of 15 µL of
TBLE solution. Once formed, only defect-free TBLE bilayers were exposed to
each preparation of Aβ at a final concentration of 20 µM. Upon injection of 50 µL
of 20 µM Aβ, a 10 x 10 µm image of the surface with 1024 x 1024 pixel resolution
was taken before sealing the fluid cell to prevent evaporation. The bilayer was
imaged again 6-8 h, and then 16-20 h after exposure to Aβ.

5.2.4 SPAM imaging conditions
10 x 2.5 µm images were captured with 512 x 128 pixel resolution using
SPAM. Via a combination of a signal access module (Veeco, Santa Barbara, CA)
and CompuScope 14100 data acquisition card (Gage, Lachine, Quebec),
cantilever deflection trajectories were captured at 2.5 MS/s and 14-bit resolution
with a vertical range of 2 V. A Fourier transform based harmonic comb filter was
applied to the deflection signal. To obtain the time-resolved tip acceleration, the
second derivative of the filtered cantilever deflection was used. the time-resolved
tapping force between the tip and sample was recovered using the effective
mass, meff, of the cantilever.12 meff was determined using a thermal tuning
method by obtaining the spring constant and resonance frequency of the
cantilever.

5.2.5 Quantitative Image Analysis
AFM image analysis was performed using MATLAB and the image
processing

toolbox

(MathWorks,

Natick,

MA)

as

described.13
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dimensions of Aβ aggregates were measured automatically from AFM images.
AFM images were: 1) Imported into MATLAB; 2) flattened to correct for
background curvature; 3) converted into binary maps of aggregate locations
using a height threshold (assigning values of 1 to any image pixel that
represented a height above the threshold and assigning a value of 0 to any pixel
corresponding to a height below the threshold) in order to locate individual
aggregates; 4) specific features (height, volume, contour length, etc.) of each
individual aggregate were measured by implementing pattern recognition
algorithms to the binary map.
To determine fibril contour length and end to end distance a fast parallel
thinning algorithm14 was used to create a pixel skeleton of each object present in
the AFM image. Once obtained, crossing over points of slightly entangled fibrils
of the fibril pixel skeletons were removed, and the endpoints of each skeleton
were determined.15 Based on the length of the entire pixel skeleton, contour
length was calculated. The end to end length between the endpoints connected
by a pixel skeleton was also calculated.

5.3 Results
5.3.1 Aβ prepped by different protocols form polymorphic aggregates in free
solution
First, the ability of the four preparation protocols form distinct Aβ fibril
polymorphs in free solution, as well as oligomers was confirmed. 20 µM solutions
of Prep A, B, C and S were incubated and sampled at 0, 4, 8, 12, 24, 48, and 72
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h, deposited on mica, and imaged ex situ by AFM. Each Aβ preparation
environment was prepared via the corresponding protocol as described in the
materials and methods and in Table 5.1. Each Aβ preparation formed oligomers

Prep

Temperature

Buffer

Agitation

Monomer
Disaggregation

AFM
imaging
conditions

A

37°C

PBS

No

Yes HFIP/TFA

Ex situ

B

24°C

Phosphate

No

No

Ex situ & in
situ

C

24°C

PBS

Yes

Yes HFIP/TFA

Ex situ & in
situ

S

24°C

PBS

Yes

Yes HFIP/DMSO

Ex situ & in
situ

Table 5.1: Polymorphic fibril preparation conditions. Each Aβ preparation used a
specific protocol to achieve fibril formation. Each preparation is explained in detail in
the materials and methods section.

within 12 h of incubation (Figure 5.1A). In order to distinguish oligomers from
fibrillar aggregates, oligomers were defined to have an aspect ratio (longest
distance across to shortest distance across) less than 2, indicating a globular,
circular structure. Oligomer height analysis of the four Aβ sample preparations
suggested that each preparation formed distinct oligomeric aggregates (Figure
5.1B). In each AFM image, individual oligomer heights were defined as the
largest height value (image pixel) contained within one round, oligomeric
structure. Prep A and B led to similar sized oligomers with an average height of
2.54 ± 0.95 nm and 2.46 ± 1.28 nm respectively with modes of 1.5-2.5 nm and
1.5-3.5 nm respectively. Prep C resulted in the smallest oligomers, which had an
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average height of 2.16 ± 0.95 nm and a mode of 1.5-2.5 nm. The oligomers
formed by Aβ for Prep S were the largest, with an average height of 5.47 ± 1.62
nm and a mode of 4-6 nm.

Figure 5.1: Aβ forms oligomers in free solution with each peptide protocol.
Oligomers formed by Prep A, B, C, and S formed a variety of oligomers. (A)
Representative ex situ AFM images of globular, oligomeric aggregates formed by
different peptide preparations. The scale bare is applicable to all images. Oligomers
are indicated by pink arrows. (B) Height histograms for oligomers formed by the
distinct peptide preparations. The average heights of measured oligomer were
calculated for each preparation.

Aβ prepared by each protocol aggregated into fibrils (Figure 5.2A);
however, the time necessary for fibril formation varied. Prep A, C, and S led to
fibrils within 24 h, but Prep B required 72 h. Fibrils remained present for all
preparations at 72 h. While Preps A, C, and S were all rigorously disaggregated
using TFA, HFIP, and DMSO, Prep B did not undergo a disaggregation step,
which may have lowered the effective concentration of monomer and led to a
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Figure 5.2: Aβ prepped with various protocols forms fibrils with distinct
morphologies in free solution. (A) Representative ex situ AFM images of fibrils for
preparations A, B, C, and S. Images reflect times when fibrils were initially formed as
indicated. The scale bar is applicable to all images. Arrows indicate annular
aggregates (red) and fibrils (blue). (B) Average height along the fibril contour
histograms for fibrils formed by each preparation are presented. (C) For each
preparation, correlation plots of contour length to end to end length of fibrils were
constructed. The theoretical correlations for rigid structures with infinite persistence
lengths are represented by dashed lines.

longer time to initiate fibril formation. Another factor that may have caused the
slow aggregation of Prep B into fibrils is due to a change in the chemical
environment (i.e phosphate buffer (pH 7.4) without salt was used in place of
PBS). The morphology of fibrils formed by each preparation varied (Figure 5.2A
blue arrows). A variety of image analyses were performed to investigate the
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morphological differences of the fibrils. A different method to determine height for
the fibrils was used because the height can vary along the length of a fibril. In this
case, the average height (or thickness perpendicular to the long axis of the fibril)
along the contour of each fibril was determined. This average height along the
contour varied for fibrils comprised of the different Aβ preparations (Figure 5.2B).
Fibrils were defined with an aspect ratio greater than 2.5. Fibrils of Prep A had
average height along their contour of of 3.76 ± 1.96 nm with a mode 2-4 nm, and
the fibrils had a broad, bumpy morphology. Prep A was the only one to form a
subpopulation of highly curved, annular aggregates (Figure 5.2A red arrows).
Prep B formed the thinnest fibrils with an average height of 1.63 ± 1.35 nm and
the smallest mode of 1-2 nm, with these fibrils appearing to have very smooth
morphology. Prep C fibrils had an average height of 2.99 ± 1.58 nm with a mode
similar to Prep A of 2-3 nm. While fibrils formed by Prep C had a very smooth
morphology, these fibrils were associated into large bundles. Similar to oligomer
formation, Prep S also formed the thickest fibrils in free solution (average height
of 5.30 ± 1.98 nm with a mode of 4-6 nm). Fibrils formed by Prep S were highly
entangled and had large variation in height, almost periodic, along their contour.
The Aβ fibrils formed by each preparation varied in their persistence
length (or curvature) along their long axis. The relationship between contour
length and end to end distance was compared in order to demonstrate the
variation in fibril curvature between the different Aβ preparations (Figure 5.2C).
The contour length and end to end distance would be equal for a rigid structure
with an infinitely large persistence length. The corresponding correlation plot for
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an infinitely rigid structure would have a line with a slope of 1 (represented by
dashed lines in Figure 5.2C). Correlation between the contour length and end to
end distance will deviate from this theoretical dashed line as persistence length
decreases and fibril structures become less rigid. Fibril rigidity along its long axis
have been measured for each Aβ peptide preparation. For the more rigid fibril
structures observed for Prep B and S, a large portion of the data points for the
correlation between contour length and end to end distance fell near the
theoretical line, corresponding to more rigid fibrils. Based on the correlation plots,
Prep A and C formed a large number of short, curved fibrils that deviated from
the theoretical line for an infinitely rigid structure.

5.3.2 Aβ prepped by different protocols form polymorphic aggregates in the
presence of TBLE bilayers
Model lipid membranes (supported TBLE bilayers) were exposed to each
Aβ preparation, and in situ AFM images were taken to determine how the peptide
history alters the Aβ/lipid interaction. It is important to note that interaction of
Prep A with lipid bilayer was not studied due to the higher temperature needed in
the preparation (37°C). As this higher temperature would change the bilayer
properties, it would not be a fair comparison with the other Aβ preparations.
TBLE bilayers are an excellent model surface due to the physiologically relevant
mix of lipid components they contain (i.e., cholesterol, sphingolipids, isoprenoids,
gangliosides, and both acidic and neutral phospholipids). Near defect-free
bilayers were determined by AFM and have been shown to maintain many
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properties of free membranes.16,17 As demonstrated in Chapter 4, unperturbed
TBLE bilayers appear smooth in AFM images and are stable for at least 24 h. No
noticeable interaction of the Aβ peptide with the bilayer was seen at time points
ranging from 4-6 h, therefore later time points (16-20 h after exposure to Aβ)
were chosen. TBLE bilayers were exposed to each Aβ preparation (Prep B, C,
and S) at a final concentration of 20 µM (Figure 5.3A). The Aβ peptide was
directly injected into the AFM fluid cell and an image was taken immediately upon
injection to ensure that the injection process did not damage the lipid bilayer.
AFM imaging was resumed after ~ 16 h of co-incubation. All AFM images
presented were taken within ~16-20 h of exposure to each Aβ preparation
(Figure 5.3A).
Upon exposure of a TBLE bilayer to 20 µM of Aβ from each Aβ
preparation, stable and relatively immobile oligomers and fibrils appeared on the
TBLE bilayer. These aggregates were associated with regions of the bilayer that
had increased surface roughness, indicating that the aggregates had disrupted
the bilayer structure. Aβ from Prep B predominantly aggregated into a large
number of small oligomeric aggregates with a few short fibrils present. Prep C led
to a large number of oligomeric aggregates on the bilayer surface and a smaller
number of fibrils. When TBLE bilayers were exposed to freshly prepared aliquots
of 20 µM Prep S, which has been previously observed in the literature,10,11 as
well as in Chapters 3 and 4, the peptide readily aggregated into oligomers and
fibrils on the TBLE bilayer.
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Each fibril growth condition promoted the formation of Aβ oligomers on
supported TBLE bilayers. Correspondingly, oligomer heights were analyzed via
AFM image analysis (Figure 5.3B), and oligomers were defined morphologically
as before. However, it is possible that oligomers observed here are not solely
comprised of Aβ and may contain some lipid components. Prep B formed small
oligomers of Aβ on the bilayer with an average height of 2.16 ± 1.32 nm with a
mode of 0.5-1.5 nm. Due to the presence of some larger oligomers and a
broader distribution of oligomer size, the average height of Prep C was larger in
the presence of the TBLE bilayer (3.27 ± 1.56 nm with a mode of 2.5-3.5 nm).
While the majority of oligomers formed by Prep S were small (mode of 0.5-1.5
nm), there appeared to be two populations of oligomers with a significant number
of oligomers larger than 5 nm in height. As a result, oligomers of Prep S had an
average height of 3.36 ± 2.33 nm. Prep B formed the smallest oligomers on the
bilayer, but these were very similar to the smaller subpopulation of oligomers
formed by Prep S. Prep C formed an intermediate size of oligomer with a broad
distribution.
In comparing oligomers formed in free solution or in the presence of the
bilayer, several interesting observations should be noted. Oligomers formed by
Prep B were similar in height and distribution, but the mode of the height was
slightly smaller in the presence of the bilayer, which may suggest partial insertion
into the bilayer. The size of oligomers formed by Prep C was much larger on the
bilayer than in free solution (3.27 ± 1.56 nm and 2.16 ± 0.95 nm respectively)
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Figure 5.3: Fibril growth conditions influence Aβ interaction on lipid bilayers. (A)
In situ AFM images of Preps B, C, and S exposed to TBLE for 16-20 h. Scale bar is for
all AFM images. Note that the color scheme for each image is different. Arrows
indicate oligomers (pink) and fibrils (blue). (B) Height histograms of oligomers on
TBLE are shown. (C) Histograms of the average height along the contour of the fibril
in the presence of TBLE bilayers are presented. (D) Correlation plots of the contour
length to the end to end distance of fibrils are shown. Dashed line represents the
theoretical correlation for rigid structures with infinite persistence lengths.
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suggesting that a different oligomer species is formed, perhaps due to the
incorporation of lipid components directly into the oligomer structure. Neither of
the subpopulations of oligomers corresponds directly with the oligomers formed
by Prep S in free solution, again suggesting a different oligomer structure in the
presence of the bilayer.
Fibril formation on TBLE bilayers was observed for each peptide
preparation in this study. The fibril morphologies seemed to vary slightly (Figure
5.3C and D). As seen in the free solution experiments, the time frame required
for fibril formation varied between 24-72 h for each Aβ preparation. For the
experiments on the TBLE bilayer, the time frame for fibril formation decreased to
~16-20 h. This reduction in time required for fibril formation suggests the lipid
bilayer facilitates fibril formation for each of these Aβ preparations. Prep B fibrils
had an average height of 1.55 ± 1.10 nm with a mode of 1-2 nm (Figure 5.3C).
Prep C aggregated into short, thinner fibrils with an average height of 1.87 ± 0.99
nm with a mode of 1-2.5 nm. Prep S formed much larger fibrils on the bilayer
than the other preparations average height 5.08 ± 2.38 nm with a mode of 3.5-5
nm (Figure 5.3C). The fibrils formed on the bilayer had shorter persistence
lengths and a large distribution from the theoretical line for a rigid structure
indicating more curvature and less rigidity than the fibrils formed in free solution
(Figure 5.3D). Prep B formed the thinnest fibrils on a lipid bilayer surface, while
Prep S formed the thickest. The thin fibrils of Prep C were much smaller than
fibrils of Prep S on the bilayer. While the average height of Prep C was similar to
Prep B, Prep C had a much smaller mode.
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Similar to oligomers, there were distinct differences in the morphologies of
fibrils observed in the presence of the bilayer in comparison to those formed in
free solution. In Prep B, elongated, curly fibrils were present that differ in
morphology than those formed in free solution. In free solution, fibrils of Prep B
had a more rigid morphology than those formed on the bilayer suggesting that
Prep B aggregated into distinct polymorphic fibrils on the bilayer surface. Prep S
had the thickest fibrils on both a TBLE bilayer and in free solution, both being ~5
nm. On the bilayer, the fibrils of Prep S became smaller and less rigid with a
slight decrease in average height and mode than in free solution. This
observation is similar to what was shown by measurements of Prep C fibrils on
the bilayer. This may imply possible insertion of Prep C and Prep S fibrils into the
bilayer surface due to the decreased height and smaller mode measured.

5.3.3 Aβ prepped by different protocols alter bilayer morphology
In order to determine the extent of interaction of each distinct Aβ
preparation with the bilayer, the surface roughness and percent surface area of
bilayer disrupted containing aggregates was calculated from in situ AFM images
(Figure 5.4) using imaging processing software. Each Aβ preparation had a
strong interaction with the lipid bilayer, and the fraction of the bilayer surface area
that was disrupted by each preparation was similar in magnitude. For Prep B,
42.51 ± 5.11% of the bilayer surface area exhibited increased disruption, while
Prep C and S showed a bilayer surface area of disruption to be 37.28 ± 2.70%
and 36.14 ± 3.01% respectively (Figure 5.4A). While the regions of bilayer
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disruption for Preps B, C, and S, had different aggregate morphologies, there
was no significant difference in the measured percent surface area of bilayer
disruption. Although, the percent surface area of bilayer disruption was similar
after exposure of Preps B, C, and S, the resulting surface roughness with bilayer
disruption varied. A freshly formed, near defect-free TBLE bilayer has a RMS
surface roughness of 0.22 ± 0.07 nm (Figure 5.4B). RMS roughness
measurements of the areas of the destabilized bilayer were restricted to areas of
the AFM images that contained disrupted regions. RMS measurements are an
indirect measure of bilayer structural order. RMS was measured from AFM
images after ~16-20 h of exposure to each Aβ preparation. Significant bilayer
roughening (p<0.01) occurred after exposure to Prep B with an increased surface
roughness of 2.33 ± 0.17 nm. Prep C had significant (p<0.01) roughening of the
bilayer with a RMS surface roughness of 5.03 ± 0.50 nm. Lastly, disrupted
portions of the bilayer from Prep S displayed significantly (p<0.01) increased

Figure 5.4: Quantification of lipid
bilayer roughening. (A) Percent
area of TBLE bilayers containing
increased roughness induced by Aβ
is presented. Exposure to each Aβ
preparation resulted in similar bilayer
disruption.
(B)
Quantitative
assessment of bilayer disruption by
RMS roughness of AFM images after
exposure to various Aβ preparations.
TBLE that had not been exposed to
any peptide acts as the control. Aβ
exposure
induced
significant
roughening in comparison to the
TBLE bilayer and amongst each
preparation. (* indicates p<0.01)
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RMS surface roughness (13.04 ± 1.11 nm). Prep S resulted in the largest RMS
surface roughness of all the preparations. This large surface roughness is due to
the presence of large size of oligomers and fibrils that interacted with the bilayer
promoting disruption.

5.3.4 Aβ prepped by different protocols alter the local mechanical properties of
TBLE bilayers
To study how different Aβ preparations affect the local mechanical
properties (i.e. adhesion and compressibility) of a supported TBLE bilayer, the
specialized AFM technique SPAM was used.12 As explained in Chapter 1, SPAM
recovers the time-resolved tip/sample force that is associated with each tapping
event while a tapping mode AFM image is taken. The forces experienced
between the tip and sample during one tapping event are comprised of two
specific components, Fmax and Fmin. Fmax is defined as the largest repulsive (or
positive) force and responds to the compression modulus of the sample, while
Fmin is the largest attractive (or negative) force that represents the adhesive
properties of the surface with respect to the AFM probe tip. With this, SPAM can
be used to help map the mechanical properties of a sample with high resolution
while using the AFM to acquire images as seen in Chapters 2 and 4.13,18
As shown in Figure 5.4, Prep B, C, and S disrupted regions of the bilayer
with varied roughness. Spatially resolved forces maps (Fmax and Fmin) were
generated which correspond to topographical AFM images of bilayer exposed to
Aβ for 16 – 20h (Figure 5.5). In the force maps, there is contrast between the
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event histograms of Fmax and
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every tapping event. For all Aβ
fibril growth preparations, the
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Aβ
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bilayer promoting disruption, a
smaller magnitude of Fmax and
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Figure 5.5: Various Aβ preps cause disruption
of TBLE bilayers, which alter the local
mechanical properties of TBLE bilayers.
Topography, Fmax, and Fmin images of TBLE
bilayers exposed to (A) Prep B, (B) Prep C, and
(C) Prep S, were obtained using SPAM.
Histograms of every tapping event (right of
images) for Fmax and Fmin illustrate the
undisrupted bilayer and the disrupted bilayer
region. The histograms were sorted based on the
AFM topography image.
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the AFM tip (based on Fmin). The shifts in Fmax and Fmin for Prep B and C were
relatively small, while Prep S had a more substantial shift. When compared with
the RMS measurements seen in Figure 5.4, the larger changes in the mechanical
properties of the bilayer exposed to Prep S may correspond to the larger induced
roughness of the surface, as this may imply a more disordered lipid bilayer.
Overall, these observations indicate the interaction of Aβ prepped under specific
fibril growth conditions and TBLE bilayers results in increased bilayer surface
roughness and a change in mechanical properties (decrease in Young’s modulus
and reduced adhesion between the tip and surface).

5.4 Discussion
In this study, various preparations of Aβ were used to determine the
impact of peptide history on its interaction with fibril growth in the presence of
TBLE bilayers. The interaction of the unique aggregates formed on a model lipid
membrane was investigated. The ability of Aβ to form different types of
polymorphic aggregate structures or deposits, has been shown to have a strong
correlation with the onset and severity of disease, and may underlie the
variations observed in AD pathology.19 Prep A, B, C, and S of Aβ were shown to
form distinct polymorphic aggregates in free solution. Prep B, C, and S also
resulted in different aggregate species when exposed to TBLE bilayers, and
these aggregates were different than those observed under free solution
conditions. When supported TBLE bilayers were exposed to Aβ under specific
fibril growth conditions (Prep B, C, and S), changes in the stability of the bilayer
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(disruption) as well as distinct aggregation patterns were observed. Despite the
differences in aggregate morphology formed in the presence of the bilayer and
induced bilayer roughness, the extent of interaction of Aβ with the bilayer was
similar for all three preparations (as measured by the fraction of the bilayer
displaying altered morphology). While all of the preparations increased the
compressibility of the bilayer, Prep S, which caused the greatest increase in
surface roughness, had a larger effect on bilayer mechanical properties. These
results suggest the change in mechanical properties may be due to how lipid
components in a bilayer respond to protein aggregation, indicating the packing
efficiency of the lipid components to be affected causing a rougher bilayer to form
that is more easily compressible. These studies provide insight into the role of
fibril growth conditions and Aβ peptide preparation on polymorphic aggregates
and their interactions with lipid membranes.
The various preparations used in this study are just a few of the commonly
used Aβ preparation protocols for fibril formation within the literature. The two
main protocols used in this study to form Aβ are from the LaDu and Wetzel labs.
The LaDu group uses HFIP and then DMSO for removing pre-existing
aggregates,9 while the Wetzel group was able to remove DMSO from the
preparation by using other volatile solvents such as HFIP and TFA for
disaggregation. The Tycko group has also identified high dependence of fibril
morphology on precise growth conditions.6 The morphology of Aβ aggregates is
sensitive to subtle differences in fibril growth conditions (i.e. temperature, buffer
composition, pH, monomer disaggregation). With each preparation of a peptide
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forming such distinct polymorphic structures as seen in the mentioned studies, it
leads to the question: which preparation is most relevant to disease for use in
experiments? The large number of disaggregated monomer preparations, as well
as fibril growth conditions, can lead to ambiguity and confusion within the
literature. For example, the observation of pores by Aβ, which are considered a
potential mechanism for toxicity, could be partially due to peptide preparation.
Aβ-induced pores result in a flux of Ca2+ ions and have been shown to cause cell
death due to Aβ binding to lipid membranes. Although this mechanism has been
studied at length,20-26 it is important to question that these interactions may solely
be due to the protein preparation. As seen in this chapter, the chemical
environment and growing conditions for Aβ aggregates have lead to an increased
variability in the properties of Aβ aggregates, in particular it has greatly
influenced the formation of polymorphs and also affected the interaction of
aggregates with a supported TBLE bilayer.
Recently, polymorphic Aβ aggregates have been shown to behave like
prions at both the molecular level and in mouse models. It is argued that selfpropagation of protein aggregates plays a central role in neurodegenerative
diseases.27,28 A feature of prion disease is the ability for misfolded prion protein
(PrP) to travel from an infected cell to a naïve cell. When in contact with a naïve
cell, the infectious or Scrapie form of prion peptide (PrPSc) propagates protein
misfolding by converting encountered normal prion protein (PrPC) to PrPSc.29
Prion-like infectivity has been demonstrated in transgenic mice by intracerebral
injection of mouse or human AD brain material that initiate Aβ pathology (induce
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amyloid plaque formation),30 as well as microinjections of mutant human tau
protein induce misfolding of endogenous tau in mice.31 By monitoring Aβ
deposition in live mice using bioluminescence imaging, Aβ aggregates have been
shown to demonstrate widespread cerebral β-amylodiosis in transgenic mice
induced by inoculation of purified Aβ and synthetic Aβ suggesting that “Aβ prions”
spread throughout the brain in a manner analogous to PrP prions.28 These
observations suggest that there may be a “prion-like” mechanism in the formation
of polymorphic aggregates of Aβ.
The discrete conformations, or strains, of prion aggregates that induce
different disease phenotype have been observed in mammalian32,33 and yeast3436

systems. Such strain effects in prions demonstrate the importance of

polymorphic aggregate structures of the same protein in varying pathogenicity.
Here, polymorphic aggregates (oligomer and fibril) of Aβ are shown to be present
based upon the growth conditions and initial peptide preparation in both free
solution and on a TBLE bilayer. When fibril formation is determined based upon
preparation and used to seed new aggregate growth in the same conditions, a
unique fibril polymorph is isolated in these conditions. The important question to
ask is if these distinct polymorphic aggregates play differing roles in AD and if
conditions within the brain associated with aging create the right environment to
induce pathogenic aggregation of Aβ. A potential environmental factor present in
the brain is lipid membranes, and it has been shown that lipids can stabilize toxic
Aβ aggregate species and even revert non-toxic Aβ aggregates into toxic ones.37
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The aggregation conditions and Aβ preparations studied here demonstrate
how easily Aβ aggregation is impacted by environmental factors. With alterations
in

temperature,

buffer

composition,

agitation

and

the

initial

monomer

disaggregation, polymorphic aggregate formation was shown to heavily influence
lipid bilayers and to promote various degrees of bilayer disruption. In correlation
with data observed with Aβ mutations and fragments, it is tempting to speculate
that chemical environments of lipid membranes in correlation with the various Aβ
preparations, add another factor into influencing polymorphic aggregates of Aβ.
Different polymorphs of Aβ have been proposed to be associated with variations
in AD phenotype, similar to strain effects with prion disease. With this, the
variations in AD pathology may be caused by the ability of Aβ to form
polymorphic aggregate structures.
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6. Outlook: Future studies of Aβ aggregation in association with
the onset of Alzheimer’s disease

The studies presented in this dissertation were aimed at explicating the
interactions of Aβ (i.e. specific amino acid sequences, point mutations in the
central hydrophobic core) with surfaces, and in particular supported lipid
membranes. With its ability to physically interact with biological complexes while
imaging with nanoscale resolution, AFM was an essential tool used in the studies
presented here. Under near physiological conditions, physicochemical properties
of biological samples can be determined through the interaction of the cantilever
probe tip with the sample surface. The overall goal of this project was to provide
a better understanding of distinct Aβ interactions to aid in deciphering the
potential pathways of Aβ toxicity associated with AD.
6.1 Introduction
As Aβ in a physiological or cellular environment is exposed to a variety of
surfaces, one of the goals of this study was to elucidate how surface interactions
dictate aggregate structure, as surfaces may play a role in the formation of
potentially toxic aggregates associated with AD. With respect to surfaces, a
potentially relevant environmental factor regulating Aβ aggregation is lipid
bilayers. The fluid surfaces provided by lipid bilayers are well-known to influence
protein structure and dynamics, which can nucleate the aggregation process.
Importantly for AD, lipid bilayer properties alter protein conformation and exert
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enormous influence on the aggregation state, as substantial enhancement of Aβ
aggregation is observed in the presence of lipid membranes.1-5 While cellular
membranes may act to aid protein aggregation,6-8 these same membranes may
be damaged by the aggregation process, leading to membrane dysfunction
caused by membrane permeabilization by Aβ either perturbing bilayer
structure9,10 or by forming unregulated pores.11-14 While several physicochemical
aspects of membranes (such as phase state, curvature, charge, and elasticity)
associated with lipid composition play an important role in specific peptide/lipid
interactions, these interactions are also dependent on protein properties.
Understanding the basic interaction between Aβ and lipid membranes could lead
to a better understanding of Aβ aggregation associated with cellular membranes.
In Chapter 2, the influence several amyloid proteins have on lipid
membrane mechanics was investigated through numerical simulations and the
specialized AFM technique SPAM. This study determined the morphological and
mechanical changes associated with exposing lipid bilayers to amyloidogenic
proteins. The similar physical impact on bilayers of these amyloid-forming
proteins suggests that this may represent an intrinsic amyloid/lipid interaction
with potential implication for a common toxic mechanism. In Chapter 3, the
addition of disease-related point mutations (Arctic, Italian, Iowa, and Flemish)
can directly lead to distinct polymorphic aggregates of Aβ in the presence of
surfaces (mica and TBLE bilayer), suggesting that electrostatic and hydrophobic
interactions between the peptide and surface strongly influence the aggregation
process. While several physicochemical aspects of membranes (such as phase
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state, curvature, charge, and elasticity) associated with lipid composition play an
important role in specific peptide/lipid interactions, these interactions are also
dependent on protein properties. The aim of Chapter 4 was to aid in
understanding the basic interaction between specific amino acid sequences
(fragments) of Aβ with lipid membranes in order to better understand Aβ
aggregation associated with cellular membranes. Although surfaces influence
conformational changes of Aβ, chemical preparation also plays a critical role and
is associated with the formation of polymorphic aggregates of Aβ as seen in
Chapter 5. Together, these studies provide insights into how specific Aβ
polymorphs may play an important role in disease pathology, as well as to
elucidate the role of surfaces in promoting or inhibiting Aβ aggregation to further
prove useful in the development of novel therapeutic strategies.

6.2 AFM as a tool in studying Alzheimer’s disease
AFM has become a standard imaging technique for exploring diseaserelated protein aggregation in three dimensions with nanoscale spatial resolution.
In studying protein conformational diseases that cause neurodegeneration, AFM
provides the ability to directly image biological processes and track important
morphological changes dynamically under near physiological conditions. Shown
in Chapters 2-5, AFM has the ability to differentiate between polymorphic
structures of Aβ, as well as determine the overall influence amyloid-forming
proteins have with surfaces. These studies provided a deeper understanding into
the toxic mechanisms associated with Aβ aggregation in AD.
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6.2.1 Effect of age-related changes in mechanical properties of lipid membranes
associated with Aβ aggregation
The association between cellular membranes and Aβ potentially
constitutes an initial step in mechanisms associated with Aβ toxicity. As shown in
the studies described in this dissertation, understanding the interaction between
lipid membranes and Aβ provides insight into the initial association of Aβ with
membranes. Membranes changes are thought to be heavily associated with
aging, a primary risk factor in AD, which can increase the susceptibility of a lipid
membrane to Aβ aggregation and binding. An important aspect of aging within a
cell is the production of reactive oxygen species (ROS) promoting oxidative
damage/stress. Developed by Harman,15 the “free radical theory” also known as
the “oxidative stress hypothesis,” has been proposed as a means to understand
aging within a cell. This theory simply states that aging results in damage
generated by the production of ROS. The main tenet of this hypothesis is that
accrual of molecular oxidative damage, induced by ROS, is the main causal
factor underlying loss in physiological function.16 In AD brains, lipid peroxidation
and Aβ oligomer accumulation is evident near damaged cells membranes.17
The accumulation of cholesterol is another age-related mechanism
associated with AD that is shown to alter the mechanical properties of a
membrane. The brain is the most cholesterol-rich organ in the human body.18,19
Influencing the development of AD, alterations in cholesterol levels promote the
cleavage of APP into amyloidogenic components accelerating neuronal
degeneration.18 Aβ distribution within cholesterol rich membranes and synthetic
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lipid membranes decreases when cholesterol levels are reduced. Cholesterolinduced elevations in Aβ aggregate formation and binding lead to neurotoxicity
and AD pathogenesis.19
In Chapters 2-5, the applicability of mechanical measurements in studying
Aβ/lipid interactions is demonstrated in depth. Recently, studies have shown the
ability to map the mechanical properties of lipid membranes with cholesterol
illustrating how mechanical properties of TBLE bilayers change as a function of
cholesterol content.20 It would be interesting to determine if Aβ's interaction with
lipid membranes can be modulated by changing bilayer mechanical properties by
oxidative damage and/or cholesterol content to mimic age-related alterations in
cellular surfaces. Such a study would be facilitated by the SPAM technique and
may elucidate that subtle mechanical changes in membranes can increase their
susceptibility to Aβ binding and aggregation.

6.2.2 Determining mechanical changes in neuronal cells due to Aβ binding and
toxicity
Another potential study that would be interesting to perform would be how
cellular surfaces of neuronal cells will be altered by Aβ binding. The proposed
study above incorporated the effects of specific alterations to model membranes
that mimic aging on Aβ binding and aggregation on the lipid surface. Similar
treatments may be applicable in inducing age-related changes in neuronal cells
and further measuring Aβ binding and toxicity. It has been shown that Aβ binding
to a cellular surface appears to be essential for toxicity and has detrimental
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effects on membranes.21 It is important to note that Aβ has been shown to
selectively bind a subset of cells in homogenous cell culture when added
exogenously.7 This selective interaction of Aβ to a subset of cells suggests that
there are specific characteristics of cells that make them particularly vulnerable
or resistant to Aβ binding and toxicity. As a result localized surface properties,
(i.e compressibility, charge, and rigidity) may influence the ability of Aβ to attach
to cellular surfaces. Recent observations have demonstrated that neuronal cells
can be sorted based on Aβ being able to bind the lipid membrane of the cell,
resulting in a subpopulation of cells that are either resistant or sensitive to Aβ
binding.7 By systematically mimicking age-related cellular changes in neuronal
cells with chemical treatments, local cellular mechanical properties associated
with these changes can potentially be correlated with susceptibility to Aβ binding
by a combination of AFM and cell sorting.

6.3 Concluding remarks
The overall results presented in this dissertation provide a detailed
understanding of the physicochemical aspects and mechanisms of Aβ selfassembly and how Aβ aggregates vary further influencing surface interactions in
relation to the onset of AD. These studies illustrate the versatility of AFM and
how its ability to image biological complexes, as well as to physically interact with
the surface, make it the optimal technique in studying amyloidogenic protein
aggregation at interfaces. SPAM, a specialized AFM technique, allowed for the
mapping of surface properties at the same rate of scanning as tapping mode
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AFM, while tracking the physicochemical mechanical changes of the lipid
membrane due to amyloid-forming protein aggregation. Using SPAM, a general
trend for amyloid diseases was proposed suggesting that changes in membrane
mechanical properties occur due to amyloid-forming protein aggregation. In
particular, Aβ was studied at length to elucidate the effects of its aggregation.
Point mutations of Aβ around positions 21-23 were shown to alter: rates of Aβ
aggregation, polymorphic fibrillar structures, interaction with surfaces, and
insertion into model lipid membranes by changing hydrophobicity, propensity to
form specific secondary structures, and the charge following the missense
mutation. Moreover, specific amino acid sequences within Aβ (fragments), (i.e.
residues 16-23 and 30-35) were determined to play a major role in Aβ
aggregation and binding to model membranes and the subsequent changes in
mechanical properties of the membrane. To further study the effects of Aβ
aggregation and interaction with surfaces, TBLE bilayers were exposed to
various chemical preparations of Aβ. Each peptide preparation protocol resulted
in polymorphic aggregate structures, which promoted membrane disruption and
altered bilayer morphology.
The results of these studies strongly indicate that Aβ binding to and
subsequent aggregation on lipid membranes is influenced by a variety of factors
including hydrophobicity, amino acid sequence, peptide preparation, as well as
membrane properties. The next important step is to translate these fundamental
properties of the Aβ/lipid bilayer interaction into cellular models to determine if
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basic properties of cellular membranes dictate their susceptibility to Aβ binding
and related cellular toxicity.
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